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Abstract  	  
Aging has become a major challenge for Western countries, as it is estimated 
that two-thirds of all deaths are related to age-associated diseases. This includes 
cancer, diabetes, neurodegenerative disorders, cardiovascular diseases, etc. Biological 
aging is defined as the progressive loss of function over time, and even though the last 
decades of research have shed light upon many cellular processes involved in aging, 
many mechanisms remain to be understood.  
Cellular quality control mechanisms have been implicated in aging, as proteins 
involved in these are altered during biological aging. Thus, cellular processes become 
dysfunctional and normal growth is impaired. The different compartments of cells 
each have distinct quality control mechanisms to ensure a rapid turnover of proteins, 
cellular structures and lipids. This includes the mitochondrial unfolded protein 
response, the endoplasmic reticulum unfolded protein response, the cytosolic heat 
shock response and autophagy. Protein quality control is an essential mechanism to 
maintain protein homeostasis. Additionally, it has been found to be associated with 
aging in a wide range of organisms from yeast to mammals.  
The endoplasmic reticulum is the major site for lipid biosynthesis, protein 
maturation and membrane synthesis. Because of its essential role in protein 
maturation, the endoplasmic reticulum has a vastly developed protein quality control 
system, which ensures re-folding or degradation of mis- or unfolded proteins. Some 
of these pathways, such as the endoplasmic reticulum associated degradation 
pathways and the endoplasmic reticulum unfolded protein response pathways have 
been linked to aging. Additionally, autophagy has been suggested to play a role in 
compartment-specific protein homeostasis. Recent studies have further indicated that 
these pathways are essential for normal lifespan, and more importantly, that long-
lived organisms have elevated activity of one or more of these pathways. This led us 
to ask whether selecting for mutants with improved protein quality control 
mechanisms would confer longevity. 
Indeed, we found that to be true. By performing a forward genetic screen, selecting 
for C. elegans mutants with increased ability to cope with tunicamycin-induced 
endoplasmic reticulum stress, we identified four independent gain-of-function 
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mutations in glutamine-fructose-6-phosphate amino-transferase 1 (gfat-1) that led to 
lifespan extension. GFAT-1 regulates the rate-limiting step of the hexosamine 
pathway, which uses fructose-6-phosphate from glycolysis to synthesize UDP-N-
Acetylglucosamine (UDP-GlcNAc). UDP-GlcNAc is a precursor for N-glycans. In 
addition, gfat-1 gain-of-function mutants had enhanced activity of different cellular 
degradation pathways, which led to alleviated proteotoxicity of several C. elegans 
models of neurodegenerative disorders, and by supplementing wild type animals with 
GlcNAc (a derivate of UDP-GlcNAc) we were able to mimic the longevity and 
amelioration of toxic proteins observed in gfat-1 gain-of-function mutants. These 
findings suggest novel therapeutic approaches to promote health and extend lifespan 
through endogenous molecule modulation of protein quality control, and hence, might 
be important for future studies of neurodegenerative disorders.  
From the tunicamycin resistance screen, we also identified several long-lived 
mutants with defects in the chemosensory system. Such deficiency has previously 
been associated with longevity. These mutations also have improved protein quality 
control mechanisms, as they had decreased levels of aggregated proteins in the 
endoplasmic reticulum upon introduction of an unstable endoplasmic reticulum 
resident protein. In addition to the screen, we also found a handful of wild C. elegans 
isolates with improved ability to cope with tunicamycin-induced endoplasmic 
reticulum stress. Together, these studies may shed light upon novel mechanisms to 
modulate endoplasmic reticulum quality control mechanisms and induce longevity. 
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Zusammenfassung  	  
In westlichen Ländern ist das Altern eine große Herausforderung, da bis zu 
zwei Drittel aller Todesfälle auf altersassoziierte Erkrankungen zurückzuführen sind. 
Altersasasoziierte Erkrankungen beinhalten Krebs, Diabetes, neurodegenerative 
Erkrankungen, Herz-Kreislauf-Erkrankungen, usw. Biologisches Altern wird als 
progressiver Funktionsverlust über die Zeit definiert. Obwohl in den vergangenen 
Jahren viele dem Altern zugrunde liegende zelluläre Mechanismen erkannt wurden, 
bleiben noch viele Alterungsprozesse unverstanden. 
Die zellulären Mechanismen, die mit dem Alterungsprozess in Verbindung 
gebracht werden beinhalten die Qualitätskontrolle von Proteinen. Die dabei 
beteiligten Proteine verändern sich mit dem Altern. Die verschiedenen 
Zellkompartimente besitzen unterschiedliche Mechanismen zur Qualitätskontrolle. 
Gemeinsam gewährleisten sie die Erhaltung von Proteinen und Lipiden. Dies 
beinhaltet die mitochondriale „unfolded Protein Response“ (UPR), die UPR des 
endoplasmatischen Retikulums, und die cytosolische Hitzeschockantwort, sowie 
Autophagie. Proteinqualitätskontrolle ist ein wichtiger Mechanismus, um 
Proteinhomöostase zu erhalten, und sie spielt im Alterungsprozess von Hefe bis hin 
zu Säugetieren eine wichtige Rolle. 
Das endoplasmatische Retikulum spielt in Lipid-Biosynthese, Proteinreifung 
und Membran-Synthese eine zentrale Rolle. Aufgrund der wesentlichen Rolle bei der 
Proteinreifung hat das endoplasmatische Retikulum eine stark ausgeprägte 
Proteinqualitätskontrolle, die eine Neufaltung oder einen Abbau von falsch gefalteten 
oder ungefalteten Proteinen sicherstellt. Außerdem spielt Autophagie eine wichtige 
Rolle in der kompartimentspezifischen Proteinhomöostase. Neue Studien haben ferner 
gezeigt, dass diese Prozesse für die normale Lebensdauer wichtig sind, und besonders 
in langlebigen Organismen eine essentielle Rolle spielen. Zudem wurde festgestellt, 
dass die Aktivität von einem oder mehreren dieser Prozesse erhöht ist. Deswegen 
stellten wir die Frage, ob gezielte Selektion von Mutanten mit verbesserter Protein-
Qualitätskontrolle Langlebigkeit vermitteln würde. 
Tatsächlich fanden wir heraus, dass dies zutrifft. In einem genetischen Screen, 
der C. elegans Mutanten mit erhöhter Tunicamycinresistenz isolierte, haben wir 
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gehäuft langlebige Mutanten gefunden. Wir identifizierten vier unabhängige „Gain-
of-function“ Mutationen im glutamin fructose-6-phosphat aminotransferase 1 (gfat-1) 
Gen. GFAT-1 ist für den geschwindigkeitsbestimmenden Schritt des Hexosamin 
Biosynthesewegs verantwortlich, der Fructose-6-phosphat aus der Glykolyse 
verwendet, um UDP-N-Acetylglucosamin (UDP-GlcNAc) zu synthetisieren. UDP-
GlcNAc ist ein Vorläufer für die N-Glycane. Zudem hatten GFAT-1 „gain-of-
function“ Mutanten erhöhte Aktivität von verschiedenen zellulären Abbauwege, und 
die Mutation verringerte Proteintoxizität in mehreren C. elegans Modellen von 
neurodegenerativen Erkrankungen. Durch Nahrungesergänzung mit GlcNAc (ein 
Vorläufer von UDP-GlcNAc) konnten in Wildtyp-Tieren ähnliche Verbesserungen 
festgestellt werden. Diese Ergebnisse deuten auf neue therapeutische Ansätze hin, die 
die Gesundheit verbessern, und das Leben verlängern könnten. 
Aus dem Tunicamycinresistenz-Screen isolierten wir weitere langlebige 
Mutanten. Diese zeichnen sich durch Defekte im olfaktorischen System aus. Solche 
Mutationen sind schon vorher mit Langlebigkeit in Verbindung gebracht worden. 
Diese Mutationen verbesserten ebenfalls die Proteinqualität. 
Neben dem Screen identifizierten wir auch einige C. elegans-Isolate aus der 
freien Natur, die sich durch Tunicamyzinresistenz auszeichnen. Gemeinsam zeigen 
diese Studien, dass die Qualitätskontrolle des endoplasmatischen Retikulums zur 
Modulierung des Alterunsprozesses beiträgt und Langlebigkeit induzieren kann. 
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1.A.  Aging and society  	  
Aging is defined as the progressive loss of biological function over time, 
including a decline in cellular homeostasis, making aging a major risk factor for 
multiple diseases including cancer, cardiovascular disease and neurodegenerative 
disorders. Many researchers are searching for “the key to youth”, however, the 
underlying proximal mechanisms of aging and the relative contribution of various 
defense mechanisms essential to longevity remain elusive.   
In Western countries, the demography phenomenon is characterized by a 
decreased fertility, a deceased mortality, and an increased life expectancy (Costello, 
2007) (Steyn, 2006). This has led to a major challenge for governments, societies and 
healthcare systems because of the increased incidence of diseases with age. 
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Figure 1.1. The total number of both men and women over 65 is increasing.  
The percentage of all (total), the number of men and of women between 45 and 64 
(left bars) and over 65 (right bars) in 1999-2000 (green) and in 2009-2010 (blue) 
(Virginia M. Freid, 2012).  
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A massive increase in the number of humans over 65 years old has occurred over the 
last 10 years, and this tendency continues (Virginia M. Freid, 2012). In Figure 1.1 the 
number of humans between 45 and 64 (left), and over 65 (right) are shown. It is 
striking to notice that the total number of people (men and women together) over 65 
has increased by almost 10% in only 10 years, from 2000 to 2010. This puts an 
enormous pressure on society since many diseases can be categorized as aging-
associated diseases (AADs). Recent numbers have suggested that approximately two-
thirds of all deaths are related to AADs (Lopez AD, 2006) employing aging as the 
major risk factor for fatalities in general. AADs are diseases whose frequency 
increases with biological aging or cellular senescence, which is the state where cells 
cease to dvivide (Campisi J, 2007). Over the last years, it has been suggested that 
cellular senescence links multiple pathologies of aging, both degenerative and 
hyperplastic. Cells undergoeing senescence is unlikely to explain all aging 
phenotypes, but the role of senescence in AADs should not be ignored. Examples of 
AADs include cancer, cardiovascular diseases, diabetes, arthritis, and 
neurodegenerative disorders, which constitute the major reasons for death in the 
Western world (Lopez AD, 2006). Together, as the human population is getting older 
and AADs accounts for the major deaths, modern society faces aging as a huge and 
expensive challenge. Research targeting cellular senescence and biology of aging is 
therefore essential to shed light on involved mechanisms, and hold the potential to 
decelerate causes of AADs. 
1.B.  Cellular aging and longevity 
In addition to environmental influences, several genetic components and 
cellular pathways have been shown to modulate the aging process, many of which are 
conserved from simple organisms to mammals. These include dietary restriction 
(DR), reduced insulin/IGF (insulin growth factor) signaling, reduced mitochondrial 
respiration, and signals from the reproductive system (Kenyon C. J., 2010). The last 
decades of research have revealed that these pathways modulate diverse downstream 
processes that decelerate the naturally occurring decline in function and homeostasis 
leading to cellular aging and senescence. Thus, stress resistance, metabolism, quality 
control mechanisms and immunity are involved in life- and healthspan.  
Genetic mutations known to promote long life across a variety of species also 
affect stress response or nutrient sensation (Walford RL, 1987). One example of this 
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is DR, which has been shown to decelerate the aging process in different organisms 
from yeast to higher primates (Colman, 2009). Recent research has aimed to 
understand the exact mechanisms of DR-induced longevity. Earlier it was believed 
that it was caused by a chronic state in which animals experienced life-long hunger. 
However, Mair et al. were able to show that in the fruit fly Drosophila, the lifespan 
extension came from an acute response to DR (Mair, 2003).  
Many other conditions modulate lifespan and life expectancy across various 
species, and in most, if not all cases, aging modulation is not a stochastic process, but 
rather is under tight genetic control (Campisi, 2013). For example, single genetic 
variations in the yeast SIR2 histone deacetylase have been shown to modulate the 
lifespan of budding yeast. Similarly, genetic modifications in higher organisms have 
also been found to impact the aging process; knockdown of the Drosophila gene 
methuselah led to increased lifespan and enhanced stress resistance in flies (Lin Y. J., 
1998), and mutations in the mammalian gene encoding the protein p66shc extend the 
lifespan of mice about 30% (Migliaccio E., 1999), together supporting the evidence 
that single genetic mutations can modulate organismal aging.  
1.C.  C. elegans longevity 
The roundworm Caenorhabditis elegans (C. elegans) is a well-studied 
organism in different aspects of cellular biology and aging. Due to its fast 
development, high fertilization rate and short lifespan (15-20 days post reproduction), 
it is widely used in aging research. Hermaphrodites constitute the majority of the 
population in a reproductively growing laboratory stock, and each worm produces 
200-300 eggs during the first five days of adulthood. After hatching, larvae go 
through 4 larval stages, L1-L4 (L. Byerly, 1976), before reaching adulthood in 72 
hours. C. elegans development and lifecycle is responsive to environmental factors 
including temperature, food availability, and population density. If conditions are not 
optimal, animals may enter one of several alternative stages of arrested development, 
which are specialized for survival under harsh conditions. These include L1 arrest, 
occurring if larvae experience unfavorable conditions upon hatching. Best studied is 
the long-lived dauer diapause, occurring during the third larval stage. These 
alternative states are not mutually exclusive and in theory, a worm can undergo both 
stages sequentially (www.wormbook.org). 
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1.C.1  C. elegans dauer  
The C. elegans dauer stage has been found to display extreme resistance to 
stress and exceptional longevity (Richard L Russell, 1975) (L. Byerly, 1976). After 
the discovery of the dauer larva stage, many genes coupled to dauer entry were also 
found to influence adult behavior and lifespan (Patrice S. Albert, 1988). In 1993 
Kenyon and colleagues reported that single genetic mutations in the dauer-
constitutive gene daf-2 (abnormal dauer formation), the C. elegans homolog to the 
mammalian insulin receptor, extended the average C. elegans hermaphrodite lifespan 
more than 100%. The lifespan extension was dependent on the activity of the fork-
head transcription factor DAF-16 (Kenyon C, 1993), which is also involved in the 
formation of dauer larvae. Environmental and dietary responses are as well coupled to 
conserved molecular and cellular pathways, which play important roles in dauer entry 
and lifespan. These include the neurosensory system, the TGF-β pathway, the 
insulin/IGF pathway, serotonergic pathways, and the steroid hormone signal 
transduction pathways (Nicole Fielenbach, 2008). As these pathways are associated 
with metabolism, growth and survival, regulation of the dauer diapause has been 
coupled to studies involving cancer, cellular growth and aging. When C. elegans 
larvae enter the dauer diapause, their energy metabolism shifts towards a standby and 
energy-saving phase. Specifically, cells are downregulating metabolic processes. For 
example, the activity of the tricarboxylic acid cycle (TCA) that metabolizes fatty 
acids to provide ATP has been found remarkably decreased (Wadsworth W G, 1989). 
Since the discovery of single genetic mutations influencing the dauer decision and 
lifespan extension, many studies have been made to identify other mutations that 
modulate C. elegans lifespan.  
 
1.C.2  Mutations leading to longevity 
Some of the most studied C. elegans mutant animals with extended lifespans include 
the germline-deficient animals glp-1 (abnormal germline proliferation), the DR 
mimick eat-2 (eating: abnormal pharyngeal pumping), the insulin/IGF signaling 
depleted daf-2, and mutations in the mitochondrial coenzyme Q homolog, clk-1 (clock 
biological timing abnormalities)	  (Kenyon C. J., 2010). 
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Decreased energy metabolism is a common phenotype among several long-
lived C. elegans mutants, such as that observed in the mitochondrial mutant clk-1 
(Wong A, 1995). daf-2 mutant animals have also shown decreased mitochondrial 
consumption (own observation).  Loss-of-function (lof) mutations in eat-2 are also 
associated with decreased oxygen consumption and lowered metabolic rates (Bernard 
Lakowski, 1998). Conversely, overexpression of CLK-1 activity in WT worms 
increases mitochondrial activity, accelerates behavioral rates during aging and 
shortens lifespan (S. Felkai, 1999). Together, the reduced respiration found in 
different long-lived mutants suggests that longevity is promoted by decreased 
mitochondrial function, which is conserved among other species (S. Felkai, 1999).  
Another mechanism by which lifespan extension may be achieved in C. elegans is by 
depletion of the germ cells either genetically (i.e., by temperature sensitive mutations 
in the glp-1 gene) or physically using laser ablation (Nuno Arantes-Oliveira, 2002). 
Germline longevity is dependent on the nuclear hormone receptor DAF-12/FXR 
(Nuno Arantes-Oliveira, 2002) and its bile acid-like ligands, the fork-head box A 
(FOXA) transcription factor PHA-4 and DAF-16 (Honor Hsin, 1999), the latter 
modulated by the kri-1 (human KRIT1 (Krev interaction trapped) homolog) (Jennifer 
R. Berman, 2006). The exact mechanisms remain unknown, however, recent studies 
have suggested a correlation between germline longevity and miRNAs (Yidong Shen, 
2012), lipid metabolism and autophagy (Lapierre LR, 2011) and increased 
proteasomal activity (Vilchez D, 2012). Furthermore, TOR (target of rapamycin), 
which in other organisms has been found to modulate the aging process (DE Harrison, 
2009) (Matt Kaeberlein, 2011), was found reduced in glp-1 mutant animals. 
Downregulation of TOR was associated with an increased level of PHA-4, required 
for the enhanced autophagy levels seen in these animals. These results were suggested 
to couple the TOR/PHA-4 pathway to enhanced autophagy in glp-1 mutant animals, 
whereas changes in lipid metabolism were suggested to be under control of DAF-16 
(Lapierre LR, 2011). Downregulation of TOR and subsequent enhanced transcription 
of PHA-4 is also seen during DR in C. elegans, (Panowski SH, 2007), suggesting that 
this is an overlapping mechanism between several long-lived C. elegans mutants. 
 
1.C.3  C. elegans vs. higher organisms 
Many of the genes and mechanisms modulating C. elegans lifespan have also 
	   25	  
been found to play a role in the aging process of higher organisms. This includes 
modulations of nutrient-signaling pathways, such as the insulin/IGF and the TOR 
pathways, suggesting that they may induce a physiological state similar to that 
resulting from periods of food absence (Harrison DE, 2009). Indeed, DR extends 
lifespan of diverse organisms, including yeast, flies, worms, fish, rodents, and rhesus 
monkeys (Walford RL, 1987) (Colman, 2009). In addition, upon TOR-mediated and 
DR-induced longevity, autophagy was found enhanced, and importantly, required to 
sustain the extended lifespan (Jing Cui, 2013) (Malene Hansen, 2008). A knockdown 
of components of the autophagic pathway in the remarkably long-lived C. elegans 
strain daf-2 abrogates its long lifespan (Hars ES, 2007), suggesting that autophagy 
plays an essential role in longevity, at least in C. elegans (Alicia Meléndez, 2003). 
This was again supported by similar observations in glp-1 and eat-2 mutant animals, 
where inhibition of autophagy decreased longevity (Malene Hansen, 2008) (Lapierre 
L.R., 2011). In Drosophila, inhibition of mTOR signaling extends lifespan, as it does 
in yeast and C. elegans (Kapahi P, 2004), but there is no evidence in flies for a role of 
autophagy as aging-modulator. In mice, pharmacological approaches using 
resveratrol, spermidine and rapamycin, an mTOR inhibitor, provide an indication that 
activation of autophagy, as well as other processes, may be associated with longevity 
in higher organisms (Eisenberg T, 2009) (Lagouge M, 2006) (Harrison DE, 2009). 
And recently, research by Pyo and colleagues shows that overexpression of Atg5 in 
mice activated autophagy and extended their lifespan (Jong-Ok Pyo, 2013), again 
indicating that autophagy plays an important role in longevity. 
1.D.  Cellular quality control mechanisms 
Resistance to exogenous stress has repeatedly been hypothesized to be 
involved in longevity of mammalian cells (Mullaart E., 1990) (Finch, 1990), since 
exposure to environmental stress causes numerous alterations in cellular and 
extracellular components, resulting in deleterious physiological changes that affect 
longevity (Kirkwood, 1977) (Mullaart E., 1990). Increased resistance to stress, either 
by increased prevention of the initial damage or by improved repair of injurious 
events, leads to reduced damage and increased longevity.  
Many mutations associated with C. elegans longevity have also been found to play a 
role in cellular homeostasis and quality control, leading to resistance to exogenous 
	   26	  
stress. daf-2 mutants, for example, are resistant to heat and oxidative stress (Dillin, 
2008), glp-1 mutants are resistant to bortezomib (proteasome inhibiting drug) 
(Vilchez D, 2012) and clk-1 mutants show higher resistance to mitochondrial 
interruptions (Johnson, 1996). Enhanced ability to handle various stress factors arises 
from increased activity of quality control mechanisms, amplified transcription of 
genes involved in stress resistance and improved DNA repair mechanisms, which are 
important cellular processes implicated in aging and senescence (H. Koga, 2011) 
(Hsu, 2003) (Takashi Tatsuta, 2008).  
 
1.D.1  Protein quality control 
Quality control is an evolved ability for the cells to remain “healthy” and to 
ensure a clean environment. Cells possess specialized pathways to protect against 
DNA damage, and to turn over and degrade redundant and dysfunctional organelles 
and proteins. The latter include the ubiquitin-proteasome system (UPS), the 
mitochondrial unfolded protein response (UPR), the endoplasmic reticulum (ER) 
UPR and autophagy (L D Osellame, 2013). Lately, autophagy, which by degrading 
proteins and damaged organelles is involved in cellular quality control, has been 
suggested to be organelle specific, such as pexophagy, reticulophagy, ribophagy and 
mitophagy (Sebastián Bernales, 2006) (Dunn WA, 2005) (Kraft C, 2008) (Kim I, 
2007). Furthermore, chaperone mediated autophagy (CMA), which turns over 
proteins containing a specific motif, has become better understood, and is implicated 
in cellular homeostasis (Cuervo AM, 2004). What these quality control pathways all 
have in common is that they are all implicated in various diseases, including AADs; 
dysfunction of one or more of these mechanisms induces or increases the incidence of 
disease, particularly neurodegenerative disorders and lysosomal dysfunctions (L D 
Osellame, 2013). Additionally, senescent cells experience a decrease in the activity of 
these processes, also increasing the risk of cellular dysfunctions due to altered quality 
control (Hsu, 2003).  
A major cellular quality control mechanism involved in biological aging is 
protein quality control; maintaining protein homeostasis is essential for optimal 
protein performance and to sustain cellular functions (H. Koga, 2011).  Protein quality 
control mechanisms constitute a major regulatory output of longevity pathways, and 
many AADs are associated with a decline in protein homeostasis (Jason E. Gestwicki, 
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2012). This is particularly associated with neurodegenerative conditions, which stem 
largely from a failure to properly handle protein misfolding, aggregation and toxicity 
(Kimura, 2007). The protein homeostasis network is required under normal conditions 
to support chaperone-assisted protein folding and suppression of aggregate formation 
(W. E. Balch, 2008), however, their importance is more clearly recognized in stress 
conditions, during biological aging, and conformational diseases (Barral, 2004). In 
terms of biological aging, work in C. elegans and Drosophila has suggested that 
molecular chaperones directly control longevity. Knockdown of the major heat shock 
factor, hsf-1, in C. elegans reduces longevity (James F. Morley, 2004). Additionally, 
disruption of the mitochondrial UPR by inhibition of hsp-70 (heat shock protein 70) 
promotes a progeria-like phenotype (Hsu, 2003) (Kimura, 2007) suggesting 
dependence for protein quality control in lifespan of C. elegans. On the other hand, 
overexpression of HSF-1 promotes longevity in both C. elegans (Hsu, 2003) and 
mouse models, which have also been linked to alleviated proteotoxicity (Mitsuaki 
Fujimoto, 2005). Additionally, numerous heat shock proteins, such as HSP-16, HSP-
70, HSP-27 and mitochondrial HSP-70 have been shown to be directly related to both 
C. elegans and Drosophila lifespan (Tatar, 1997) (Yokoyama, 2002). In mammals, 
molecular chaperones also seem to be required for protein homeostasis. Studies 
involving Hsf1 knock-out mice suggest that Hsf1 is required to protect against 
demyelination and gliosis that can occur during WT aging (Homma, 2007). 
Additionally, mutations in molecular chaperone genes, such as Hsf4, sHsp, and α-B-
crystallin, have been associated with AADs, such as cataract formation, desmin-
related myopathy, and distal motor neuropathy (Bu, 2002) (Vicart, 1998). Lastly, Min 
et al. showed that inhibition of the ubiquitin ligase/cochaperone, CHIP, whose normal 
function in mice is to target proteins for degradation via the UPS, led to accelerated 
aging due to altered protein quality control (Jin-Na Min, 2008).  
 
1.D.2  Mitochondria protein quality control 
Reactive oxygen species (ROS) are generated as a result of oxygen 
consumption by the electron transport chain in the mitochondria. ROS is detrimental, 
and causes cellular damage. For this reason, the mitochondria contain specific protein 
quality control systems (Murphy, 2009). Mitochondrial protein quality control 
mechanisms keep mitochondrial proteins functional until the damage is not 
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influencing the proteins and components of the system. When cells undergo stress, 
induced by misfolded proteins, the mitochondrial UPR is turned on. Chaperones 
(HSP-6 and HSP-60) localized in the mitochondrial matrix are required for protein 
import, and also facilitate protein folding. On the other hand, proteases that are 
localized in the inner membrane will degrade proteins that fail to fold or assemble 
correctly (Tatsuta T. and Langer, 2008). Tom70 is a receptor essential to the import of 
un- or misfolded proteins, and Hsp90 and Hsp70, were found essential for targeting 
proteins and translocating them to mitochondria. (Jason C. Young, 2003). During 
aging and in neurodegenerative diseases components of mitochondrial protein quality 
control mechanisms, such as the chaperones Hsp90 and Hsp70 as well as the Lon 
protease, become functionally impaired (Van Dyck L, 1994). The Lon protease family 
is a family of proteases located in the mitochondrial matrix which are required for 
mitochondrial function and are suggested to play a role in mitochondrial heat shock 
response since their activity, regardless of their constitutive activation, is enhanced 
after thermal stress. It has also been shown that mitochondria play an important role 
in aging and AADs (Tatsuta T. and Langer, 2008), however, the focus of this project 
has been on ER protein quality control mechanisms. 
1.E.  ER Protein quality control 
The ER is the major site of protein synthesis, lipid biosynthesis, membrane biogenesis 
and various other essential processes. Specifically, the ER is responsible for the 
structural folding and maturation of proteins of approximately a quarter of the 
proteins that cross the secretory pathway (Bernd Bukau, 2006), and therefore contains 
specific protein quality control mechanisms. Protein folding is dependent on a 
multitude of post-translational modifications that occur in the ER. This includes N-
linked glycosylation, disulfide bond formation, lipidation, hydroxylation and 
oligomerization. N-linked glycosylation is an important, ER- and Golgi-specific 
event, which is initiated by the transfer of a core oligosaccharide from a dolichol 
phosphate. The sugar is then transferred from the membrane-bound dolichol 
phosphate to a consensus Asn-X-Ser/Thr residue in the polypeptide of newly 
synthesized proteins (S.C. Hubbard, 1981). The attachment of an N-glycan serves 
several purposes in protein folding. Glycans are hydrophilic molecules and therefore 
increases the solubility of glycoproteins, and defines the surface for potential protein 
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interactions. Additionally, due to their large hydrated volume, they guard the 
attachment area from surrounding proteins, and enable oligosaccharides interactions 
with the peptide backbone and stabilize its conformation. Lastly, it serves as a lectin 
machinery to report on the folding status of the protein (M.R. Wormald, 1999) (L. 
Ellgaard A. H., 2003) (L. Ellgaard M. M., 1999) (Figure 1.2). Together, these 
mechanisms ensure accurate folding and proper maturation of newly synthesized 
proteins.  
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Figure 1.2 Protein maturation in the endoplasmic reticulum (ER).  
Proteins structurally mature in the ER, which involves various processes such as 
formation of disulfide bonds and attachment of complex sugars called N-glycans. If 
WT or mutated proteins initially fold incorrectly, or if the folding process is 
subsequently interrupted, the ER posseses various response mechanisms to maintain 
proper protein homeostasis. This includes induction of ER unfolded protein response 
and ER associated degradation (ERAD). 
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Correspondingly, the ER provides an environment optimized to face 
challenges occurring from mis- or unfolded proteins. This includes a high 
concentration of ER resident chaperones that ensures proper folding as well as 
additional protein quality control mechanisms which coordinate the degradation and 
refolding of mis- and unfolded proteins (E. Anken, 2005) (L. Ellgaard A. H., 2003) 
(Roth, 2010). Various mutant polypeptides or WT misfolded proteins associated with 
human aging and disease are targeted for degradation by an ER protein quality control 
system, which also requires the cytosolic proteasome for degradation (Jeffrey L. 
Brodsky, 1999). Together, the ER protein quality control mechanisms are responsible 
for the removal of mis- and unfolded proteins to ensure protein homeostasis in the 
ER. 
The presence of luminal unfolded proteins triggers the ER UPR, a signaling 
cascade that, among others, results in attenuated translation, enhanced ER associated 
degradation (ERAD), and induced expression of ER-resident proteins such as heat 
shock protein 4 (HSP-4) (P. Walter, 2011).  
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Figure 1.3 The ER Unfolded protein response pathways. 
Un- and misfolded proteins promote a signaling cascade called the unfolded protein 
response (UPR) in the ER. ER UPR consists of three “arms” that are all anchored in 
the ER membrane. Downstream events ensure the transcription of chaperones, ER 
associated degradation components and attenuated translation. The three pathways are 
initially regulated by activating transcription factor 6 (ATF-6), inositol requiring 
enzyme 1 (IRE-1) and protein kinase R-like ER kinase (PERK). 
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The canonical ER UPR pathway consists of three major arms, which all have sensors 
anchored in the ER membrane (Figure 1.3): Activating transcription factor 6 (ATF-6), 
Inositol requiring enzyme 1 (IRE-1) and Protein kinase R-like ER kinase (PERK). In 
resting cells, the three ER stress sensors are associated with the abundant ER 
chaperone BiP (immunoglobulin-heavy-chain-binding protein) on their luminal 
domains. BiP is a member of the heat shock protein 70-chaperone family, and it plays 
a critical role in ER protein folding and quality control. During ER stress, BiP is 
dissociated from the receptors, and prefers binding to un- or misfolded proteins 
initiating one of the three main signaling branches of the UPR (Jingshi Shen, 2005) 
(David Ron, 2007). BiP has been found to play an important role in natural aging, as 
well as in lifespan extension. The expression of HSP-4, the C. elegans homolog to the 
mammalian BiP, is altered in aged animals (Rebecca C. Taylor, 2013), and it was 
even shown that BiP/HSP-4 plays a role in dietary restriction-induced longevity in 
both worms and flies (Viswanathan M, 2005) (Hyunsun Jo, 2009). In addition, Chen 
et al. showed that hypoxia inducible factor 1 (HIF-1) is involved in DR mediated 
longevity, and that both hif-1 mutants and DR animals fail to extend lifespan when 
components of the ER UPR are depleted (Di Chen, 2009). Moreover, the ABU 
(activated in blocked UPR) proteins, which are involved in the non-canonical ER 
stress response pathways, were suggested as important components of the sir-2.1 and 
resveratrol-induced lifespan extension pathway (Ya-Lin Liu, 2009). In fact, the ER 
stress response pathways have all been implicated in aging and senescence of distinct 
organisms and cells. 
 
1.E.1  Inositol-Requiring Enzyme 1 
An essential mediator of the ER UPR is IRE-1. Induction of the IRE-1-branch 
of the ER UPR upregulates the expression of genes whose products promote protein 
folding and degradation of misfolded proteins in the ER (Jonathan H. Lin, 2007). The 
role of IRE-1 was first observed in Saccharomyces cerevisiae, where it was found that 
knockdown of IRE-1 almost negated the UPR pathway. In addition, this was 
associated with an attenuation of the expression of a large number of genes including 
ER chaperones, enzymes involved in maintaining the proper oxidizing environment in 
the ER and components of the ERAD pathway. This indicated that IRE-1 is an 
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essential component of the canonical ER UPR pathway (Cox J. S., 1993) (Mori K., 
1993) (Fumihiko Urano, 2000). IRE-1 is a bifunctional enzyme possessing both a 
kinase activity and an endoribonuclease (RNase) activity. Dissociation from BiP 
triggers IRE-1 oligomerization and activation of its RNase activity by trans-
autophosphorylation. Activated IRE-1 induces splicing of mRNA that encodes a 
transcription factor named X-box binding protein 1 (XBP1 in  metazones; in 
yeast it is named Hac1). The splicing occurs by cutting XBP1 mRNA twice, cutting 
out an intron. The two remaining mRNA fragments are then ligated, generating a 
spliced mRNA ready for translation and a subsequent boost of XBP1 protein 
synthesis (David Ron, 2007) (Jingshi Shen, 2005) (Jonathan H. Lin, 2007). XBP1 is a 
transcription factor that when active, induces the transcription of ER UPR target 
genes such as ER chaparones and ERAD proteins (Wu J., 2006).  
In organismal and mammalian biology, IRE-1 and the downstream activation 
of XBP-1 play several essential roles. For example, the pathway is fundamental for 
bone-morphogenic protein-2 induced osteoblast differentiation (Takahide Tohmonda, 
2011), proteasomal and lysosomal degradation (Wei-Chieh Chiang, 2012), cell fate 
determination (Brandizzi, 2013), and has been implicated in longevity (Sivan Henis-
Korenblit, 2010), suggesting a broad and general role in cellular biology for the IRE-
1-branch of the ER UPR. Additionally, this indicates that ER protein quality control 
and protein homeostasis play essential roles in cellular health, and recent research has 
linked the IRE-1 pathway to multiple diseases including metabolic diseases, 
neurodegenerative diseases, inflammatory diseases, and cancer (Wang S, 2012).  
 
1.E.2  Activating Transcription Factor 6 
Another key regulator of the ER stress-induced transcriptional pathway is 
ATF-6. ATF-6 is a transcription factor synthesized as an ER membrane precursor, 
anchored in the membrane of ER. The protein’s C-terminal is located in the ER 
lumen, wheras the N-terminal faces the cytosol – the N-terminal contains the DNA 
binding domain (Min Hong, 2004). Upon sensation of stress and misfolded proteins, 
ATF-6 relocates to the Golgi apparatus membrane, a requirement for its activation. 
Here it is cleaved by the S1P/S2P (site-1 protease/site-2 protease) protease system to 
generate activated ATF-6 (Jingshi Shen, 2005). 
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The translocation from ER to the Golgi apparatus and the subsequent cleavage by 
S1P/S2P is the central step in the activation of ATF-6. The ER chaperone BiP binds 
to the luminal domain when the cells are unstressed – this will block the intrinsic 
Golgi apparatus localization signals. When misfolded proteins accumulate in the ER, 
ATF-6 releases from the BiP association allowing its transport to the Golgi apparatus 
(Kyosuke Haze, 1999).  
When ATF-6 arrives in the nucleus, it functions as a transcription factor and 
binds to sterol regulatory elements (SRE) and ER stress elements (ERSE) (Min Hong, 
2004). Binding to SRE (SRE will be bound to a sterol regulatory element binding 
protein – SREBP) will recruit histone deacetylase 1 (HDAC1) causing an inhibition 
of SRE-mediated transcriptional activation. Activatated ATF-6, together with the 
heteromeric nuclear factor Y (NF-γ), also binds to ERSE and activates the 
transcription of genes involved in ER UPR such as BiP and grp78 (glucose regulated 
proteins 78). Grp78 is an ER chaperone protein that protects cells against stress 
(Jingshi Shen, 2005) (Bertolotti, 2002). 
The ER stress-induced ATF-6 pathway is implicated in deceleration of 
biological aging and cellular senescence since its activation leads to increased 
expression of chaperones involved in protein quality control and induced transcription 
of the transcription factor CHOP (C/EBP homologous protein), which is involved in 
ER stress mediated cell survival and apoptosis (Can E. Senkal, 2009) (Oyadomari S, 
2004).  
 
1.E.3  Pancreatic Endoplasmic Reticulum Kinase 
The third mechanism of the three ER UPR branches that plays a role in ER 
stress responses involves phosphorylation of a subunit of the eukaryotic initiation 
factor 2α (eIF2α), which suppresses translation and thus reduces the folding load in 
the ER. A family of protein kinases, PERK, phosphorylates eIF2α in response to ER 
stress conditions. The release of BiP, in response to mis- or unfolded proteins, allows 
oligomerization and autophosphorylation of PERK. PERK then phosphorylates eIF2α 
at serine 51 (Ruchira SOOD, 2000). eIF-2 undergoes a guanine exchange reaction 
which is carried out by eIF-2B. The phosphorylation eIF-2 leads to inhibition of eIF-
2B activity, reducing the guanine nucleotide exchange and thus the rate of translation 
(Yuguang Shi, 1998) (Aparna C. Ranganathan, 2008). This reduces the overall 
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frequency of messenger RNA translation initiation. However, some mRNAs are 
preferably translated in the presence of phosporylated eIF2α – such as ATF-4 mRNA. 
ATF-4 is a transcription factor involved in activating the transcription of ER UPR 
target genes, encoding factors used in amino-acid biosynthesis, the oxidative stress 
response and apoptosis (David Ron, 2007). 
 
1.E.4  ER associated degradation  
Evidently, cells have to cope with protein damage in order to survive. For this 
they have evolved a dual response: damaged proteins are either repaired or eliminated 
by protein quality control mechanisms consisting of large networks of chaperones and 
proteolytic systems (Alexander Buchberger, 2010). Preferably, cells repair un- or 
misfolded proteins using ER-resident chaperones, however, irreparable proteins are 
identified and targeted for ERAD, or degraded in lysosomes by autophagic processes. 
When proteins in the ER are targeted for degradation, they are transported to ER 
membrane-bound complexes. Here they are unfolded and translocated out to the 
cytosol, where they now function as substrates of the UPS. Substrates of the UPS are 
tagged with ubiquitin in an ATP-consuming process. This requires a catalytic cascade 
of E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme) and E3 
(ubiquitin protein ligase) activities (Hochstrasser, 1996). The ER membrane-bound 
protein complex that is responsible for translocation is a part of the ERAD pathways, 
and consists, among others, of two proteins called SEL-1 and SEL-11 in C. elegans. 
These were first recognized in yeast (called Hrd3p and Hrd1, respectively) (Masayuki 
Kaneko, 2002) (Min Sung Choi, 2010) (Randolph Y. Hampton, 1996).  
Polypeptides that do not meet the protein quality control standards are 
recognized and retained within the ER, and are later delivered to ERAD ligases. This 
interaction limits immature proteins to the ER and supports their maturation. In 
mammalian cells, calnexin/calreticulin (CNX/CRT) is an ER specific lectin-type 
chaperone, which assists re-folding and folding of immature glycoproteins (Helenius, 
2004). To prevent blockage of the ER folding machinery, polypeptides that cannot be 
refolded must be removed from the CNX/CRT protein cycle. This is regulated by 
EDEM and ER mannosidase I (Jyoti D. Malhotraa, 2007). Proteins fixed in the 
CNX/CRT protein cycle are eventually trimmed by ER mannosidase I, which leads to 
their recognition by EDEM. EDEM and CNX interact with each other via their 
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transmembrane domains, and concurrent binding of CNX and EDEM to a misfolded 
protein may provide the signal that triggers its degradation (Kazue Kanehara, 2007). 
Additionally, it was found that overexpression of EDEM enhanced degradation by 
ERAD due to induced release of proteins from CNX (Oda Y, 2003). This suggests 
that ERAD is dependent on various ER specific events including ER resident 
chaperones and EDEM. 
ERAD dysfunction has previously been associated with several diseases, and 
plays an important role in protein quality control. For example, a polymorphism in 
SEL-1, the ERAD membrane bound protein, has been associated with Alzheimer’s 
disease (Giuliana Saltini, 2006). Other work has pointed out a relationship between 
p97, a human AAA ATPase, and overload of aggregated proteins in the ER, as a 
consequence of inhibited ERAD (Kobayashi T, 2002). Excessive amounts of 
aggregated ER proteins inhibit the ATPase activity of p97, leading to abnormal ER 
growth and cell death. This is similar to deficits in the neurodegenerative disorder, 
Machado-Joseph disease (Kobayashi T, 2002).  
 
1.E. 5  Autophagy 
Autophagy is an evolutionarily conserved process ensuring cellular 
homeostasis through degradation of long-lived proteins and functionally unnecessary 
or damaged intracellular organelles in lysosomes (Cuervo, 2008). Through 
degradation, autophagy provides energy by turnover of intracellular proteins and 
organelles to ensure rejuvenation. Autophagy also provides energy necessary for 
adaptation to various conditions, such as when nutrition is limited or when cells are 
experiencing stress (i.e., exposure to heat or drugs including tunicamycin, bortezomib, 
H2O2 and others) (Susann Patschan, 2008) (Maiko Ogata, 2006). In addition, 
autophagy functions as mechanism for removal of unwanted cellular structures by 
degradation of excess or injured organelles, including damaged mitochondria and ER 
(Bergamini E., 2007).  
At least three types of autophagy are known – CMA, macroautophagy and 
microautophagy. The difference between these systems is the way that they deliver 
target structures to the lysosomes. CMA is a mechanism that allows a direct 
lysosomal import of proteins that contain a particular pentapeptide motif (Majeski, 
2004). In contrast, microautophagy and macroautophagy involve membrane 
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rearrangements that finish at the lysosome and encapsulate proteins.  
Macroautophagy (hereafter referred to as autophagy) is the most studied 
autophagy pathway described in the literature, which involves the sequestration of 
cytoplasm into a double-membrane cytosolic vesicle referred to as an 
autophagosomes (Figure 1.4). The autophagosome subsequently fuses with a late 
endosome or lysosome to form an autophagolysosome. Inside the 
autophagolysosome, lysosomal hydrolases degrade the sequestered material, which 
then becomes available to the cell for recycling (www.wormbook.org).  
Numerous studies have shown that autophagy plays an important role in 
diverse physiological and pathological processes, including cell growth, cell 
differentiation and development, immune responses, cancer, neurodegeneration, 
infection and metabolic syndromes (Rabinowitz J. D. & White, 2010) (Vellai, 2009).  
The molecular mechanism of autophagy involves several conserved genes (atg), 
which have multiple functions in various physiological contexts. In particular, Atg5 is 
important for mammalian cell development, differentiation and maintenance of 
homeostasis (Kuma A, 2004). Atg5 is induced during ER stress, and Atg5-knockout 
mice die early. Tissue-specific Atg5-deficiencies, especially in neuronal cells, develop 
progressive insufficiencies in motor function from neurodegeneration. In addition, 
Atg5 has been implicated in human aging, as the transcriptional level of Atg5 is 
altered during natural aging (Rouschop KM, 2010). Accordingly, recent studies in 
mice have shown that overexpression of Atg5 is sufficient to extend lifespan, 
presumably due to alleviated protein aggregation (Jong-Ok Pyo, 2013). 
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Figure 1.4 Induction of autophagy. 
Autophagy is a cellular self-degrading pathway that provides organisms with energy 
under fasting and unfavorable conditions. By activation of ATG proteins, 
autophagosomes will be formed. Autophagosomes then dock and fuse with 
lysosomes. Here, autophagosomes are broken down. The cellular compartments (e.g. 
mitochondria, ER, proteins and fat) can be recycled, yielding energy for cellular 
survival.  
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 Autophagy is the major regulated cellular pathway for degrading long-lived 
proteins and the only known pathway for degrading cytoplasmic organelles. As 
autophagy improves the condition of cells by “cleaning”, it is potentially a powerful 
anti-aging mechanism. Autophagy has been found to be a major provider of fatty 
acids and other metabolites (Rajat Singh, 2009). Thus, a reduction of autophagy leads 
to an accumulation of lipids, proteins and non-processed macromolecules, as well as 
reduced turnover of cellular organelles. 
When autophagy is induced, autophagosomes are generated under control of 
the atg genes. These genes were first identified in yeast, but many of them have a C. 
elegans homolog. Figure 1.5 shows an overview of the protein-interactions occurring 
upon initiation of autophagy; a huge network of proteins is related to the induction 
and formation of autophagosomes. 
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Figure 1.5 The autophagy genes. 
Induction of autophagy and autophagosome formation is dependent on various 
proteins that are encoded by the atg genes. These create a complex network of 
proteins that assist in salvaging proteins and components for induction, followed by 
docking and fusion to lysosomes, and lastly the degradation of cellular waste 
components. 
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Autophagosomes that contain cellular building blocks such as lipids, cytosolic 
proteins, and organelles such as mitochondria and ER, are enclosed by membranes 
constituting lysosomes. The internal environment in the lysosomes, together with 
degradative enzymes, degrades the autophagosomal membranes and the contents are 
broken down and recycled. This will provide cells with energy-yielding molecules 
such as fatty acids, amino acids, etc. (Rajawat Y.S., 2009) (Kaarniranta, 2009). 
Autophagy is recognized as an important biological process that functions to promote 
health and longevity (Czaja et al, 2010) (Cuervo et al, 2008) (Alicia Meléndez, 2003). 
This is underlined by observations during the aging process where the efficiency of 
autophagic degradation declines and intracellular waste products accumulate 
(Kaarniranta, 2009). Additionally, recent C. elegans work from Lapierre et al. 
suggests that both the insulin receptor mutant, daf-2, and the germline-less mutant 
glp-1 are dependent on autophagy to maintain their long life (Lapierre LR, 2011). 
Together, autophagy plays an essential role in protein quality control and cellular 
homeostasis, and, at least in lower organisms, it has been coupled to aging. The 
mechanism by which autophagy is regulated has been extensively examined in yeast, 
and due to high conservation of the involved proteins, the mechanism is predicted to 
be similar (Ohsumi, 2001).  
1.F.  Protein quality control and aging 
During aging, there is a shift in the balance between the protective responses 
of the ER UPR and the apoptotic pathways, which are pathways induced when 
cellular damage becomes irreversible (Marishka K. Brown, 2012). Key ER-resident 
chaperones and enzymes within the ER such as BiP, PDI and calnexin, which are all 
required for proper folding, are altered during the aging process. Chaperones are 
progressively oxidized with age, which may contribute to their functional decline 
(Jonathan E. Nuss, 2008). BiP expression levels, for example, are significantly 
reduced in several species with age. In the cerebral cortex of aged (22-24 months old) 
mice compared with that on young (3 months old) mice, BiP proteins levels are 
decreased 30% (Naidoo N., 2008). BiP mRNA and protein expression levels are also 
decreased in the hippocampus of aged versus young rats (Paz Gavilan M., 2006). And 
in C. elegans, HSP-4 and especially its ability to respond to ER stress is significantly 
altered in old worms (Rebecca C. Taylor, 2013). This suggests a broad conservation 
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of age-associated protein alterations occurring in stress-induced pathways.  
Age appears to modify other components of the ER protein quality control 
mechanisms, in addition to chaperones. PERK mRNA is significantly reduced in the 
hippocampus of aged rats (Paz Gavilan M., 2006), and another study reported that the 
kinase activity of eIF2 is downregulated when isolated from aged rat brain tissue. In 
addition, in both yeast and mammalian neuron-like cells, overexpression of ERAD 
components ameliorates polyQ toxicity (Martin L. Duennwald, 2008). Due to these 
findings, it has been suggested that impaired ER protein homeostasis is a broad and 
highly conserved contributor to polyQ toxicity in yeast, mammalian cells, and human 
cells expressing full-length polyQ-expanded huntingtin protein, the causative agent of 
the neurodegenerative disorder Huntington’s disease (Martin L. Duennwald, 2008). 
Additionally, new research has stated that long-term alcohol consumption and aging 
may promote liver tumor genesis in females through interfering with DNA 
methylation and expression of genes involved in the ERAD pathways (Hui Han, 
2013). 
In fact, many human diseases result from altered protein-protein interactions, 
often occuring due to improper protein folding (Carrell R. W., 1997). Defective 
protein folding can lead to unstructured accumulation of proteins, which become toxic 
to the cells. Misfolding leading to toxic aggregation-prone proteins can either occur 
constitutively, as a result of coding sequence mutations, or be induced by exogenous 
stress, such as heat shock or hypoxia. Another important group of diseases resulting in 
formation of toxic protein accumulations are the serpinopathies. These result from 
mutations in members of the serine protease inhibitor (serpin) family of proteins, 
which lead to the formation of toxic aggregation-prone proteins. 
Conceivably, improved protein quality control mechanisms could provide 
substantial health benefits by reducing aggregation of toxic protein species. Indeed, 
recent results show that overexpression of certain genes in these pathtways are able to 
extend lifespan (Rebecca C. Taylor, 2013) (Hsu, 2003). This includes the ER UPR 
(Sivan Henis-Korenblit, 2010), components of the proteasomal degradation process 
(Vilchez D, 2012) and overexpression of the heat shock factor, HSF-1 (Hsu, 2003) (J. 
F. Morley, 2004).  
In addition to ER protein quality control mechanisms, autophagy, the cellular self-
degradation process, is essential for many lifespan-extending pathways and was 
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recently suggested as a target for treatment of various diseases, including 
neurodegenerative diseases (Frank Madeo, 2010) (Beth Levine, 2008).  
1.G.  What can we learn from natural variations? 
When Sydney Brenner in 1974 described the genetics of C. elegans, he revealed 
novel genetic variations performed using EMS (ethyl methanesulfonate) in a uniform 
genetic background that changed the animals’ behavior and morphology (Brenner S. , 
1974). Now, 40 years later, many hundreds of genes have been identified; genes that 
regulate the roundworms’ lifecycle, movement, cellular abilities and much more. 
However, we might be able to learn from natural genetic variations that have occurred 
in wild strains of C. elegans. The behavior of different wild strains is distinct, due to 
natural variations in the animals’ genome (J Hodgkin, 1997), thus, there is a 
possibility that behavior, and responses to different types of stress, vary among strains 
according to their origin. Some laboratories have compared patterns of genetic 
diversity between mutation accumulation lines to wild isolates. The mutation 
accumulation lines represent the original mutational process, whereas various 
differences observed among wild isolates is the result of mutations as well as 
population structure and phenotypic selection. Denver and colleagues compared 
mutation patterns in mutation accumulation lines against the wild isolates, and found 
an excess of transitions over transversions in wild isolates (Denver D.R., 2004). This 
was due to a mutational bias. In contrast, they found that indels (insertion-deletions) 
and replacement mutations in coding regions were less frequent among wild isolates 
than in mutation accumulation lines, suggesting that they are counter selected (Denver 
D.R, 2000). The genetic diversity in C. elegans is generally low compared to other 
organisms, such as the fruit fly, which is also frequently used for laboratory 
experiments. This is partly due to C. elegans’ self-mating abilities (Hartl D.L, 1997). 
Phenotypic evolution is the product of mutational and environmental changes, 
and these evolutionary pressures occur more frequently among C. elegans wild 
isolates compared to inbred laboratory strains (Denver D.R., 2004). The effect of 
random mutation on the rate and pattern of phenotypic variation can then be 
compared with the actual natural diversity (Davies E.K, 1999). For example, wild 
isolates have been found to display differences in developmental programs 
(Eisenmann D.M., 1998), plugging (some wild isolate males leave a plug after 
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mating) (Hodgkin J., 1997) and broodsize (Hodgkin J, 1991). Very importantly, some 
wild isolates of C. elegans have enhanced ability to resist toxic environments, such as 
very high temperatures (J Hodgkin, 1997).  
Another significant difference between the primary laboratory strain N2 (Bristol) and 
many wild isolates is a lack of the npr (neuropeptide receptor 1) mutation, which is 
found in the WT laboratory C. elegans strain (Mario De Bono, 1998). NPR-1 is a 
predicted G-protein-coupled receptor similar to the neuropeptide Y receptors, and is 
expressed predominantly in the AQR, PQR and URX neurons. Several lof mutations 
in the npr-1 gene cause the animals to diffuse across a bacterial lawn. This behavior 
stems from the animals’ ability to sense O2 and CO2, which is controlled by the URX 
neurons (Hallem E.A., 2008). In fact, it was recently shown that ablation of URX 
neurons in the npr-1 mutants restores CO2 avoidance, suggesting that NPR-1 enables 
CO2 avoidance by inhibiting the URX neurons (Carrillo MA, 2013). Other wild 
strains, as for example the Hawaiian WT strain (CB4856), the German strain RC301 
and the English strain CB4932, lack this lof mutation, which makes them aggregate 
on food sources to form clumps.  
In nature, conditions are often harsh, and temperature changes, absence of 
food and population density vary among different origins. Natural variability among 
different strains dependent on their origin may therefore shed light over novel genes 
involved in stress response pathways and behavior. The C. elegans Genetics Center 
(CGC) maintains a worm repository (http://www.cgc.cbs.umn.edu/) containing many 
C. elegans wild isolates, collected from many different countries, environments and 
climates. We decided to order some of these strains, to investigate natural variations 
that lead to resistance to TM, and to analyze their lifespan. Since they have random 
natural variations, we might be able to elucidate genetic mutations leading to 
enhanced stress resistance and longevity from the wild C. elegans isolates.  
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1.H.  Summary and hypothesis 
In conclusion, aging leads to a decline in function across various cells in 
different organisms. Defects in protein quality control mechanisms have been 
implicated in aging, which lead to unbalanced protein homeostasis when interrupted. 
Genetic studies initiated using yeast have revealed proteins that might play a role in 
protein homeostasis, aggregation and quality control, and continued research in higher 
multicellular organisms and in mammalian cellular systems have suggested that there 
is an increased incidence of AADs when protein quality control mechanisms are 
impaired. Additionally, we know from C. elegans research that long-lived mutants 
depend on protein quality control mechanisms such as ER UPR and autophagy. 
Lastly, recent evidence suggests that enhanced autophagy is sufficient to alleviate 
proteotoxicity and extend lifespan in mice, and that over expression of hsf-1 or 
improved degradation by the proteasome alone can extend the lifespan of C. elegans.  
From the high degree of conservation many of these protein quality control 
mechanisms have among a wide range of organisms, we aim to utilize the power of 
genetics in C. elegans to better understand lifespan regulation and protein quality 
control mechanisms. This should provide a particularly excellent tool to further 
elucidate novel roles of protein quality control in the regulation of proteotoxicity and 
longevity. We therefore hypothesized that improved ER protein quality control 
mechanisms in C. elegans would confer longevity.  
C. elegans natural isolates are typically found in the soil, where they live under 
very harsh circumstances. Since wild C. elegans animals have undergone natural 
variations that in some cases have led to increased resistance to stress and higher 
ability to enter the dauer larvae stage, we hypothesized that genetic variations in these 
animals would reveal new targets and genetic mutations important for quality control 
mechanisms and longevity.  
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CHAPTER 2. Experimental Procedures 
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2.A.  Alignment of sequence data 
Sequence data was obtained from MPIPZ (Max-Planck-Institute Pflanzenzüchtung) 
and Cologne Genomic Center, and processed using MAQGene (Henry Bigelow, 
2009). The MAQGene output was imported as files readable in Excel spreadsheets, 
and we piled up the sequences and determined the specific mutations in each mutant. 
The data indicated at which chromosome the mutation was found, the specific base 
position mutated, reference and sample base, the depth, what kind of mutation, the 
class, the amino acid change and in which parent feature the mutation had occurred.   
2.B.  Autophagy Quantification  
Autophagosomes were scored as reported previously (Lapierre L.R., 2011). 15 - 25 
transgenic lgg-1::gfp animals per condition where whole-mounted and foci were 
counted using 100x magnification on a Zeiss Axio Imager.Z1 microscope in the seam 
cells of L3 larvae. For quantification of p62::GFP puncta, 10-20 early L4 larvae were 
whole-mounted and GFP foci in the posterior pharyngeal bulb were quantified. For 
quantification we used 100x magnification and additionally 2x zoom on a Leica TCS 
SP5-X confocal microscope (see section 2.G. Confocal Microscopy). 
2.C.  C. elegans microinjection 
DNA plasmids were injected into the distal arm of the gonad in very young adult 
hermaphrodites, myo-2::mCherry was used as co-injection marker. 3-6 animals were 
placed on 2% agarose pads on glass slides, and covered with injection oil. DNAs were 
injected at 500 kPa pressure. Worms are recovered using M9 buffer and subsequently 
placed on NGM (nematode growth media) plates seeded with OP50. Animals 
successfully receiving the injected DNAs are picked after at least 3 generations. 	  
2.D.  C. elegans strains and culture 
Nematodes were cultured at 20°C on NGM agar plates seeded with the E. coli strain 
OP50, unless indicated otherwise (Brenner S. , 1974). For the genetic dominance test, 
gfat-1 mutant animals were crossed with N2 males and TM resistance was scored in 
the F2 offspring of F1 heterozygous animals.  
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2.E.  C. elegans wild isolate collection and isolation 
C. elegans wild isolates (Dragon #1, Dragon #9 and Dragon #10) were found in the 
soil in a vineyard in Drachenfeldt, near Bonn. They were collected in eppendorf 
tubes. Later they were bleached, isolated on plates and kept under normal laboratory 
conditions. Wild isolates that were resistant to TM were backcrossed to N2 on TM. 
2.F.  Compound feeding and developmental TM resistance assay 
For developmental TM resistance assays with GlcNAc and UDP-GlcNAc (Sigma) 
UV-radiation-killed bacteria were transferred to plates containing 10 µg/mL TM. 
Compounds were then added to the plate surface resulting in a 10 mM compound 
concentration in the plates. 50 – 80 synchronized WT (N2) eggs per condition were 
added to the plates and development to L4 or adult stage was scored after 4 and 5 
days. For adult exposure experiments for lifespan analyses with D-Arg or GlcNAc, 
compounds were mixed with the NGM agar to a final concentration of 10 mM unless 
otherwise noted. UV-killed OP50 bacteria were added on the plates. For motility 
assays, adult exposure were carried out by maintaining animals on normal NGM agar 
plates seeded with OP50. The animals were then daily exposed to GlcNAc or D-Arg 
for 6 hours in S-basal media supplemented with UV killed OP50 bacteria.  
2.G.  Confocal Microscopy  
20-30 animals were collected on 5% agarose pads on glass slides, and anesthetized 
using 10μL 2mM levamisole. Immediately after mounting, the animals were 
visualized at a SP5X confocal microscope. In case of quantifying p62 foci, pictures 
were taken at 100x plus 2.0 times zoom. Number of foci was quantified from the 
pictures.  
2.H.  Gene alleles and strains 
N2 (Bristol) 
DR1572: daf-2(e1368)III 
GR1307: daf-16(mgDf50)I 
RB1169: oga-1(ok1207)X 
RB653: ogt-1(ok430)III 
AA2503: gfat-1(dh468)II 
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AA2560: gfat-1(dh784)II 
AA2561: gfat-1(dh785)II 
AA1409: eat-2 (ad465)II 
MQ887: isp-1(qm150)IV 
KX15: ife-2(ok306)X 
CB4037: glp-1(e2141ts)III 
 
AA2962: gfat-1(dh468)II; daf-2(e1368)III 
AA3214: gfat-1(dh784)II; daf-2(e1368)III 
AA2883: gfat-1(dh785)II; daf-2(e1368)III 
 
AA2959: gfat-1(dh468)II; daf-16(mgDf50)I  
AA2884: gfat-1(dh784)II; daf-16(mgDf50)I 
AA2885: gfat-1(dh785)II; daf-16(mgDf50)I 
 
AA2961: gfat-1(dh468)II; ogt-1(ok430) III 
AA2886: gfat-1(dh784)II; ogt-1(ok430) III 
AA3032: gfat-1(dh785)II; ogt-1(ok430) III 
 
AA2960: gfat-1(dh468)II; oga-1(ok1207)X 
AA2911: gfat-1(dh784)II; oga-1(ok1207)X 
AA2912: gfat-1(dh785)II; oga-1(ok1207)X 
 
SJ4005: N2; zcIs4[Phsp-4::GFP]V 
AA2773: gfat-1(dh468)II; zcIs4[Phsp-4::GFP]V 
AA3215: gfat-1(dh784)II; zcIs4[Phsp-4::GFP]V 
AA3216: gfat-1(dh785)II; zcIs4[Phsp-4::GFP]V 
 
AM141: N2; rmIs133[P(unc-54) Q40::YFP] 
AA2988: gfat-1(dh468)II; rmIs133[P(unc-54) Q40::YFP] 
AA2945: gfat-1(dh784)II; rmIs133[P(unc-54) Q40::YFP] 
AA2953: gfat-1(dh785)II; rmIs133[P(unc-54) Q40::YFP] 
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AM322: N2; rmEx135[F25B3.3p::Q86::YFP] 
AA2992: gfat-1(dh468)II; rmEx135[F25B3.3p::Q86::YFP] 
AA2949: gfat-1(dh784)II; rmEx135[F25B3.3p::Q86::YFP] 
AA2957: gfat-1(dh785)II; rmEx135[F25B3.3p::Q86::YFP] 
 
NL5901: N2; pkIs2386[Punc-54::alphasynuclein::YFP + unc-119(+)] 
AA2993: gfat-1(dh468)II; pkIs2386[Punc-54::alphasynuclein::YFP + unc-119(+)] 
AA2950: gfat-1(dh784)II; pkIs2386[Punc-54::alphasynuclein::YFP + unc-119(+)] 
AA2958: gfat-1(dh785)II; pkIs2386[Punc-54::alphasynuclein::YFP + unc-119(+)] 
 
UA44: baInl1[Pdat-1::α-syn high, Pdat-1::gfp] 
AA3023: gfat-1(dh468)II; baInl1[Pdat-1::α-syn high, Pdat-1::gfp] 
AA3024: gfat-1(dh784)II; baInl1[Pdat-1::α-syn high, Pdat-1::gfp] 
AA3025: gfat-1(dh785)II; baInl1[Pdat-1::α-syn high, Pdat-1::gfp] 
 
CL2006: N2; dvIs2[pCL12(Punc-54::human Abeta peptide 1-42 minigene; pRF4(rol-
6(su1006)))] 
AA2963: gfat-1(dh784)II; dvIs2[pCL12(Punc-54::human Abeta peptide 1-42 
minigene; pRF4(rol-6(su1006)))] 
AA2963: gfat-1(dh785)II; dvIs2[pCL12(Punc-54::human Abeta peptide 1-42 
minigene; pRF4(rol-6(su1006)))] 
 
PP657: unc-119(ed4)III; hhIs76[unc-119(+); unc-54::srp-2(H302R)::yfp] 
AA3116: gfat-1(dh468)II; unc-119(ed4)III; hhIs76[unc-119(+); unc-54::srp-
2(H302R)::yfp] 
AA3118: gfat-1(dh784)II; unc-119(ed4)III; hhIs76[unc-119(+); unc-54::srp-
2(H302R)::yfp] 
AA3119: gfat-1(dh785)II; unc-119(ed4)III; hhIs76[unc-119(+); unc-54::srp-
2(H302R)::yfp] 
 
DA2123: adIs2122(lgg-1::GFP; rol-6(su1006)) 
AA3129: gfat-1(dh468)II; adIs2122(lgg-1::GFP; rol-6(su1006)) 
AA3128: gfat-1(dh784)II; adIs2122(lgg-1::GFP; rol-6(su1006)) 
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AA3131: gfat-1(dh785)II; adIs2122(lgg-1::GFP; rol-6(su1006)) 
 
AA3173: N2; dhEx940[gfat-1P::FLAG-HA::cfp::gfat-1 3'UTR; myo-2::mCherry] 
AA3174: N2; dhEx941[gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1 3'UTR; myo-
2::mCherry] 
 
AA3349: dhEx940[gfat-1P::FLAG-HA::cfp::gfat-1 3'UTR; myo-2::mCherry]; unc-
119(ed4)III; hhIs76[unc-119(+); unc-54::srp-2(H302R)::yfp] 
AA3350: dhEx941[gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1 3'UTR; myo-
2::mCherry]; unc-119(ed4)III; hhIs76[unc-119(+); unc-54::srp-2(H302R)::yfp] 
 
HZ589: bpIs151(p62::gfp; unc-76)IV; him-5(e1490)V 
AA3354: gfat-1(dh468)II; bpIs151(p62::gfp; unc-76)IV; him-5(e1490)V 
 
KJ5944: N2; jhEx61 [pcnx1::cnx-1::GFP+pRF4] 
AA3351: gfat-1(dh468)II; jhEx61[pcnx1::cnx-1::GFP+pRF4] 
AA3352: gfat-1(dh784)II; jhEx61[pcnx1::cnx-1::GFP+pRF4] 
AA3353: gfat-1(dh785)II; jhEx61[pcnx1::cnx-1::GFP+pRF4] 
 
AA3329: dhEx978[(pRedFlp-Hgr)(sel-1[28094]::S0001_pR6K_Amp_2xTY1ce_-
EGFP_FRT_rpsl-_neo_FRT_3xFlag)-dFRT::unc-119-Nat; myo-2::mCherry] 
2.I.  Isolation of detergent insoluble protein fraction 
Animals were lyzed in RIPA buffer (50 mM Tris pH7.5, 150 mM NaCl, 5 mM 
EDTA, 0.5% SDS, 0.5% sodium deoxycholate, 1% NP40, 1 mM PMSF, Roche 
Complete Inhibitors 1x), insoluble material was pelleted by centrifugation at 16,000 x 
g. Pellet was washed once in RIPA buffer and then solubilized in 8M urea buffer 
(50 mM Tris pH7.5, 8 M urea, 2% SDS, 50 mM DTT). Protein solutions were then 
mixed with 2x Laemmli buffer and separated by SDS PAGE.  
2.J.  LC/MS/MS analysis 
Synchronized worm populations were used for analysis. Extraction was done with 
Methanol/Chloroform. For absolute quantification of UDP-HexNAc an Acquitiy 
UPLC (Waters) was connected to a XevoTM TQ (Waters). An Acquity UPLC BEH 
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Amide 1.7 µm, 2.1 x 30 mm column was used at 15°C. Solvent A was 0.22 µm 
MilliQ-Water + 0.05% Ammonium Hydroxid (Sigma-Aldrich), 19% filtered through 
0.22 µm, and B 95% acetonitrile/5% 0.22 µm MilliQ-Water. A linear gradient from 
98% B to 0 % in 2 min at a flow rate of 0.45 ml/min was used. 2 µL of standard and 
sample were injected. The sample manager was set to 6°C. The TQ was operated in 
negative ESI MRM (multi reaction monitoring) mode. The source temperature was 
set to 150°C, desolvation temperature was 650°C and desolvation gas was set to 
800 L/h, cone gas to 50 L/h. The following MRM transitions were used for UDP-
GlcNAc m/z 302.48 (M-H+)- to 110.95 (quantifier) collision energy 10V, m/z 302.48 
to 78.84 (qualifier) collision 30V, m/z 302.48 to 281.89 (qualifier) collision 18V, 
cone was in all cases 15V. As data management software MassLynx (Waters) and for 
data evaluation and absolute quantification TargetLynx (Waters) were used. All 
standards were freshly prepared after two months and dissolved in 50% MeOH and 
stored at -20°C. With UDP-HexNAc eluting at 0.83 min a standard calibration curve 
was calculated using following concentrations: 15, 25, 50, 100, 250, 350, 500, 
750 ng/mL (daily fresh diluted with 50% MeOH individually from stock solutions 
100 µg/ml). Correlation coefficient: r < 0.990; response type: internal standard, area; 
curve type linear; weighting 1/x. The peak integrations were corrected manually, if 
necessary. A new calibration curve as quality control standards were used during 
sample analysis and showed between 0.5% and 40% deviation respectively. Blanks 
after the standards, quality control and sample batch proved to be sufficient. No carry 
over was detected.  
For absolute quantification of Pyruvate and Fructose-6-phosphate with internal 
standard Uridine-5,6-d2 (Sigma) a Acquitiy UPLC (Waters) was connected to a 
XevoTM TQ (Waters). A zic-Hilic column was used at 20°C. Solvent A was 100mM 
Ammonium Acetate (Sigma-Aldrich) B Acetonitrile. A linear gradient from 60% B to 
30 % in 1 min at a flow rate of 0.7 ml/min was used. 2 µL of standard and sample 
were injected. The sample manager was set to 6°C. The TQ was operated in negative 
ESI MRM (multi reaction monitoring) mode. The source temperature was set to 
150°C, desolvation temperature was 650°C and desolvation gas was set to 800 L/h, 
cone gas to 50 L/h. The following MRM transitions were used for Pyruvate m/z 86.86 
(M-H+)- to 86.86 (quantifier) collision energy 4V, cone was 20V, for Fructose-6-
phosphate m/z 258.84 to 96.96 (quantifier) collision energy 12V, m/z 258.84 to 78.89 
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(qualifier) collision energy 22V, m/z 258.84 to 168.95 (qualifier) collision energy 
14V, cone was in all cases 16V, for Uridine-3,5-d2 m/z 244.90 to 111.24 (quantifier) 
collision 16V, m/z 244.90 to 152.52 (qualifier) collision 14V, cone was 24V. As data 
management software MassLynx (Waters) and for data evaluation and absolute 
quantification TargetLynx (Waters) were used. All standards were freshly prepared 
after two months and dissolved in 40% 100mM Ammonium Acetate/60% Acetonitrile 
and stored at -20°C. With Pyruvate eluting at 0.49 min using following 
concentrations: 10, 50, 100, 250, 500, 1000, 2000, 3000 ng/mL and with Fructose-6-
phosphate eluting at 0.65 min using following concentrations 200, 400, 800, 1200, 
2000, 2500, 3000, 4000 ng/ml a standard calibration curve was calculated with the 
internal standard Uridine-5,6-d2 eluting at 0.47 min concentration 100 ng/ml for the 
internal standard (daily fresh diluted with 40% 100mM Ammonium Acetate/60% 
Acetonitrile individually from stock solutions 100 µg/ml). Correlation coefficient: 
r < 0.990; response type: internal standard, area; curve type linear; weighting 1/x. The 
peak integrations were corrected manually, if necessary. A new calibration curve as 
quality control standards were used during sample analysis and showed between 0.5% 
and 40% deviation respectively. Blanks after the standards, quality control and sample 
batch proved to be sufficient. No carry over was detected.  
2.K.  Lifespan assays 
Adult lifespan analyses were performed at 20°C on E. coli OP50 with young adults as 
t = 0. 100-150 animals, distributed on 7-10 plates, were used per condition and 
transferred to fresh plates/scored every day or every second day. The secondary 
longevity screen after TM selection was done on plates containing 50 µM FUDR. 
Animals in all RNAi lifespan assays were grown on NGM plates containing OP50 
during development, and transferred to RNAi plates as young adults (L4+1 day, t=0). 
Animals were kept on RNAi bacteria containing plates throughout the experiment. 
Worms that had undergone internal hatching, vulval bursting, or crawling off the 
plates were censored. Throughout the experiment strain and/or treatment was 
unknown to researcher. In some experiments all plates were numbered and randomly 
mixed. In both cases data were assembled upon completion of the experiment. 
Statistical analyses were performed with the Mantel-Cox Log Rank method in Excel 
(Microsoft).  
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2.L.  Mutant mapping and sequence analysis 
Rapid SNP mapping was done as previously described (Hammarlund M., 2005). 
Genomic DNA was prepared using the QIAGEN Gentra Puregene Kit. Whole 
Genome Sequencing was done on the Illumina HiSeq2000 platform. Sequencing 
outputs were analysed using the MAQGene pipeline (Bigelow et al., 2009). Output 
from the MAQGene pipeline was analysed in Excel. 100bp paired-end reads were 
used with the average coverage larger than 20-fold.  
2.M.  Paralysis and motility assays 
Paralysis of dvIs2[pCL12(Punc-54::human Abeta peptide 1-42 minigene; pRF4(rol-
6(su1006)))] animals was scored daily by prodding animals at head and tail with a 
wire on NGM plates. Alive animals that were unable to roll were scored as paralyzed. 
Motility assays using rmIs133[P(unc-54) Q40::YFP], baInl1[Pdat-1::α-syn high, 
Pdat-1::gfp] and pkIs2386[Punc-54::alphasynuclein::YFP + unc-119(+)] were 
scored at the 7th day of adulthood (L4+8 days). When genetic modifications using 
RNAi were used, animals were transferred to RNAi plates as young adults (L4+1 
day). At L4+8 days, animals were transferred to M9, and motility was determined by 
counting bodybends over a 30 second interval.  
2.N.  Plasmid construction and transgenes 
gfat-1P::FLAG-HA::cfp::gfat-1-3'UTR 
The gfat-1 promoter of 3.8kb was amplified from genomic DNA by PCR and inserted 
in front of the cfp sequence in the pDC6 vector (kind gift from Dr. Magner, Antebi 
lab). The gfat-1 3’UTR of 517bp was amplified from genomic DNA by PCR and 
inserted downstream of cfp to yield a transcriptional reporter construct.  
gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1-3'UTR 
The gfat-1 promoter of 3.8kb was amplified from genomic DNA by PCR and inserted 
in front of the cfp sequence in the pDC6 vector. The gfat-1 open reading frame and 
3’UTR of 3354bp was amplified from genomic DNA by PCR and inserted 
downstream of cfp to yield the translational fusion construct.  
gfat-1P::FLAG-HA::cfp::gfat-1::gfat-1-3'UTR and gfat-1P::FLAG-HA::cfp::gfat-1-
3'UTR were injected into N2 to generate dhEx941 and dhEx940, respectively.  
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The sel-1P::gfp fosmid (Transgenome Project) were injected into N2 to generate 
dhEx978. myo-2::mCherry was used as co-injection marker.  
2.O.  Proteasome Activity Assay 
Proteasome chymotryptic and tryptic activity was assayed according to standard 
procedures (Fredriksson Å., 2012) as the rate of hydrolysis of the fluorogenic peptide 
suc-LLVY-AMC (Sigma) or ac-RLR-AMC (Enzo), respectively. Extracts were 
prepared in 25 mM Tris HCl pH7.5 using a dounce homogenizer. 20 μg protein was 
incubated with 12.5 μM suc-LLVY-AMC in a total volume of 200 μL. AMC 
fluorescence was measured using 355 nm excitation and 460 nm emission filters with 
free AMC (Sigma) as standard every 2 minutes for one hour at 25°C. 
2.P.  qRT-PCR 
Synchronized worms at indicated stages were collected in TRIzol (Invitrogen) and 
frozen in liquid nitrogen. Total RNA was prepared by RNeasy Mini kit (QIAGEN) 
and cDNA was subsequently generated by iScript cDNA Synthesis Kit (BioRad). 
qRT-PCR was performed with Power SYBR Green master mix (Applied Biosystems) 
on a ViiA 7 Real-Time PCR System (Applied Biosystems). ama-1 was used as 
internal control. Primer sequences are as listed in Extended Experimental Procedures. 
2.Q.  qRT-PCR primers 
Gene Primer Sequence (5’-3’) 
gfat-1 gfat-1-f GTCCAACCACGCTACTCATTTGC 
 gfat-1-r TGACAGGTCCAGAATGTTGTTTGG 
gna-2 gna-2-f ACATTCACGAAGCGGGAACACG 
 gna-2-r GTGACAACTTGTAGACGCCAATCG 
daf-16 daf-16-f ATCAGACATCGTTTCCTTCGG 
 daf-16-r TTAACCGTTTCTCTGGACTAGC 
sod-3 sod-3-f CACGAGGCTGTTTCGAAAGG 
 sod-3-r GAATTTCAGCGCTGGTTGGA 
dod-3 dod-3-f CGTATATGGACCCAGCTAATG 
 dod-3-r ATGAACACCGGCTCATTC 
dod-8 dod-8-f ACAGGATGTCTTCAAAAGGAATATGG 
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 dod-8-r TTGCTGGGGTGATAGCTTGG 
ama-1 ama-1-f GGATGGAATGTGGGTTGAGA 
 ama-1-r CGGATTCTTGAATTTCGCGC 
hsp-4 hsp-4-f GTGGCAAACGCGTACTGTGATGA 
 hsp-4-r CGCAACGTATGATGGAGTGATTCT 
xbp-1 xbp-1-f CCGATCCACCTCCATCAAC 
 xbp-1-r ACCGTCTGCTCCTTCCTCAATG 
xbp-1 xbp-1-f sp TGCCTTTGAATCAGCAGTGG 
spliced xbp-1-r ACCGTCTGCTCCTTCCTCAATG 
hsp-3 hsp-3-f TTTCTCTACCGCCGCTGACAAC 
 hsp-3-r CGTTCTCCTTCGAAGACCTGGATG 
R02D3.8 R02D3.8-f GCTTCTGCGGAGCACACAAATC 
 R02D3.8-r TGCAGCTTGTAGATGGCCAGAAG 
B0280.1b B0280.1b-f GGAGGATTAAATGGTCGGCCTGAG 
 B0280.1b-r AATGGCGAGAGAAGCGAGAACC 
T26F2.2 T26F2.2-f GGACGAGCCGCTTGATTTAATGC 
 T26F2.2-r AGAAGTCTGCTCCGATCACCTTTG 
pdi-2 pdi-2-f ATGGACTCAACCCTCAACGAGGTC 
 pdi-2-r TCCAGCTGGGAAGAACTTGATGG 
pdi-3 pdi-3-f GATGCCACCGCCAATGATGTTC 
 pdi-3-r GCCAGAAGAGAGTTGGGAATCCTC 
cnx-1 cnx-1-f TACAATGGAGAGTGGAGCATCGG 
 cnx-1-r ATTGCATGATGGCGTGCCTTTG 
crt-1 crt-1-f TGTGGCAGGTCAAGTCAGGAAC 
 crt-1-r TTTCTTCGTCGGCCTTCTCCTTC 
pha-4 pha-4-f GCCAATTTCATGCAAGGAGG 
 pha-4-r GCCAGTGGTAAAACCAAGAGGT 
bec-1 bec-1-f TGCAGTTGCTCGAGTTTTTG 
 bec-1-r TGACACCATTGTCAACCAGTG 
lgg-1 lgg-1-f ACCCAGACCGTATTCCAGTG 
 lgg-1-r ACGAAGTTGGATGCGTTTTC 
atg-1 atg-1-f ACAAATCCCTGTCGTTCCAG 
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 atg-1-r AATGAGCCGTTGGATAATGC 
lipl-4 lipl-4-f ATGGCCGAGAAGTTCCTACATCGT 
 lipl-4-r GGTGAATTGGCGACCCAATCGAAA 
sel-1 sel-1-f AGTCAGCGACTCTGGTATCTGC 
 sel-1-r TGCAGTGAGTAACGAGCCTGTG 
sel-11 sel-11-f AGGCTGAGCATCTGTCAGAACG 
 sel-11-r CACGGAATACAGTGAATGCGAGAC 
rpn-6 rpn-6-f ACACTCAGGCTCTTCCACTTGC 
 rpn-6-r TCCTCAAGTTCGACTTCCACGAG 
rpn-8 rpn-8-f TGTACGATCGGTGGTCGCTTTG 
 rpn-8-r TCAGCCTTCTGGAGAGAGATCTTG 
hsp-16.2 hsp-16.2f ACTTTACCACTATTTCCGTCCAGC 
 hsp-16.2-r CCTTGAACCGCTTCTTTCTTT 
hsp-70 hsp-70-f AATGAACCAACTGCTGCTGCTCTT 
 hsp-70-r TGTCCTTTCCGGTCTTCCTTTTG 
hsp-6 hsp-6-f GAACCGGAAAGGAACAACAGATCG 
 hsp-6-r TTTGGTCCTTGGAAAGTCCTCCAG 
hsp-60 hsp-60-f AAATGCCGGTCTTGAGCCATCG 
 hsp-60-r AGAGCTGTGCGAACCACCTTAG 
gfp gfp-f TTTCACTGGAGTTGTCCCAATTC 
 gfp-r CTTCACCCTCTCCACTGACAGAA 
 
2.R.  Quantification of SRP-2H302R::YFP aggregation 
SRP-2H302R::YFP puncta were scored in transgenic animals in WT, gfat-1 gof or Dyf 
mutant backgrounds. At least 20 animals were whole-mounted per experiment and 
GFP puncta were counted using a Zeiss Axio Imager.Z1. For clarity of imaging, only 
the aggregates in the animals’ head regions were scored. 
2.S.  RNAi clones 
Gene Sequence 
Name 
Library 
ire-1 C41C4.4 Ahringer 
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xbp-1 R74.3 Ahringer 
pek-1 F46C3.1 Ahringer 
atf-6 F45E6.2 Ahringer 
hsp-4 F43E2.8 Ahringer 
cnx-1 ZK632.6 Ahringer 
crt-1 Y38A10A.5 Ahringer 
pdi-1 C14B1.1 Ahringer 
pdi-2 C07A12.4 Ahringer 
sel-1 F45D3.5 Vidal 
sel-11 F55A11.3 Vidal 
rpn-6 F57B9.10 Ahringer 
rpn-8 R12E2.3 Ahringer 
stt-3 T12A2.2 Ahringer 
ostd-1 M01A10.3 Ahringer 
ostb-1 T09A5.11 Ahringer 
dad-1 F57B10.10 Ahringer 
ribo-1 T22D1.4 Ahringer 
ZK686.3 ZK686.3 Ahringer 
atg-18 F41E6.13 Vidal 
unc-51/atg-1 Y60A3A.1 Vidal 
gfat-1 F07A11.2 Ahringer 
gna-2 T23G11.2 Ahringer 
hsf-1 Y53C10A.12 Ahringer 
 
2.T.  RNA interference 
RNAi experiments were performed as described earlier (Kamath R.S., 2003) (Rual, 
2004). For whole life or developmental knockdown, synchronized eggs were put on 
corresponding RNAi plates containing IPTG and ampicillin. For adult only 
knockdown, L4 larvae were picked to NGM plates containing OP50, and 24 hours 
later transferred to the RNAi plates, L4+1 day. gfp (GFP::L4440) RNAi or empty 
vector (L4440) were used as a non-targeting control. RNAi clones used are listed in 
2.S.   
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2.U.  Statistical analysis 
Results are presented as mean ± s.e.m. unless noted otherwise. For each experiment, 
at least 3 biological replicates were carried out and genotypes and/or treatment were 
blinded during analysis. Statistical tests were performed with One-way ANOVA with 
Bonferroni post-test (ANOVA) with GraphPad Prism (GraphPad software) unless 
otherwise noted. Chi-square two-tailed P-values were calculated with GraphPad 
QuickCalcs. Significance levels are *P<0.05, **P<0.01, ***P<0.001 vs. WT control 
unless otherwise noted.  
2.V.  Thermo tolerance Test 
Thermo tolerance assays were conducted at the indicated temperature and alive 
worms were scored every or every other hour. Plates were initiated with 20-25 adult 
animals each, and the plates were mixed in the incubator every time to avoid 
differences in heat exposure at different locations within the incubator. All plates 
were numbered randomly.  
2.X.  Tunicamycin resistance screen 
L4 larvae were exposed to 0.3% or 0.1% ethyl methane sulfonate (EMS, Sigma) in 
M9 buffer for 4 hours. After recovery over night, young adult animals were 
transferred to new plates to perform an egg-lay (F1). F1 progeny were developed on 
NGM plates seeded with OP50 and then allowed to lay eggs (F2) on NGM agar plates 
containing 10 µg/mL tunicamycin (TM, Calbiochem). TM was dissolved in DMSO 
and nematode development on vehicle control plates did not differ from standard 
NGM plates. F2 development was scored after 4 and 5 days and resistant mutants, 
defined as fully developed and fertile animals, were transferred to standard plates and 
outcrossed 4 times with the parental N2 strain using tunicamycin selection.  
2.Y.  Western blotting 
25 L4 animals were suspended in Laemmli lysis buffer under reducing conditions. 
Proteins were separated by reducing SDS-PAGE and transferred to PVDF 
membranes. Membranes were then incubated with specific antibodies to GFP 
(Clontech), α-tubulin (Sigma), and SEL-1 (produced in the Sommer laboratory).  
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3.A.  Introduction 
Several protein quality control mechanisms have been found implicated in 
aging and AADs. Especially interesting, many long-lived organisms have enhanced 
ability to cope with various stresses due to improved protein quality control 
mechanisms (L D Osellame, 2013). This includes mutants of C. elegans. For example, 
the DR mimicked mutant eat-2, the insulin signaling depleted mutant daf-2 and the 
germline-less mutant glp-1 do all show enhanced levels of autophagy (Malene 
Hansen, 2008) (Lapierre LR, 2011). Thus, they depend on autophagy to sustain their 
extended lifespan. Furthermore, it has been found that the long life of both glp-1 and 
daf-2 mutant animals is dependent on the canonical ER UPR pathways. From various 
stress resistance-assays, other research groups found that these mutants are more 
resistant to stress persuaded by heat and various drugs inducing oxidative, 
mitochondrial and ER stress (Vilchez D, 2012) (Sivan Henis-Korenblit, 2010) (Taylor 
RC, 2013). This suggests a link between enhanced stress resistance and long life.  
We designed a forward genetic screen aiming at selecting mutants with 
increased resistance to ER stress. ER stress can be induced by pharmacological 
suppression of N-glycosylation, which can be achieved with the drug tunicamycin 
(TM). TM blocks the enzymatic assembly of N-glycans and is a well-known inducer 
of ER stress. TM interrupts the ER functions by inhibiting the addition of complex 
sugars to the growing sugar-chain on newly synthesized proteins (S-C Kuo, 1976), 
and in worms, it has been shown that exposure to TM induces ER stress and 
furthermore triggers the ER stress response pathways through the IRE-1/XBP-1 
signaling pathway (Marcella Calfon, 2001) (Xiaohua Shen, 2001). The Kenyon lab 
showed that this particular branch of the ER UPR pathway is important for the 
remarkable longevity of the daf-2 mutants (Sivan Henis-Korenblit, 2010). 
Interestingly, they also found that daf-2 mutant animals have a higher threshold for 
induction of ER UPR upon treatment with lower doses of TM. 
Together, previous studies have shown a correlation between enhanced stress 
resistance and longevity, and we hypothesized that improved ER quality control 
mechanisms would promote long life.  
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3.B.  Results 
3.B.1  The screen 
To identify novel genes involved in ER stress resistance and protein quality 
control, we designed a forward genetic screen, using developmental abilities on the 
ER-interrupting drug, TM, as first selection criteria.  
Performing a TM killing concentration experiment (data not shown), we decided to 
use the concentration 10 μg/mL in the screen. Furthermore, we decided to select TM 
resistant mutants after development, since it made the method easier and thereby 
allowed us to screen through higher numbers of mutated genomes. The chosen 
concentration abolished all kinds of WT development, which again eased the factual 
screen, and gave rise to screen through large numbers of genomes.  
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Figure 3.1 A developmental TM resistance screen  
(A). Screening flow (B). Representative images of WT controls and tunicamycin 
(TM) resistant C. elegans mutants after developmental screen for resistance to 
10 µg/mL TM (C). Schematic overview of the screening results 
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To introduce random genetic mutations in the C. elegans genome, we did chemical 
mutagenesis on young adult hermaphrodites (F0) using EMS. The young F0 animals’ 
progeny (F1) were isolated 4-5 days after the parental egg-lay. Figure 3.1A shows the 
structure of the screen (see Experimental Procedure for more details about the screen), 
and in Figure 3.1B (right picture) an example of a TM resistant mutant is shown. 
From the more than 200.000 mutated genomes, we were able to isolate 358 mutants 
that completed development on plates containing TM (Figure 3.1). We performed a 
preliminary survival analysis on these, and found that 109 of tend to live longer 
(Figure 3.1C), indicating that the screen is enriching for long-lived animals. Of the 
109 long-lived mutants, 66 were Dyf (dye filling phenotype) (see Dyf section, chapter 
6).  
We performed whole genome sequencing on 38 of the long-lived mutants. 
Most of the candidate hits revealed from sequencing were singletons, however, in a 
couple of cases we identified independent alleles of the same gene, increasing the 
likelihood that that specific mutation is the actual mutation causing TM resistance and 
extended lifespan. Additionally, phenotype specificity has been used to make 
qualified assumptions on for example the identity of some of the Dyf mutants.  
 
3.B.2  Glutamine-Fructose-6-phosphate Amino-transferase 1 
In one case, we had four independent hits in the same gene (F07A11.2), 
Glutamine-Fructose-6-phosphate Amino-transferase 1 (gfat-1). We had four 
independent point mutations leading to a single amino acid change in each mutant. In 
Figure 3.2A (top panel) a part of the third C. elegans chromosome is shown, 
specifying the position of gfat-1. It is additionally displaying the exact location of the 
mutations, and indicating the changed amino acid. We excluded the gfat-1(dh844) 
from the following work (for more information, see chapter 10).  
GFAT-1 is highly conserved from C. elegans to humans, and even the mutated 
amino acids in the gfat-1 mutants are conserved (Figure 3.2A, bottom). In Figure 3.2B 
the mammalian crystal structure of GFAT-1 is shown, and two of the changed amino 
acids are shown in yellow (top; dh784 and bottom; dh785). In both cases, the amino 
acid is located on the surface of the protein, suggesting that the mutations are likely to 
cause a structural change of the protein. However, this is still unknown.  
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Figure 3.2 Mutations in gfat-1 result in resistance to TM 
(A). Multiple sequence alignment of gfat-1 protein sequences surrounding the amino 
acid substitutions of alleles dh468, dh784, and dh785 (B). Illustrative structure of 
GFAT-1, mutated amino acids are indicated in yellow (C). The hexosamine pathway 
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In mammals, GFAT-1 regulates the rate-limiting step of the hexosamine pathway 
(Figure 3.2C), which in multiple steps converts fructose 6-phosphate into UDP-N-
Acetylglucosamine (UDP-GlcNAc). Due to the high similarity between mammalian 
GFAT-1 and C. elegans GFAT-1 we assumed that the functions were equally similar. 
UDP-GlcNAc is a precursor of N- and O-linked glycosylation of proteins, and 
therefore serves as a posttranslational modifier of proteins. This makes the 
hexosamine pathway a key regulator of several pathways, as N- and O-linked 
glycosylation are essential for many proteins.  
 
3.B.3  gfat-1 gain-of-function mutations protect against TM 
The three different gfat-1 mutants showed distinguishable resistance to TM 
(Figure 3.3A). The gfat-1(dh468) showed lowest resistance, and as the concentration 
of TM was increased to 20 μg/mL, all development was abolished. On the other hand, 
gfat-1(dh784) and gfat-1(dh785) had developing larvae even at 150 and 100 μg/mL 
respectively, indicating that specific alleles cause concentration-specific resistance to 
TM. To confirm the gfat-1 mutants’ resistance to TM, we knocked down gfat-1 or 
gna-2 (glucosamine 6-phosphate N-acetyltransferase 2), which regulates the 
conversion of glucosamine 6-phophate to N-Acetylglucosamine 6-phosphate (the 
following step of the hexosamine pathway), and scored the animals’ resistance to TM. 
Surprisingly, the N2 WT (wild type) animals were not resistant to TM when gfat-1 or 
gna-2 were knocked down by RNAi, and along the same line, gfat-1(dh468) mutant 
became sensitive to TM when treated with RNAi against gfat-1 or gna-2 (Figure 
3.3B). We measured the mRNA level of gfat-1 and gna-2 after RNAi treatment, and 
did however find that mRNA levels were reduced upon the RNAi treatment (Figure 
3.3 C).  
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Figure 3.3 Knockdown of gfat-1 causes TM sensitivity in gfat-1 mutants 
(A). Quantification of developmental TM resistance assay of alleles dh468, dh784, 
and dh785 using different concentrations, 0 µg/mL TM to 200 µg/mL TM (B). 
Developmental TM resistance assay was performed on 10 µg/mL TM-supplemented 
RNAi plates. Eggs were transferred to gfat-1 or gna-2 RNAi plates so TM exposure 
and RNAi mediated knockdown occurred simultaneously (n=3) (C). Quantitative real-
time PCR measurements of gfat-1 and gna-2 mRNA levels after developmental RNAi 
treatment of either gene in WT. Analysis was done in day 1 adults (n=3) (D). 
Developmental TM resistance assay with the offspring of heterozygous animals 
reveals that alleles dh468, dh784, and dh785 were statistically significant different 
from a distribution expected for a recessive allele (data are means±s.e.m., n=18, 
*P<0.05, ***P<0.001 by chi-squared test) 
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Earlier it has been found that knockdown of gfat-1 (F07A11.2) by RNAi in 
worms causes embryonic lethality and developmental arrest (www.wormbase.org), 
however, we did not observe any changes in developmental timing, pumping rate or 
brood size (Supplemental Figure 1A, B, C) in the gfat-1 mutants. That led us to 
speculate whether the mutations we had detected were gain-of-function (gof) 
mutations instead of lof mutations. Additionally, we observed that the gfat-1 
mutations were dominant, leading to at least partial resistant in heterozygous animals 
(Figure 3.3D). gof mutations are usually dominant, again indicating that the gfat-1 
mutations were gof mutations. Together, these results suggested that GFAT-1 lof 
causes TM sensitivity, and we therefor hypothesized that the gfat-1 mutations in the 
mutants from the screen were gof mutations.  
Conceivably, resistance to TM in the gfat-1 mutants stems from gof mutations, 
and we would therefore expect these mutants to have an increased flux through the 
hexosamine pathway, resulting in a higher level of the end product, UDP-GlcNAc. To 
test this, we measured the levels of UDP-GlcNAc by Liquid-Chromatography/Mass-
Spectrometry (LC/MS) and found that the three independent gfat-1 mutants all had 
significantly increased levels of UDP-GlcNAc in both early larvae stages (L1/L2) and 
in young adults (Figure 3.4A). We additionally created a transgenic worm strain, 
overexpressing gfat-1 under its own promoter and found that these animals were 
resistant to TM (Figure 3.4B). Furthermore we were able to feed UDP-GlcNAc and 
GlcNAc (a UDP-GlcNAc precursor) to WT animals, and rescue their TM sensitivity 
(Figure 3.4C).  	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Figure 3.4 gfat-1 gof mutations lead to resistance to TM.  
(A). Representative LC/MS scans of adult C. elegans extracts (left) and quantitative 
LC/MS analysis of pooled L1/L2 larvae and adult animals for UDP-HexNAc levels in 
dh468, dh784, and dh785 alleles of gfat-1 (n=8) (right) (B). Developmental TM 
resistance assay using transgenic animals expressing cfp or gfat-1::cfp fusion under 
gfat-1 regulatory elements (n=3) (C). Quantification of developmental TM resistance 
assay in adult animals after supplementation of indicated compounds on TM plates 
(n=6 **P<0.01, ***P<0.001 vs. D-Arg) (D). Quantification of western blot from 
control and 10 µg/mL TM treated WT and gfat-1 gof mutant animals stained with 
HRP-coupled ConcavalinA. TM treatment was initiated at L4 and done for 18 hours 
(n=4) 
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Elevated levels of UDP-GlcNAc are likely to be the reason for the resistance to TM 
observed in the gfat-1 mutants. UDP-GlcNAc serves as a precursor for N-glycans, 
and we speculated whether the resistance to TM toxicity observed when UDP-
GlcNAc is elevated was due to the animals’ ability to maintain proper levels of N-
glycans. To test this we used Concavalin A staining, and measured bound proteins by 
western blot (WB). Concavalin A is a lectin, and binds all N-glycosylated proteins. 
Interestingly, we found that the level of N-glycosylated proteins was decreased in WT 
animals when they were exposed to TM, which suggests that TM toxicity in WT 
animals stems from inhibited N-glycosylation of proteins. Conversely, no effect was 
observed in the gfat-1 mutants, suggesting that they are able to maintain a proper level 
of N-glycosylation during TM treatment (Figure 3.4D). All together these results 
suggest that gfat-1 mutant animals from the TM resistance screen have gof mutations 
in gfat-1. GFAT-1 gof presumably leads to an increased flux through the hexosamine 
pathway, which results in resistance to TM.   
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3.C.  Discussion  
We have used a forward genetic screening method to select mutants with 
enhanced abilities to cope with TM-induced ER stress. From the screen we have 
identified four independent mutations in gfat-1, which encodes GFAT-1 that catalyzes 
the rate-limiting step of the hexosamine pathway. We identified all the mutations as 
gof mutations, and detected an increased flux through the hexosamine pathway 
resulting in higher levels of the pathway’s end product, UDP-GlcNAc. In addition, 
WT animals became resistant to TM when we overexpressed gfat-1 under its own 
promoter. Consistently, WT animals were able to develop in the presence of TM 
when we supplemented them with UDP-GlcNAc or GlcNAc. Together, these results 
suggest that GFAT-1 gof or supplementation with hexosamine pathway metabolites 
enhance the ability to cope with TM-induced ER stress.  
We hypothesize that the TM resistance stems from mechanisms downstream of 
GFAT-1, however, we can not exclude that gfat-1 gof or overexpression of gfat-1 
downregulate the glycolysis pathway. Previously it has been suggested that caloric 
restriction enhance the resistance to various stresses (Byung P. Yu, 2006) and Schulz 
et al. showed in addition that glucose restriction extended the lifespan of WT animals, 
whereas increased levels of glucose shortened the lifespan (Schulz TJ, 2007). We did, 
however, not detect any changes in pyruvate levels in the gfat-1 gof mutants, 
suggesting that glucose metabolism is unchanged, but we cannot completely exclude 
it.  
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4.A.  Introduction 
In the previous chapter, I have presented our results suggesting that GFAT-1 
gof leads to increased levels of UDP-GlcNAc and that this results in resistance to 
TM-induced ER stress. ER stress resistance and ER protein quality control 
mechanisms have previously been found to play a role in C. elegans longevity 
(Rebecca C. Taylor, 2013) (Sivan Henis-Korenblit, 2010). Additionally, previous 
studies have indicated that these mechanisms decline with age in C. elegans (Rebecca 
C. Taylor, 2013), again suggesting them to be involved in aging.  
Improved protein homeostasis can result from enhanced folding and re-folding 
or from increased turnover of proteins, as a consequence of amplified activity of the 
degradation pathways. The ER has a specific degradation mechanism termed ERAD. 
ERAD recognizes un- or misfolded proteins in the ER lumen, and transfers them to 
protein complexes located in the ER membrane. Here, the proteins will be unfolded 
and translocated out to the cytoplasm, where they after ubiquitination are substrates 
for the proteasome. Inhibition of ERAD is associated with a higher incidence of 
AADs such as Alzheimer’s disease, and point at an important link between altered 
protein homeostasis and aging (Kobayashi T, 2002) (Giuliana Saltini, 2006). 
Furthermore, autophagy, which also plays a role in protein homeostasis (Cuervo, 
2008), has been related to aging. Together, this suggests that improved protein quality 
control mechanisms play a role in aging.  
4.B.  Results  
4.B.1  GFAT-1 gof protects against ER stress and extends lifespan 
gfat-1 gof mutations in C. elegans led to resistance to a WT lethal concentration of 
TM, suggesting that these mutants have improved protection against TM-induced ER 
stress. We therefore looked into the possible connection between GFAT-1 gof and ER 
stress response pathways. A known target of the ER UPR is the ER chaperone HSP-4 
(heat-shock protein 4), which expression is highly increased upon ER stress. We used 
a C. elegans transgenic strain that has gfp expressed under control of the hsp-4 
promoter, giving us the opportunity to determine the expression levels of hsp-4 by 
measuring GFP intensity (Figure 4.1). Interestingly, we found that all gfat-1 gof 
mutant animals showed lower expression of hsp-4 after TM-treatment for 4, 6 and 8 
	   75	  
hours compared to WT controls (Figure 4.1A), suggesting that they are protected 
against TM in a way that they never register the ER stress. Alternatively, they are 
dealing with the TM toxicity upstream of the ER UPR. Consistently, we observed 
similar effects when treating WT animals with UDP-GlcNAc upon TM exposure 
(Figure 4.1B), again suggesting that increased levels of hexosamines are protecting 
the cells against TM-induced ER stress. To confirm the results we measured the hsp-4 
mRNA expression level by qPCR and found that during normal conditions, the WT 
and the gfat-1 gof mutants’ hsp-4 levels are similar. However, after 8 hours exposure 
to TM we observed a doubling of hsp-4 mRNA level in WT animals, whereas no 
changes were observed in the gfat-1 gof mutants (Figure 4.1C).  
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Figure 4.1 gfat-1 gof mutants show less induction of ER stress responses 
(A). WT or gfat-1 gof mutants carrying the Phsp-4::gfp reporter were exposed to 
10 µg/mL TM on day 1 of adulthood. Quantitative analysis show that the gfat-1 
alleles dh468, dh784, and dh785 significantly suppressed GFP induction after 8 hours 
(n=3) (B). Transgenic animals carrying the Phsp-4::gfp reporter were exposed to 
10 µg/mL TM on day 1 of adulthood on plates seeded with UV-killed OP50 bacteria 
and supplemented with 10 mM of indicated compounds. (n=3, ANOVA ***P<0.001 
vs. D-Arg) (C). Quantitative real-time PCR measurements of hsp-4 mRNA in control 
and 10 µg/mL TM treated WT and gfat-1 gof mutant animals. Treatment was done as 
in (B) (D). Phsp-4::gfp transgenic animals were exposed to 10 µg/mL TM on day 1 of 
adulthood after RNAi mediated knockdown of gfat-1 or gna-2 during development. 
gfat-1 or gna-2 knockdown hyper sensitizes WT animals to TM-induced Phsp-4::gfp 
expression (n=3, *P<0.05 vs. gfat-1 or gna-2 RNAi treatment) (E). Quantitative real-
time PCR measurements of gfat-1 mRNA in control and 10 µg/mL TM treated 
animals. Treatment was done as in (B) (t-test) 	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Employing GFAT-1 and the hexosamine pathway upstream of the ER UPR, and 
assuming that GFAT-1 is also the rate-limiting enzyme in the hexosamine pathway in 
C. elegans, as it is in mammals, we asked whether WT hsp-4 expression would be 
affected upon depletion of components of the hexosamine pathway. Interestingly, we 
found an additive increase in hsp-4 expression after 8 hours of TM exposure in WT 
animals, when gfat-1 or gna-2 were knocked down by RNAi (Figure 4.1D). 
Additionally, gfat-1 mRNA expression levels were increased in WT animals when 
exposed to TM. Together, these results suggest the hexosamine pathway as a key-
regulator of the ER stress response pathways, since blocking the hexosamine pathway 
enhance the stress response, and activation of the hexosamine pathway decreases the 
response. ER stress response pathways are also turned on when animals are exposed 
to heat. We did however not detect any resistance to heat in the gfat-1 gof mutants 
(Supplemental figure 4.1D).  
Previously, Henis-Kohrenbilt and colleagues showed that long-lived daf-2 mutant 
animals are protected against ER stress, and that the ER stress response pathways are 
essential for their remarkable lifespan extension (Sivan Henis-Korenblit, 2010). We 
carefully tested the lifespan of the gfat-1 gof mutants, and interestingly, we found 
them all to be significantly long-lived (Figure 4.2A). To make sure that the longevity 
arises directly from mutations in gfat-1, we knocked down gfat-1 or gna-2 by RNAi 
in one of the gfat-1 gof mutants (dh468), and observed an attenuation of lifespan 
extension, without significant changes in WT lifespan (Figure 4.2B). This suggests 
that the lifespan extension is directly related to enhanced flux through the hexosamine 
pathway resulting from gfat-1 gof mutations.  	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Figure 4.2 Enhanced hexosamine pathway flux extends lifespan 
(A). Kaplan-Meier survival curves of gfat-1 alleles dh468, dh784, dh785 show 
significant lifespan extensions (left panel: WT median lifespan 21 days, gfat-1(dh468) 
median lifespan 30 days, P<0.0001; middle-left panel: WT median lifespan 21 days, 
gfat-1(dh784) median lifespan 25 days, P<0.0001; middle-right panel: WT median 
lifespan 21 days, gfat-1(dh785) median lifespan 23 days, P=0.0004; right panel: WT 
median lifespan 21 days (B). Kaplan-Meier survival curves of WT and gfat-1(dh468) 
animals using the indicated RNAi treatment (C). Lifespan assay using transgenic 
animals expressing cfp or gfat-1::cfp fusion under gfat-1 regulatory elements (Pgfat-
1::cfp median lifespan 21 days, Pgfat-1::gfat-1::cfp median lifespan 30 days, 
P<0.0001) (D). Survival curves of WT animals on NGM plates supplemented with the 
indicated compounds. Animals were maintained on UV-killed OP50 E. coli. D-Arg 
was used as osmolarity control. (10 mM D-Arg median lifespan 18 days, 10 mM 
GlcNAc median lifespan 27 days, P<0.0001) (E). Average median lifespan extension 
observed supplementing the indicated GlcNAc concentrations to WT animals, n=3 
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GFAT-1’s ameliorating role in aging was additionally supported when we observed 
that overexpression of gfat-1 in WT animals mimicked the longevity phenotype found 
in gfat-1 gof mutants (Figure 4.2C). Lastly, however very interestingly, we were able 
to extend WT animals’ lifespan by supplementing GlcNAc to the media (Figure 4.2D) 
even down to 1mM GlcNAc (Figure 4.2E). Hence, 25mM GlcNAc reversed the 
lifespan extension, but did not cause a decrease in lifespan compared to WT N2 
animals. This suggests that the lifespan extension is concentration-dependent. 
 
4.B.2  GFAT-1 gof-induced lifespan extension is independent of already known 
longevity pathways 
Several longevity pathways in C. elegans, including reduced insulin/IGF signaling 
pathway and germline removal, depend on the FOXO transcription factor DAF-16 to 
maintain their long life (Kenyon C. J., 2010). DAF-16 also mediates resistance to 
various types of cellular stress, so we tested the role of DAF-16 in the gfat-1 gof 
mutants. We found that GFAT-1 gof-induced TM resistance was independent of 
DAF-16 in all three gfat-1 gof mutant alleles (data not shown). Additionally, 
expression of DAF-16 target genes such as sod-3, dod-3 and dod-8 were unchanged in 
the gof mutants (Figure 4.3A, C), at least when measured by qPCR. Notably, GlcNAc 
supplementation and gfat-1 gof mutation extended the lifespan of daf-16(mgDf50) 
and daf-2(e1368) mutants (Figure 4.3D, F), pointing at a longevity mechanism at least 
partially independent from the DAF-16/FOXO and DAF-2 longevity pathways. No 
changes in UDP-GlcNAc levels were observed in other tested long-lived animals, 
including those carrying mutations in genes affecting the insulin signaling pathway 
(daf-2), gonadal outgrowth (glp-1) and mitochondrial function (isp-1), dietary intake 
(eat-2), and protein translation (ife-2) (data not shown). Collectively, these results 
indicate that known longevity pathways do not obviously activate the hexosamine 
pathway, implying that GFAT-1 gof is a novel mechanism to extend lifespan in the 
roundworm C. elegans.  
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Figure 4.3 gfat-1 gof mutants are long-lived, independent of the DAF-2/DAF-16 
longevity pathway 
(A). Developmental TM resistance assay using gfat-1 gof and daf-16 single and 
double mutants (B). Developmental TM resistance assay using gfat-1 gof, oga-1 and 
ogt-1 single and double mutants (C). Quantitative real-time PCR measurements of 
DAF-16 target genes in adult animals from indicated genotypes shows no induction in 
gfat-1 gof mutants (D), (E). Kaplan-Meier survival curves of daf-16(mgDf50) (D) and 
ogt-1(ok430) (E) treated with indicated compounds (F). Kaplan-Meier survival curves 
of gfat-1 gof, daf-2 and daf-16 single and double mutants (G). Kaplan-Meier survival 
curves of gfat-1 gof, ogt-1 and oga-1 single and double mutants (H). Kaplan-Meier 
survival curves of gfat-1(dh468) using indicated RNAi bacteria.  
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In addition to N-glycosylation, which is specifically inhibited by TM, the hexosamine 
pathway gives rise to precursors used for O-glycosylation. O-glycosylation was 
previously implicated in C. elegans lifespan: O-GlcNAc transferase (ogt-1) lof 
mutants are short-lived while O-GlcNAcase (oga-1) mutants are modestly long-lived 
(Rahman M.M., 2010). This suggests that enhanced O-glycosylation of client proteins 
is associated with longevity. However, neither oga-1 nor ogt-1 affected the gfat-1 
mutants’ developmental TM resistance (Figure 4.3B). Moreover, GlcNAc 
supplementation extended the lifespan of ogt-1 mutants (Figure 4.3E), and both the 
ogt-1 and oga-1 mutants lived longer when crossed into the gfat-1(dh468) mutant 
background (Figure 4.3F). These results indicate that O-glycosylation does not play 
an appreciable role in developmental TM resistance or longevity of gfat-1 gof 
mutants.  
HSF-1 is a key regulator of C. elegans stress response pathways, and we 
therefore looked at hsf-1 mutants’ lifespan when introduced into the gfat-1 gof mutant 
background. We did not observe any differences between the lifespan of gfat-
1(dh468) mutant animals on RNAi against hsf-1 and gfp (data not shown). However, 
hsf-1 RNAi made all animals very short-lived, making it hard to detect any specific 
changes in lifespan.  
4.B.3  GFAT-1 gof improves ER protein quality control 
Given that we observed resistance to TM-induced ER stress, we hypothesized 
that improved ER protein homeostasis might contribute to the observed lifespan 
extension. We therefore asked whether elevation of hexosamine pathway metabolites 
causes changes in the protein-folding milieu within the ER lumen. To this end, we 
made use of the neuroserpin homolog and folding sensor serpin 2 (SRP-2), which is 
fused to YFP (SRP-2H302R::YFP). SRP-2 accumulates in the ER lumen due to a point 
mutation, and the aggregation is modulated by the heat shock response and the UPR 
(Schipanski A., 2013). srp-2::yfp is expressed in the body wall muscles due to co-
expression with the unc-54 promoter. 0 the head region as a read-out for ER 
degradation and/refolding functions. A time course analysis revealed an increase in 
SRP-2H302R::YFP puncta from the L4 to adult stage and no further increase after the 
first day of adulthood in WT animals. At all measured time points, SRP-2H302R::YFP 
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accumulation was significantly reduced in gfat-1 gof mutants (Figure 4.4A) and in 
Figure 4.4B representative photos are shown.  
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Figure 4.4 Enhanced hexosamine pathway flux alleviates SRP-2H302R aggregation 
in the ER 
(A). Time course of SRP-2H302R::YFP aggregation. Quantification was done in head 
region of ≥ 20 animals (data are mean ± s.d., representative result from n=3 
experiments, ***P<0.001 vs. gfat-1) (B). Representative fluorescent images of Punc-
54::srp-2H302R::yfp transgenic animals crossed to the indicated strains. Head regions 
are shown and arrows point to SRP-2H302R::YFP aggregates (C). Quantification of 
SRP-2H302R::YFP aggregates after exposure to the indicated compounds at indicated 
stages of life. Supplementation with compounds was done for the 24 hours prior to 
quantification (n=3) (D). Quantification of SRP-2H302R::YFP in cfp and gfat-1::cfp 
transgenic animals (representative result from n=3 experiments, t-test)	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Next, we tested if GlcNAc supplementation might alleviate WT SRP-2 
aggregation. Interestingly, GlcNAc treatment ameliorated protein aggregation in 
young adults (Figure 4.4C, left) when supplemented with GlcNAc from L1. More 
importantly, we were able to clear already established SRP-2H302R::YFP aggregates 
when provided at a later time during adulthood. Remarkably, 24h exposures to 
GlcNAc reduced SRP-2H302R::YFP puncta at various adult time points until day 12 of 
adulthood (Figure 4.4C). Together these data reveal that increased hexosamine 
pathway metabolite levels not only improve the ER’s capacity to prevent 
accumulation of aggregated proteins, but also reverse aggregation. Lastly, we also 
observed reduced aggregation of SRP-2 in gfat-1::cfp transgenic animals (Figure 
4.4D), again indicating that enhanced hexosamine pathway flux, induced genetically 
or pharmacologically, improve ER protein homeostasis. 
To make sure that the improved prevention and removal of SRP-2 aggregates 
is directly linked to enhanced hexosamines, we knocked down gfat-1 and gna-2 in 
gfat-1(dh468) gof mutants by RNAi and quantified the number of SRP-2 aggregates. 
We observed a decrease in SRP-2 aggregates in gfat-1(dh468) gof mutant animals 
upon treatment with control RNAi (empty vector) compared to WT animals. 
Conversely, the decrease was rescued when gfat-1 or gna-2 were knocked down 
(Figure 4.5A), supporting the hypothesis that improved ER protein quality control is 
linked to the gfat-1 gof mutation. Additionally, we measured the overall protein levels 
of SRP-2, and found no changes (Figure 4.5B, C), suggesting that reduced protein 
aggregation is a result of improved protein homeostasis and not a general 
downregulation of protein-occurrence. 	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Figure 4.5 GFAT-1 gof improves SRP-2H302R aggregation without affecting 
overall SRP expression 
(A). Quantification of SRP-2H302R::GFP aggregates in WT and gfat-1(dh468) animals 
after treatment with indicated RNAi. Knockdown of gfat-1 or gna-2 abolishes the 
suppression of SRP-2H302R::GFP aggregated formation in gfat-1(dh468) animals (B). 
Western blotting of SRP-2H302R::GFP and α-tubulin in cfp and gfat-1::cfp transgenic 
animals detected no significant differences in relative SRP-2H302R::GFP expression in 
the transgenic lines (C). Western blots showing protein expression levels of SRP-
2H302R::GFP and α-tubulin in L4 and adult animals. Densitometry and quantification of 
signals (right) shows no difference in relative SRP-2H302R::GFP levels in WT and gfat-
1 gof mutant animals.	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As an additional toxic aggregation prone protein, we turned to animals expressing 
human ER-targeted Aβ42 peptide in the muscles (Link, 1995) (Link C.D., 2001). 
These animals undergo progressive muscle-paralysis during adult aging due to Aβ 
toxicity. When crossed with gfat-1 gof mutants, transgenic Aβ animals showed 
significant improvements in motility at day 8 of adulthood (Figure 4.6A). Similarly, 
WT Aβ animals showed delayed paralysis after GlcNAc treatment compared to 
control animals that were fed supplemented with D-Arg (Figure 4.6B). These results 
support the idea that increased hexosamine pathway metabolites, either from GFAT-1 
gof or GlcNAc supplementation, alleviate proteotoxicity in the ER.  
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Figure 4.6 GFAT-1 gof improves ER functions in a post-translational manner 
(A). Fraction of paralyzed Punc-54::humanAβ transgenic animals in WT of gfat-1 gof 
mutant background at day 7 of adulthood (n=4) (B). Punc-54::humanAβ transgenic 
animals were treated with indicated compounds in a bath for 6 hours daily in the 
presence of UV killed OP50 and otherwise maintained under standard culture 
conditions; fraction paralyzed worms were quantified at day 7 of adulthood. (n=3 
**P<0.01 vs. D-Arg) (C). Relative mRNA levels of indicated UPR genes in WT 
animals and gfat-1 mutants (n=3) (D). Quantified protein levels of HSP-4 (left) and 
CNX-1::GFP (right) determined by Western blotting (n=4 (left) and n=3 (right)). 
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Conceivably, GFAT-1 gof leads to increased aggregation removal, prevention 
of aggregation and improved motility by upregulating one or several of the ER stress 
response pathways. Unexpectedly, however, we did not observe any changes in the 
transcriptional regulation of known UPR target genes by qPCR (Figure 4.6C), 
including hsp-4, spliced xbp-1, and target genes of the ATF-6 and PEK-1 UPR 
branches (Shen, 2005). HSP-4 protein levels were slightly increased without reaching 
statistical significance, and CNX-1 protein levels were unchanged (Figure 4.6D), 
suggesting that ER UPR is not upregulated in the gfat-1 gof mutants. 
To further explore ER functions in gfat-1 gof mutant animals we investigated 
the effects of inhibiting ER UPR components and proteins imvolved in N-
glycosylation in the aggregation dynamics of SRP-2H302R::YFP. Downregulation of the 
ER UPR pathway using RNAi against ire-1 and xbp-1 increased SRP-2H302R::YFP 
aggregates in gfat-1 gof mutants (Figure 4.7A). Knockdown of atf-6 only partly 
suppressed the beneficial effects from the gfat-1 gof mutation, and pek-1 knockdown 
had no effect. Correlatively, GFAT-1 gof-induced longevity was completely 
dependent on the ire-1 and xbp-1 (Figure 4.7B). Together, these results suggest that 
specific branches of the ER UPR pathway co-assist the improved protein homeostasis 
and longevity of the gfat-1 gof mutants. So even though we did not observe any 
changes at the transcriptional level, these results suggest that a functional ER UPR is 
required but not activated in gfat-1 gof mutant animals.  
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Figure 4.7 Improved ER functions in gfat-1 gof mutants are dependent on ER-
UPR and N-glycosylation components 
(A). SRP-2H302R::YFP aggregate count in WT and gfat-1(dh468) mutants after RNAi-
mediated knockdown of indicated UPR genes (n=3) (B). Representative survival 
demography of WT and gfat-1(dh468) animals treated with indicated RNAi targeting 
UPR genes. (WT(gfp) median lifespan 24 days, gfat-1(dh468)(gfp) median lifespan 
29 days, P<0.0001; WT(ire-1) median lifespan 22 days, gfat-1(dh468)(ire-1) median 
lifespan 24 days, P<0.005 vs. gfat-1(dh468)(gfp); WT(xbp-1) median lifespan 22 
days, gfat-1(dh468)(xbp-1) median lifespan 22 days, P<0.001 vs. gfat-1(dh468)(gfp)) 
(C). SRP-2H302R::YFP aggregate quantification in WT and gfat-1(dh468) animals 
treated with RNAi targeting indicated oligosaccharyltransferase (OST) complex genes 
(n=3) (D). Representative lifespan analysis of WT and gfat-1(dh468) animals treated 
with RNAi targeting the OST complex gene ribo-1 (WT(gfp) median lifespan 24 
days, gfat-1(dh468)(gfp) median lifespan 29 days, p < 0.0001; WT(ribo-1) median 
lifespan 24 days, gfat-1(dh468)(ribo-1) median lifespan 24 days, p < 0.0013 vs. gfat-
1(dh468)(gfp))	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Another pathway required for the gfat-1 gof mutants, is the N-glycosylation 
pathway. Preventing N-glycosylation by inhibiting components of the 
oligosaccharyltransferase (OST) complex suppressed the reduction of SRP-
2H302R::YFP puncta in gfat-1 gof mutants. Additionally, the lifespan extension was 
dependent on the OST complex (Figure 4.7C, D). These data suggest that N-
glycosylation is required for improved protein homeostasis and longevity in gfat-1 gof 
mutants. 
We were surprised to find no evidence for induction of the ER UPR or the N-
glycosylation pathways, and thus, we hypothesized that ERAD activity might be 
induced. ERAD client proteins are retro-translocated from the ER lumen to the 
cytosol before proteasomal degradation. The SEL-11 ubiquitin ligase complex 
controls this translocation and ubiquitin-dependent degradation process (Bordallo et 
al., 1998) in conjunction with the ER membrane glycoprotein SEL-1 that serves as a 
cofactor (Hampton et al., 1996). Interestingly, we found a 2-fold increase in SEL-1 
protein expression in all three gfat-1 gof mutants using Western blot analysis of worm 
lysates (Figure 4.8A). Similarly, we detected increased levels of SEL-1 protein 
expression in gfat-1::cfp transgenic animals and in WT animals supplemented with 
GlcNAc (Figure 4.8B, C). Together, this points at evidence that enhanced hexosamine 
pathway metabolites increase the expression of SEL-1 protein levels, and suggests a 
possible longevity-mechanism. 
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Figure 4.8 Enhanced flux through the hexosamine pathway increases the 
expression of SEL-1 
(A). Representative Western blot from L4 WT and gfat-1 gof mutant animals 
detecting SEL-1 and α-tubulin (left) and analysis of SEL-1 Western blots from n=3 
independent experiments. SEL-1 levels were normalized to α-tubulin (right) (B). 
Representative Western blot from L4 cfp and gfat-1::cfp transgenic animals detecting 
SEL-1 and α-tubulin (left) and analysis of SEL-1 Western blots from n=3 
independent experiments. SEL-1 levels were normalized to α-tubulin (n=4, t-test) 
(right) (C). Representative Western blot from L4 WT animals supplemented with 
indicated compounds detecting SEL-1 and α-tubulin (left) and analysis of SEL-1 
Western blots from n=3 independent experiments. SEL-1 levels were normalized to 
α-tubulin (n=7, t-test) (right) 
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We did not detect any transcriptional changes of sel-1 or sel-11 (Figure 4.9A), 
again suggesting that the increased expression level of SEL-1 stems from post-
translational modifications. We next tested the role of ERAD in SRP-2H302R::YFP 
aggregation and lifespan extension of gfat-1 gof mutants. RNAi experiments 
identified a strict requirement for sel-1 and sel-11, as knockdown suppressed the gfat-
1 mutants’ alleviated ER luminal protein aggregation (Figure 4.9B). Additionally, the 
longevity of the gfat-1 gof mutants was completely abolished upon knockdown of sel-
1 or sel-11, again suggesting a strict requirement of ERAD (Figure 4.9C). 
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Figure 4.9 ERAD is required for GFAT-1 gof-induced longevity 
(A). Quantitative real-time PCR measurements of ERAD genes in L4 animals from 
indicated genotypes (B). SRP-2H302R::YFP aggregation in WT and gfat-1 gof mutants 
treated with RNAi targeting ERAD genes sel-1 and sel-11 (n=3) (C). Lifespan 
analysis of WT and gfat-1(dh468) animals treated with indicated RNAi targeting 
ERAD gene expression (WT(gfp) median lifespan 24 days, gfat-1(dh468)(gfp) 
median lifespan 29 days, P<0.0001; WT(sel-1) median lifespan 22 days, gfat-
1(dh468)(sel-1) median lifespan 22 days, P<0.005 vs. gfat-1(dh468)(gfp); WT(sel-11) 
median lifespan 24 days, gfat-1(dh468)(sel-11) median lifespan 24 days, P<0.005 vs. 
gfat-1(dh468)(gfp)) 
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When luminal aggregated proteins are translocated to the cytoplasm, they will be 
ubiquitinated and broken down by the proteasome. We were unable to detect any 
transcriptional changes in rpn-6, which is an essential subunit for the activity of the 
26S/30S proteasome, and in rpn-8 that also serves as a proteasome regulatory particle 
(Figure 4.9A). However, since we had observed an apparent involvement of the 
ERAD machinery, we speculated whether GFAT-1 gof also led to resistance to 
bortezomib, which is a proteasome inhibitor. Indeed this was the case; we found that 
all gfat-1 gof mutants exhibited increased resistance to 30μM bortezomib (Figure 
4.10A). 
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Figure 4.10 Increased hexosamine pathway metabolites improve protein 
degradation by the proteasome 
(A). Developmental bortezomib resistance assay with indicated genotypes. gfat-1 gof 
alleles show significantly increased fraction of developed animals compared to WT at 
30 μM bortezomib (n=3) (B). Relative chymotrypsin-like proteasome activity assay 
measuring LLVY-AMC turnover at 25°C in lysates of gfat-1 gof mutant L4 larvae. 
The proteasome inhibitor bortezomib served as a negative control (n=4) (C). Relative 
trypsin-like proteasome activity assay measuring LLVY-AMC turnover at 25°C in 
lysates of gfat-1 gof mutant L4 larvae. The proteasome inhibitor bortezomib served as 
a negative control (n=3) (D). Relative chymotrypsin-like (left) and trypsin-like (right) 
proteasome activity assays measuring LLVY-AMC turnover at 25°C in lysates of WT 
L4 larvae exposed to indicated compound. The proteasome inhibitor bortezomib 
served as a negative control (n=3) 
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Bortezomib inhibits the 26S proteasome, suggesting that gfat-1 gof mutants are able 
to overcome this inhibition by either directly increasing the activity or indirectly by 
enhancing degradation of proteins in for example lysosomes. To test this, we 
measured the activity of the proteasome, and observed a mild, yet significant, increase 
in chymotrypsin-like proteasome activity, as measured by turnover of an LLVY-
tagged fluorescent substrate, in all gfat-1 gof alleles (Figure 10B). Additionally, gfat-
1(dh785) showed a significant increase in trypsin-like activity (Figure 10C). Lastly, 
we supplemented WT animals with GlcNAc and measured their proteasome 
activities; supplementation stimulated both the chymotrypsin-like and the trypsin-like 
proteasome activities in WT animals, although the trypsin-like activity did not reach 
significance (Figure 10D). Together, this suggests that enhanced hexosamine pathway 
metabolites increase degradation of proteins by the proteasome, and that it is, at least 
partly, allele-specific.   
Knockdown of rpn-6 and rpn-8 using RNAi, abrogated the lifespan extension 
of gfat-1 gof mutants, however, it also shortened WT lifespan, and it is therefore 
impossible to say anything about the specificity and importance of rpn-6 and rpn-8 in 
GFAT-1 gof longevity. Altogether, increased expression of SEL-1 and enhanced 
proteasome activity suggest that improved ER protein homeostasis in gfat-1 gof 
mutants is linked to longevity and enhanced proteolytic capacity. 
 
4.B.4  GFAT-1 gof enhances autophagy 
Autophagy has been suggested to be involved in protein quality control 
(Menzies F.M., 2011), and indeed also in longevity. Autophagy is, however, not an 
ER specific degradation pathway, but we speculated that it might also be affected, 
since a recent study has indicated that the hexosamine metabolite, glucosamine, 
induces autophagic events in cell cultures (Shintani T., 2010). When autophagosomes 
are formed, the nematode Microtubule-associated protein light chain 3 (LC3) 
homologue LGG-1 condenses into puncta. The number of puncta is reflecting the 
activity of autophagy, or at least the presence of formed autophagosomes (Melendez, 
2003). We used a transgenic C. elegans strain that has lgg-1 fused to gfp, and 
quantified the number of formed puncta (foci) in epidermal seam cells of young 
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animals. Interestingly, we found a 60-70% increase of LGG-1::GFP foci formation in 
gfat-1 gof mutants relative to WT animals (Figure 11A). Consistently, this increase 
was confirmed by WB where we detected an increase in the lipidated form of LGG-
1::GFP in all gfat-1 gof mutant alleles (Figure 11B). This enhancement was indeed 
due to increased flux through the hexosamine pathway since a knockdown of gfat-1 or 
gna-2 by RNAi reduced the increased puncta formation (Figure 11C). These results 
suggest that GFAT-1 gof induces autophagy, and that the increase in autophagic 
events is due to increased hexosamines. However, no significant changes in mRNA 
expression of known autophagy genes were observed, indicating that autophagy is 
induced post-transcriptionally (Figure 11D).  
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Figure 4.11 GFAT-1 gof enhances the level of autophagy 
(A). Average number of LGG-1:GFP foci per seam cell of L3 larvae in indicated 
genotypes shows elevated autophagosome formation in gfat-1 gof mutants, 
**P<0.001, ***P<0.001 vs. WT (B). Representative (left) and analysis (right) of 
western blot using anti-GFP antibodies to detect LGG-1::GFP fusion protein in L4 
animals, PE-LGG-1::GFP levels were normalized to α-tubulin (n=6) (C). 
Quantification of LGG-1::GFP puncta in WT and gfat-1(dh468) animals after 
knockdown of gfat-1 or gna-2 (n=3) (D). Quantitative real-time PCR measurements 
of autophagy genes in L4 animals from indicated genotypes (n=5) 
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Conceivably, autophagy is enhanced in the gfat-1 gof mutants due to increased flux 
through the hexosamine pathway leading to a higher level of hexosamines. To 
confirm this idea, we supplemented WT animals with GlcNAc and measured the level 
of autophagy. Consistent with earlier results, we found the number of LGG-1::GFP 
puncta increased in WT animals supplemented with GlcNAc compared to control 
animals supplemented with M9 or D-Arg as a control for osmolality (Figure 4.11A). 
The same was observed when we quantified LGG-1::GFP by WB, without changing 
the overall GFP expression significantly (Figure 4.11B, C).  
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Figure 4.12 GlcNAc induces autophagic degradation 
(A). Quantification of LGG-1::GFP puncta in seam cells of L3 WT animals after 
indicated treatment (n=3) (B). Representative western blot (left) and analysis (right) 
of western blot using anti-GFP antibodies to detect LGG-1::GFP fusion protein in L4 
WT animals after indicated treatment (C). Analysis of LGG-1::GFP Western blots as 
in (B) from n=4 experiments. LGG-1::GFP levels were normalized to α-tubulin (D). 
Average number of p62::GFP foci per posterior pharyngeal bulb of L4 larvae in ≥ 15 
WT and gfat-1(dh468) animals (t-test, n=3)	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We interpreted increased levels of LGG-1::GFP foci as enhanced levels of autophagy, 
but to be sure that increased LGG-1::GFP expression is a measure for enhanced 
activation and increased degradation, we quantified the turnover of p62. p62 is also 
called sequestosome 1, and is an ubiquitin-binding scaffold protein and a 
physiological substrate selectively removed by autophagy (Tian Y., 2010). We 
observed a reduction in p62::GFP foci in the posterior pharyngeal bulb when the 
transgene was expressed in the gfat-1(dh468) gof mutant background (Figure 4.11D) 
compared to WT controls. This result supports the previous presented data and all 
together, the findings suggest that enhanced hexosamines, as a result of genetically or 
pharmacologically modifications, increase the activity and turnover of proteins by 
autophagy.  
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Figure 4.13 gfat-1 gof mutants are dependent on autophagy to remain protected 
against SRP-2H302R aggregation and to sustain longevity.	  
(A). Quantification of SRP-2H302R::YFP aggregates in L4 animals after developmental 
exposure to atg-18 RNAi or L4440 empty vector control (n=3) (B) Kaplan-Meier 
survival curves of N2 and gfat-1(dh468) animals exposed to indicated RNAi from 
young adulthood (WT(gfp) median lifespan 19 days, gfat-1(dh468)(gfp) median 
lifespan 26 days, P<0.0001; WT(atg-18) median lifespan 19 days, gfat-1(dh468)(atg-
18) median lifespan 21 days, P<0.0001 vs. gfat-1(dh468)(gfp)) 
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Since autophagy was induced as a result of increased hexosamine pathway flux, we 
tested if improved ER protein homeostasis and lifespan extension of gfat-1 gof 
mutants depend on autophagy. Interestingly, we found that prevented SRP-2 protein 
aggregation in gfat-1 gof mutants was abolished by RNAi mediated knockdown of 
atg-18, which is an autophagy-specific and essential gene (Figure 4.12A). WT SRP-2 
aggregation levels did not change significantly, suggesting a specific dependence of 
autophagy in gfat-1 gof mutants. Furthermore, atg-18 RNAi shortened the lifespan of 
gfat-1 gof mutants without having an effect on adult WT controls (Figure 4.12B). 
Taken together, gfat-1 gof mutations induce autophagy, which supports ER protein 
homeostasis and lifespan extension. 
Conceivably, protein degradation by autophagy contributes to a cleaner milieu in the 
ER lumen, and as shown in Figure 4.13, autophagy is additionally required for 
GFAT-1 gof longevity. To test different possibilities for the upregulated activity of 
autophagy, we knocked down components of the N-glycosylation pathway (Figure 
4.14A), the ER UPR (Figure 4.14B), ERAD (Figure 4.14C) and in addition, TOR 
(target of rapamycin) (let-363) (Figure 4.14D).  
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Figure 4.14 GFAT-1 gof-induced autophagy increase is dependent on N-
glycosylation components and ERAD 
(A, B, C, D). Quantification of LGG-1::GFP puncta in seam cells of L3 WT and gfat-
1 gof mutant animals after inhibition of components of the OST complex (A), the 
UPR pathway (B), the ERAD pathway (C) and TOR (D) 
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When we impaired N-glycosylation in gfat-1 gof mutants by knocking down 
components of the OST complex, we observed a decrease in LGG-1::GFP puncta, 
suggesting that the autophagy-induction is dependent on N-glycosylation. This was 
not a general effect, as WT levels were not significantly changed upon knockdown of 
OST complex components  (Figure 4.14A). In contrast, we did not find any changes 
in the formation of LGG-1::GFP foci in the gfat-1 gof mutants when we knocked 
down components of the ER UPR pathways. This suggests that the upregulation of 
autophagy is independent on ER UPR (Figure 4.14B). When we, on the other hand, 
knocked down components of the ERAD pathway, we completely abrogated the 
increased number of LGG-1::GFP foci, indicating a strict dependence of ERAD 
(Figure 4.14C). Lastly, we tested the interplay with TOR, which is known to inhibit 
autophagy; knockdown of tor (let-363) increases autophagy, which for example is 
observed in DR animals (Malene Hansen, 2008). When we knocked down tor in gfat-
1 gof mutants, we did observe a modest increase in the number of LGG-1::GFP 
puncta, suggesting that GFAT-1 gof, at least partly, enhances the activity of 
autophagy in a TOR independent manner (Figure 4.14D). Together, these results 
indicate that several protein quality control mechanisms are affecting each other. 
Additionally, GFAT-1 gof-induced autophagy is independent of the ER UPR and of 
the TOR-mediated upregulation of autophagy. 
 
4.B.5  Increased hexosamine pathway metabolites alleviates proteotoxicity 
Protein quality control mechanisms are not only important for ER protein 
homeostasis, but are comprehensive mechanisms essential for cellular maintenance, 
functions and survival. Since we had observed increased degradation by autophagy 
and elevated proteasome activity in gfat-1 gof mutants and in WT animals 
supplemented with GlcNAc, we wondered whether these changes might go beyond 
the ER. To test this, we made use of additional protein aggregation models, including 
polyglutamine (polyQ40) repeats and α-synuclein, which are both cytosolic 
aggregation prone protein models. PolyQ repeats are found in aggregation-prone 
proteins such as Huntingtin, implicated in Huntington’s disease, whereas α-synuclein 
is associated with Parkinson’s and Alzheimer’s disease. Because polyQ40 and α-
synuclein transgenic animals express the ectopic toxic protein species in muscle cells 
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(under control of the unc-54 promoter), they have enhanced muscle paralysis starting 
from day 6 of adulthood. This allows us to use motility as readout for toxicity, by 
counting the number of bodybends in liquid. 
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Figure 4.15 GFAT-1 gof alleviates proteotoxicity 
(A). Motility assays using 7 days old animals with Punc-54 driven muscle specific 
expression of (left) polyQ40-YFP fusion protein, and (right) α-synuclein-GFP after 
treatment with indicated compounds (B). Motility assay using Punc-54::polyQ40 
(left) and Punc-54::α-synuclein (right) transgenic animals at day 7 of adulthood after 
exposure to indicated RNAi starting from day 1 of adulthood (C). Representative 
(left) and analysis (right) of GFP Western blots of SDS soluble and SDS insoluble 
material in Punc-54::Q40::gfp transgenic animals with the indicated genotypes (D). 
Representative (left) and analysis (right) of GFP Western blots of SDS soluble and 
SDS insoluble material in Punc-54::α-synuclein::gfp transgenic animals with the 
indicated genotypes 
A B
C D
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Interestingly, we found significant motor function improvements in both 
proteotoxic disease models upon a 6-day treatment initiated from young adulthood. 
We treated the animals for 6 hours per day with 10 mM GlcNAc or 10 mM UDP-
GlcNAc supplemented in liquid (Figure 4.15A). Consistently, we observed increased 
motility in both aggregation prone protein models when they were crossed into the 
gfat-1 gof mutant background (Figure 4.15B). The hexosamine pathway specificity 
was confirmed by RNAi knockdown experiments targeting gfat-1 or gna-2; we 
rescued the motility improvement in gfat-1 gof mutants upon inhibition of gfat-1 or 
gna-2 without changing the WT motor function (Figure 4.15B). These results suggest 
an extensive role of the hexosamine pathway in protection from proteotoxicity. 
Overall abundance of Q40::GFP and α-synuclein::GFP was not reduced in the gfat-1 
gof mutants (Figure 4.15C, D), suggesting that improved motility is due to 
amelioration of proteotoxicity and not an unspecific decrease in protein occurrence.  
Conceivably, GFAT-1 gof improves motility due to improved protein quality 
control mechanisms. To test this hypothesis, we knocked down atg-18, sel-1 and sel-
11 in gfat-1 gof mutants and measured their proteotoxicity, again using motility as 
readout. 
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Figure 4.16 GFAT-1 gof alleviates proteotoxicity in manner dependent on 
autophagy and ERAD 
(A, B, C). Motility assays using 7 days old animals with Punc-54 driven muscle 
specific expression of (A) polyQ40-YFP fusion protein, and (B, C) α-synuclein-GFP. 
Genotypes and RNAi treatment are indicated  
 
 
 
 
A B C
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Surprisingly, however interestingly, we found that both autophagy and ERAD are 
required for GFAT-1 gof-improved motility. Knockdown of atg-18, sel-1 or sel-11 
completely abolished the amended bodybends in both polyQ40 and α-synuclein 
disease models in all three gfat-1 gof alleles (Figure 4.16A, B, C). Together, these 
data show that hexosamine pathway metabolites induce a broad-spectrum protection 
against proteotoxicity in various cellular compartments.  
 
4.B.6  GFAT-1 gof does not change the transcriptional output of the ER quality 
control mechanisms 
From the presented data, we find a clear enhancement of ER protein quality 
control mechanisms and autophagy, and our results also suggest that they are required 
for the gfat-1 gof mutant’s lifespan extension. We were however not able to detect 
any changes in mRNA levels of these genes, and performed RNA sequencing to 
reveal possible changes in the transcriptome. Very surprisingly, expression levels in 
the gfat-1 gof mutants of genes involved in any of the studied pathways were 
unchanged compared to WT controls. In general, only a small number of genes 
showed significant expression changes. Among this group, it was noteworthy that 
pmk-1, pmk-2, and pmk-3, orthologues of the human p38 mitogen-activated protein 
kinase (MAPK) showed significant up-regulation. In worms, the MAPK pathway has 
been found to play a role in stress resistance via the transcription factor SKN-1 (Inoue 
H, 2005) that plays a role in oxidative stress resistance and xenobiotic detoxification. 
Additionally, latest research point at the MAPK pathway to play a role in SKN-1 and 
DAF-2 longevity mediated pathways (Okuyama T, 2010).  
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4.C.  Discussion 
In this chapter, I show results indicating that enhanced levels of hexosamine 
pathway metabolites either by gof mutations in gfat-1, by enhancing the copy number 
of WT gfat-1 or by supplementing WT animals with GlcNAc extend lifespan and 
alleviates proteotoxicity of various toxic aggregation prone proteins, which leads to 
improved motility. Our results also suggest that the protein degradation is enhanced 
by elevated levels of SEL-1, higher activity of the proteasome and by increased 
formation of autophagosomes. Lastly, the GFAT-1-induced longevity was dependent 
on these pathways and our results clearly point towards a global improvement in 
protein quality control.  
The data indicate that the improved protein homeostasis stems largely from 
post-transcriptional modifications leading to enhancement of ERAD, proteasome 
activity as well as autophagy, as we found no transcriptional changes in genes of these 
pathways. We furthermore failed to observe any transcriptional changes in stress 
response genes of for example the mitochondrial heat shock response, again 
suggesting that the observed improvements are not due to transcriptional changes. We 
did however observe transcriptional changes in genes regulating the MAPK pathway 
in C. elegans, which is involved in stress resistance and longevity modulated by SKN-
1 and DAF-16. Lifespan studies using mutants with inhibited DAF-16 did conversely 
indicate that GFAT-1 gof-mediated longevity is, at least partly, independent of DAF-
16.  
GFAT-1-induced longevity seems to be a novel mechanism to prolong life, as 
elevated levels of UDP-GlcNAc were not detected in several other long-lived C. 
elegans mutants, including mutants with reduced insulin signaling, decreased 
mitochondrial activity, inhibited gonadal signaling or dietary restriction. Earlier 
studies have suggested that O-glycosylation plays a role in daf-2 longevity, and that 
inhibition of oga-1 (O-GlcNAcase) or ogt-1 (O-GlcNAc transferase) extend and 
shortens C. elegans lifespan, respectively. We did not observe any changes, different 
from WTs, in gfat-1 gof mutants when modulating these genes. Additionally, we were 
able to extend the lifespan of these mutants by supplementing them with GlcNAc, 
suggesting that GFAT-1 induced longevity is independent of the O-glycosylation 
dependent lifespan modulations.  
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Together, these data suggest a novel mechanism to extend C. elegans lifespan 
that presumably is a result of post-transcriptional modifications of proteins involved 
in cellular protein quality control mechanisms.  
See chapter 9 for a more detailed discussion about GFAT-1.  
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Supplemental Figure 1. Additional Characterization of the gfat-1 gof mutants	  
(A). Fraction animals that completed development on TM plates after treatment with 
indicated compound (B). GFP intensity of Phsp-4::gfp transgenic animals after heat 
exposure. Genotypes are indicated under the bars (C). Developmental timing detected 
in gfat-1 gof mutants (D). Heat stress resistance assay using gfat-1 gof mutants, 
estimating the survival at 32C (E). Pumping rate mesured in young adults in indicated 
gfat-1 gof mutants (F). Number of live offspring at different days in indicated gfat-1 
gof mutants 
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CHAPTER 5. Increased sel-1 Expression is 
Sufficient to Extend Life 
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5.A.  Introduction 
In the presented data, and in Denzel, Storm et al., we showed that GFAT-1 gof 
increases the protein expression level of the ERAD component, SEL-1. Additionally, 
we find that sel-1 is required for GFAT-1 gof-induced longevity and for ameliorated 
clearance of aggregation prone proteins. We also show that GFAT-1 gof and 
supplementation with GlcNAc increase the activity of the proteasome, and from 
earlier published work, we learn that altered components of the ERAD pathway are 
involved in neurodegenerative disorders (Giuliana Saltini, 2006), which conceivably 
stems from a decline in protein homeostasis caused by inhibited degradation of 
proteins.  
Together, these results suggest an important role for ERAD in modulation of 
longevity. 
5.B.  Results 
5.B.1  Enhanced ER protein quality control is sufficient to promote longevity and 
enhance proteasome activity 
To confirm the specificity of the sel-1 dependency in gfat-1 gof mutant 
animals, and to test whether SEL-1 was not only dependent, but also sufficient to 
extend lifespan, we created a transgenic C. elegans strain overexpressing sel-1 (sel-
1::gfp). Interestingly, the strain showed a remarkable longevity phenotype, 
comparable to the longevity phenotype induced by GFAT-1 gof (Figure 5.1A). To 
ensure that the extended lifespan of sel-1::gfp transgenic animals did not arise from a 
random side effect, we knocked down sel-1 using RNAi. Inhibition of sel-1 did not 
affect WT lifespan significantly during adulthood, but abolished the lifespan 
extension in sel-1::gfp transgenic animals (Figure 5.1B). This suggests that the 
prolonged life observed as a consequence of GFAT-1 gof might be specific to SEL-1 
overexpression, as sel-1 overexpression was sufficient to extend WT lifespan. 
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Figure 5.1 sel-1 over expression is sufficient to extend lifespan and enhance 
autophagy 
(A). Representative Kaplan-Meier survival curves of indicated transgenic animals (B). 
Representatve Kaplan-Meier survival curves of indicated animals with indicated 
RNAi treatment (C). Relative chymotrypsin-like (left) and trypsin-like (right) 
proteasome activity assays measuring LLVY-AMC turnover at 25°C in lysates of WT 
and sel-1::gfp transgenic L4 larvae (n=3) (D). Analysis of western blot using anti-
GFP antibodies to detect LGG-1::GFP fusion protein in L4 animals, PE-LGG-1::GFP 
levels were normalized to α-tubulin 
 	  
94
0
se
l-1
 O
E
0.0
0.5
1.0
1.5
2.0
Fo
ld
 c
ha
ng
e 
in
 
PE
-L
G
G
-1
::G
FP
 s
ig
na
l
A B C
0 10 20 30 40
0.0
0.2
0.4
0.6
0.8
1.0
sel-1::gfp (L4440)
WT (L4440)
WT (sel-1)
sel-1::gfp (sel-1)
days
fra
ct
io
n 
al
iv
e
D
	   117	  
 
As stated earlier, SEL-1 is a membrane complex involved in retro-
translocation of unfolded proteins from the ER lumen to the cytosol, where the 
proteins after ubiquitination are substrates of the proteasome. We therefore speculated 
whether proteasome activities would be increased in sel-1::gfp transgenic animals. 
Indeed, we found both the chymotrypsin- and the trypsin-like activities enhanced in 
sel-1::gfp transgenic animals (Figure 5.1C), suggesting that protein degradation, due 
to enhanced ERAD, is increased. Earlier results (Figure 4.14) indicated that enhanced 
autophagy in gfat-1 gof mutants was dependent on ERAD, sel-1 and sel-11 
specifically. We therefore asked whether sel-1::gfp transgenic animals also had 
elevated levels of autophagy. Surprisingly, we observed increased levels of lipidated 
LGG-1::GFP in sel-1::gfp animals compared to WT control animals and to dh940, 
which carries only the promoter of gfat-1 fused to cfp (Figure 5.1D). We used this 
strain as a control for transgenic introduction to WT animals. This suggests a direct 
relationship between ERAD and autophagy, and all together we indicate that ERAD 
not only is important for the gfat-1 gof mutants, but also is sufficient to induce 
autophagy and promote long life.  
5.B.2  sel-1 overexpression improves motility of C. elegans protein aggregation 
models 
In Denzel, Storm et al., we have reported that both ERAD and autophagy are 
essential for GFAT-1 gof-induced motility improvements using the aggregation prone 
protein disease models, α-synuclein and polyQ40. Conceivably, ERAD and 
autophagy are collaborating on removing aggregated toxic proteins in these models, 
and in this way slowing muscle paralysis. 
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Figure 5.2 sel-1 over expression is sufficient to alleviate proteotoxicity 
(A). Motility assays using 7 days old transgenic sel-1::gfp animals with Punc-54 
driven muscle specific expression of (left) α-synuclein-GFP fusion protein, and 
(right) polyQ40-YFP (B) Same setup as (A) right with inhibition of indicated genes 
using RNAi 
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We tested the motility, by counting bodybends in liquid over a 30 seconds interval, in 
both α-synuclein and polyQ40 transgenic worms when crossed into the sel-1::gfp 
transgenic background. Very interestingly, we found improved motility at day 7 of 
adulthood in both models (Figure 5.2A), indicating that an increased expression of 
sel-1 is sufficient to alleviate proteotoxicity. To confirm that the improved motor 
function is a direct result of sel-1 overexpression, we knocked down sel-1 by RNAi. 
When sel-1 is inhibited, the motility improvement is ameliorated, without changing 
the WT motility significantly (Figure 5.2B), supporting the hypothesis that sel-1 
overexpression is sufficient to alleviate proteotoxicity. 
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5.C.  Discussion 
In this chapter, I show results suggesting a direct link between ERAD and 
longevity, as sel-1 overexpression is sufficient to extend WT lifespan. Additionally, 
this chapter shows that sel-1 overexpression alleviated proteotoxicity, enhanced the 
activity of the proteasome, and increased the level of autophagy. These results suggest 
that elevated SEL-1 alone is sufficient to mimic the improved protein quality control 
mechanisms observed in gfat-1 gof mutants, which was dependent on sel-1. Taken 
together, the results indicate a direct relationship between ERAD and autophagy, and 
the increased expression of SEL-1 detected in the gfat-1 gof mutants might therefore 
point towards a more direct mechanism for the mutant’s prolonged life.  
The yeast homologue to SEL-1 in C. elegans is called Hrd3p. Strikingly, Hrd3p 
is a glycosylated protein, and was found required for optimal translocation of 
unfunctional proteins from the ER to the cytosol (Richard K. Plemper, 1999). This 
provides a possible link between N-glycosylation and ERAD. Presumably, increased 
levels of UDP-GlcNAc enhance N-glycosylation of proteins, and this could be the 
link to increased levels of SEL-1. This hypothesis is additionally supported by the fact 
that gfat-1 gof mutants were dependent on functional glycosylation; inhibition of OST 
complex components shortened the lifespan extension observed in gfat-1 gof mutant 
animals, and abolished the improved motility as a consequence of advanced ER 
protein homeostasis.   
Whether the transgenic strain overexpressing sel-1 is dependent on GFAT-1 and 
N-glycosylation is not yet known, and we aim to address that in the future. SEL-1 is 
required for the retro-translocation of proteins from the ER to the cytosol, but how 
that enhances the activity of the proteasome, we likewise aim to look at. By now we 
do not have any results indicating that increased delivery of proteins to the cytosol 
will enhance ubiquitinaion, but we are currently trying to address that.  
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CHAPTER 6. Chemosensory-Deficient Mutants 
are Resistant to Tunicamycin and Long-Lived 
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6.A.  Introduction 
Besides the gfat-1 gof mutants, we were able to identify a handful of other TM-
resistant mutants from the screen. As early selection criteria in the screen, we stained 
the worms with DiI (1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine 
perchlorate, Molecular Probes), to seperate the mutant animals into two groups. C. 
elegans senses signals from the environment through ciliated sensory neurons located 
primarily in sensory organs in the head and tail. Cilia function as sensory receptors, 
and mutants with defective sensory cilia have impaired sensory perception (E L 
Peckol, 1999). DiI stains six amphid neurons, ASI, ADL, ASK, AWB, ASH and ASJ, 
and two phasmid neurons, PHA and PHB (Figure 6.1), which is absent when the 
animals carry a mutation that makes them sensory deficient (J Collet, 1998).  
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Figure 6.1 C. elegans sensory system.  
The sensory system in C. elegans consists of different neurons, of which amphid 
neurons are required for their chemosensory-abilities (ASI, ADL, ASK, ASH, AWB 
and ASJ). Their cell bodies are located near the pharyngeal bulb. 
(www.wormbook.org) 
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Mutants with inhibited ability to take up DiI, are referred to as Dyf mutants (Dye 
filling defective). They are not uninteresting, however, it has previously been shown 
that mutants with a sensory deficiency are long-lived and more resistant to distinct 
stress for example heat (Riddle, 2003) (Kenyon J. A., 1999). Additionally, it was 
shown that Dyf-induced longevity is dependent on DAF-16, suggesting an already 
known downstream modulation of aging.  
daf-2 mutant animals are as well dependent on DAF-16, but are not resistant to TM at 
the concentration used in the presented screen. Additionally, DAF-16 does not seem 
to play a role in the improved protein homeostasis observed in the gfat-1 gof mutants, 
suggesting that the mechanism leading to TM-induced ER stress resistance is 
independent of DAF-16. So even though the Dyf mutants are known to be long-lived 
and stress resistant, there might be unknown mechanisms functioning to ensure Dyf-
induced resistance to TM.  
6.B.  Results  
6.B.1  TM resistance screen enrich for Dyf mutants 
Of the 109 long-lived mutants from the screen, we found a sensory deficiency 
in approximately 60% (66 of 109) of the mutants, determined by the animals’ ability 
to take up DiI in the amphid neurons. Apfeld and Kenyon showed that the Dyf 
mutants are long-lived due to activation of DAF-16 – at least, they found that they are 
dependent on DAF-16 to sustain their long life, and the authors are additionally 
suggesting that the lifespan extension found in the cilia deficient mutants is somehow 
dependent on the DAF-2 signaling pathway. daf-2 mutant animals are known to be 
long-lived, and more resistant to stress compared to WT animals (P L Larsen, 1995) 
(C Kenyon, 1993), however, daf-2(1368) is not able to develop on 10 ug/mL TM, 
which is the concentration we used in our TM resistance screen. This suggests that the 
Dyf mutants (at least the ones that we had identified in our screen) had an increased 
ability to resist ER stress independent of the DAF-2/DAF-16 signaling pathway.  
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Table 6.1 Schematic overview of the sequenced Dyf mutants from the 
developmental TM resistance screen.  
Various mutations leading to a premature stop mutation are listed. Additionally, likely 
hit refers to genetic mutations that are likely to cause the observed phenotypes 
(lifespan extension, ER stress resistance and/or dye filling defective). 
 
 
 
!
Mutant 
DiI 
result Premature Stop Mutations Likely hit Other hits 
dh428 Dyf 
 
che-3 - missense in pos. 8062111 
 
dh467 Dyf 
 
dyf-2 - 5'UTR in pos. 13686249 
 dh431 Dyf dyf-2 - pos. 13676150 
  
dh435 Dyf 
tat-6 - pos. 3131801, crp-1 - pos. 
10480295 
 
srv-6 - pos. 4258064 (also a hit in 
dh454) 
dh438 Dyf 
 
nhr-214 - missense in pos. 12701758 
 
dh440 Dyf 
 
No mutations that pile with any 
 
dh441 Dyf 
Y76B12C.6 - pos. 1990628, osm-3 - 
pos. 3796925 osm-3 - pos. 3796925 
 dh442 Dyf 
 
che-3 - missense in pos. 8072943 
 
dh443 Dyf 
glh-2 - pos. 6514897, ZK858.8 - 
pos. 9125432 
 
nhr-214 - missense in pos. 12701753 
dh447 Dyf 
srz-43 - pos. 15636436, F14D7.6 - 
pos. 14305952 
rbc-1 (F54E4.1b) - nrRNA in pos. 
14617426 (also hit in dh461) 
 
dh448 Dyf 
 
No mutations that pile with any 
 
dh461 Dyf 
 
rbc-1 - indel insertion in pos. 14614978 
(also a hit in dh447) 
 dh449 Dyf 
 
dyf-2 5'UTR in pos. 13679167 
 dh451 Dyf 
 
No mutations that pile with any 
 
dh454 Dyf 
  
srv-6 - pos. 4258255 (also a hit in 
dh435) 
dh456 Dyf dyf-17 - pos. 19129038 
 
egl-30 (M01D7.7b) 5'UTR in pos. 
1837821 (also a hit in dh443) 
dh457 Dyf 
 
dyf-2 - missense in pos. 13679167 
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Of the 66 Dyf mutants found in our screen, we have sequenced 17 (Table 6.1), 
and in many of them, we have recognized mutations in genes that previously have 
been associated with Dyf mutants. These include dyf-2, che-3 and osm-3. 
Conceivably, the Dyf mutants’ extended lifespan is dependent on DAF-16, at least 
partly. Other factors may play a role as well, and we therefore looked at the HSP-4 
expression levels. Surprisingly, we did not find increased levels of HSP-4 expression 
in the Dyf mutants under baseline conditions, suggesting that they do not have higher 
levels of ER UPR. Exposure to TM induced the expression of HSP in WT animals, 
but not in the Dyf mutants. Conversely, we found that the expression of HSP-4 is 
lower in the Dyf mutants when exposed to TM  (Figure 6.2), suggesting that they are 
protected against TM due to decreased sensitivity, and therefore higher threshold. 
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Figure 6.2 Dyf mutants are protected against TM induced ER stress 
HSP-4::GFP expression in WT (N2) and indicated Dyf strains. The worms have been 
treated with TM for 24 hours starting from late L4.  
 
 
 
dh428& dh442& dh454&N2#
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We speculated that a defect in the sensory cilia makes the animals senseless, and in 
this way makes the threshold for TM-induced ER stress higher. A similar response to 
TM was observed in the gfat-1 gof mutants, also suggesting that they never “feel” 
stressed. However, in the gfat-1 gof mutants, the TM resistance and the low levels of 
HSP-4 expression seem to impinge on a direct competition between TM and the N-
glycan precursor, UDP-GlcNAc. Thus, by increasing the concentration of UDP-
GlcNAc the toxicity of TM would be outcompeted, whereas the mechanism in the 
Dyf mutants seems to be different.  
Very pleliminary results analyzing WB from whole worm lysates (data not 
shown) again suggested distinct mechanisms leading to TM resistance in the gfat-1 
gof mutants and the Dyf mutants. Exposure to TM does not affect the N-glycan level 
in gfat-1 gof mutants, suggesting that the mechanism leading to TM resistance is 
upstream of N-glycosylation. In the Dyf mutants, however, it seems to be different, as 
N-glycan levels are decreased upon treatment with TM. This indicates that the 
resistance to TM is downstream of N-glycosylation. The Dyf-induced protection 
against TM toxicity does not seem to be dependent on increased ER UPR (Figure 
6.2), so instead we measured the relative mRNA levels of other genes known to be 
activated during stress, including genes involved in ERAD and autophagy (Figure 
6.3A). 
Interestingly, we did not observe any significant changes in expression of any 
heat shock proteins (hsp-4, hsp-6, hsp-60 or hsp-16.2). There was a slight tendency 
that one of the Dyf mutants, dh441, had increased levels, but it was not significant. 
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Figure 6.3 Dyf mutants have improved protein aggregation conditions 
(A). Relative mRNA levels of indicated genes in WT (black bars) and some of the 
Dyf mutants (colored bars) (B). Quantification of SRP-2 aggregates in young adults in 
indicated Dyf mutants  
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On the other hand, we found a strong tendency pointing at an increased 
expression of genes related to ERAD and autophagy pathways in the Dyf mutants. 
This suggests that Dyf mutants have improved protein quality control mechanisms. 
Previously we had found both ERAD and autophagy to be required for alleviated 
protein aggregation formation in the ER, and asked whether the Dyf mutants also 
showed improved clearance of SRP-2 aggregation formation. Interestingly, we 
observed fewer SRP-2 aggregates in the 4 tested Dyf mutants (Figure 6.3B), 
suggesting that the activity of ERAD is enhanced in these mutants.  
Together, these results indicate that the sensory deficient mutants are resistant 
to TM, long-lived and have improved protein homeostasis. Additionally, the data 
suggest that Dyf mutants resist TM in a manner different from the gfat-1 gof mutants. 
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6.C.  Discussion 
Lee et al. showed that chemosensory deficiencies are likely to cause resistance 
to stress, for example heat and oxidative stress. Additionally, these mutants have been 
found to be long-lived in a DAF-16 dependent manner. Because of the link to the 
insulin/IGF signaling pathway, it was surprising that they were identified in this 
screening setup, as daf-2 mutants are not resistance to TM at the concentration used. 
It is possible that parts of the phenotypes observed in the Dyf mutants are dependent 
on DAF-16, and it is also likely that DAF-16 plays a major role in the lifespan 
extension. But regarding daf-2 mutant’s missing ability to develop on TM, there must 
be a DAF-2/DAF-16 independent mechanism modulated in the Dyf mutants.  
In our screen, we have identified 66 Dyf mutants, which all showed significant 
lifespan extensions. Additionally, we hypothesize that the TM resistance stems from a 
mechanism distinct from the mechanism that makes the gfat-1 gof mutants resistant to 
TM. The Dyf mutants further showed changes in genes involved in stress response 
pathways, and lastly, we observed improved prevention of protein aggregation in the 
ER. Whether it is the same mechanism improving the ER protein quality control 
mechanisms in the Dyf mutants, as for the gfat-1 gof mutants, is not clear. However, 
we do not expect so.  
From literature, and from personal communication with Dr. Sueng-Jae Lee, it 
is believed that the Dyf-induced longevity is completely dependent on DAF-16, 
however, our results indicate differently, at least partly. A DAF-2/DAF-16 
independent mechanism must be modulated additionally, making the Dyf mutants 
able to develop on TM. This mechanism is however still unknown, and we would 
have to do further experiments to come to a conclusion. In the presented data we have 
used the daf-2 mutant allele e1368, however, the missing TM resistance in this daf-2 
mutant can be an allele specific thing. Therefore, it is only possible to indicate that 
one mutant allele, daf-2(1368), fails to develop on TM.  
One possibility when suggesting relationships between the chemosensory 
defects and longevity, besides regulating DAF-16, is that Dyf mutants are slightly 
dietary restricted or stimulate the release of molecules that signals a DR state. DR 
worms are known to be long-lived and more resistant oxidative and thermal stress 
(Koen Houthoofd, 2002), due to enhanced quality control mechanisms, for example 
autophagy. The major transcription factor required for autophagy and longevity in DR 
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animals, PHA-4, could therefore be hypothesized to play a major role in the Dyf 
mutants. Additionally, the transcription factors DAF-16 and PHA-4 have been shown, 
at least in C. elegans, to be simultaneously enhanced in other long-lived mutants, and 
to be involved in distinct mechanisms.  Whether PHA-4 plays a role in the Dyf 
mutants’ improved stress resistance and longevity, is however, not known to this date.  
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CHAPTER 7. C. elegans Wild Isolates Display 
Improved Stress Resistance 
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7.A.  Introduction 
Under laboratory conditions, C. elegans WT animals live on average 20 days 
post reproduction. In addition, they are sensitive to TM. Due to variable conditions in 
nature, such as overcrowding, temperature changes and limited food availability, we 
wondered whether natural genomic variations in wild C. elegans isolates would reveal 
new targets and knowledge about protein quality control mechanisms. To test this we 
asked whether animals found at different origins in the wild would be resistant to TM-
induced ER stress and confer longevity.  
In most C. elegans research laboratories, the N2 (Bristol) strain is used as a WT 
control. This is also true for our laboratory, and in the following this strain will be 
referred to as N2.  
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7.B.  Results 
7.B.1  The strains 
In Bonn (Germany), we collected three (presumably) independent C. elegans 
strains in a vineyard; Dragon #1, Dragon #9 and Dragon #10. Furthermore we 
received another 29 strains from the C. elegans genetics center (CGC) from different 
origins and climates around the world (see 7.1).  
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Table 7.1 Wild C. elegans isolates 
Schematic overview of the 3 C. elegans strains collected in Bonn (Dragon #1, Dragon 
#9 and Dragon #10) and the wild isolates obtained from the C. elegans Genetics 
Center. In the columns are shown (from left) name of the strain, origin, type of 
environment when known and the F1 generation’s ability to develop in the presence of 
TM.  
 Origin Environment 
F1 
development 
on TM 
Europe  
Dragon #1 Bonn, Germany Vineyard No 
Dragon #9 Bonn, Germany Vineyard Yes 
Dragon #10 Bonn, Germany Vineyard Yes 
JU829 Tübingen, Germany Compost heap No 
MY6 Münster, Germany Compost heap No 
CB4932 Taunton, England Mushroom farm No 
ED3005 Edinburgh, Scotland Compost bin Yes 
JU262 Le Blanc, Indre, France Vegetable garden 
No 
JU393 Hermanville, France Compost pile No 
JU258 Madeira, Portugal Fruit and vegetable garden 
No 
JU775 Lisbon, Portugal Botanical garden No 
JU1400 Sevilla, Spain Rotting orange fruits 
No 
JU1401 Carmona, Spain Isolated from a snail 
No 
JU1440 Barcelona, Spain Rotting palm fruit 
No 
North America  
CB4507 Palm Canyon, CA  
No 
CB4555 Pasadena, CA Flower bed No 
CB4855 Palo Alto, CA Compost heap No 
CB4856 Hawaii Pineapple field No 
DH424 El Prieto Canyon, CA  
No 
PB306 Connecticut Valley, CT  
Yes 
PS2025 Altadena, CA Garden No 
PX174 Lincoln City, OR Forest 
No 
PX176 Eugene, OR Grass compost No 
TR388 Madison, WI  No 
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South America  
JU1171 Concepcion, Chile Compost sample 
No 
JU165 Montevideo, Uruguay Compost 
No 
Africa  
ED3040 Johannesburg, South Africa Compost 
No 
ED3042 Ceres, South Africa Plant nursery 
Yes 
ED3072 Limuru, Kenya Mushroom farm No 
LKC34 Madagascar  Yes 
Australia  
JU1615 Melbourne, Australia Compost heap 
No 
Asia  
JU1088 Kakegawa, Japan soil 
No 
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Most of the C. elegans wild isolates behaved differently from N2 animals, 
showing social behavior when cultured under laboratory conditions. This included 
population aggregation on the plates, which is known to originate from lack of a point 
mutation in npr-1 (Mario De Bono, 1998). There were no obvious correlations 
between the social behavior and the origin of the strains (supplemental table 7.1). 
DH424, TR388, CB4507 and CB4555 originate from warmer climates (compared to 
Germany) in North America, and JU1615 from Melbourne, Australia. These strains 
showed “N2 like” behavior in terms of absent population aggregation on plates, 
suggesting that C. elegans isolates from these warmer climates have a mutation in 
npr-1, comparable with the N2 laboratory strain. However, this was not a general 
observation in all strains from warm climates. It is therefore not possible to draw any 
conclusions about the animals’ behavior from their origin. The three Dragon strains 
collected in Bonn also showed aggregation behavior. 
 
7.B.2  Natural variations in wild isolates result enhanced stress resistance 
Next, we tested the animals’ ability to cope with TM-induced ER stress, and 
interestingly, we found that the F1 generation of ED3005, ED3042 PB306 and LKC34 
were able to develop normally on plates containing TM. This was also the case for 
Dragon #9 and Dragon #10. Since N2 worms are completely sensitive to TM resulting 
in complete inhibition of all F1 development, these observations suggest that natural 
variations in some wild C. elegans isolates improve the animals’ ability to cope with 
TM-induced ER stress. We did not, however, observe any correlations between the 
TM resistance and geographic origin.  
Conceivably, the TM-resistant Dragon and CGC wild C. elegans isolates may have 
enhanced protection of the ER arising from natural genetic variations. To further test 
this, we conducted thermotolerance tests byincubating the animals at 37°C for 5 
hours. We scored the number of live worms every hour starting after two hours. After 
4 hours, almost all N2 control animals were dead (Figure 7.1, 4h), whereas more than 
60% of the daf-2(e1368) mutant animals were alive, which was expected since these 
mutants are known to be more resistant to heat. Interestingly, Dragon #9 and Dragon 
#10 showed strong resistance to heat as well, and after 4 hours around 80% and 75% 
were still alive, respectively (Figure 7.1). The same tendency was observed after 5 
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hours of heat incubation, suggesting that Dragon #9 and Dragon #10 not only are 
protected against TM-induced ER stress, but also against heat-induced ER stress.  
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Figure 7.1 Natural variations in C. elegans animals found in the nature result in 
ER stress resistance.  
Heat stress resistance test performed at 37°C. The animals were scored after 2, 3, 4 
and 5 hours, and indicated with the bar graphs are the number live worms at the 
various time points in the indicated strains. The bottom figure shows some of the 
CGC strains that were tested only at the 4-hour time point. 	  
All experiments have been repeated at least twice with similar results, representative 
bar graphs shown.  
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Furthermore, we also tested the heat resistance of some of the wild strains obtained 
from the CGC. Again, we observed a slight correlation between the TM resistant 
strains and heat resistance. The wild C. elegans isolates that showed improved 
resistance to TM (ED2005, ED3042, PB306, LKC34) also showed improved 
resistance to heat (Figure 7.1, bottom). Additional strains tested show enhanced 
resistance to heat compared to N2 controls without being resistant to TM, however, 
suggesting that the modulations causing TM-induced and heat-induced ER stress are 
different. This was also supported from our observations using gfat-1 gof mutants; 
they show advanced resistance to TM without being resistant to heat.  
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7.C.  Discussion   
From the wild strains isolated in Bonn (Dragon strains) and from the strains we 
received from CGC, we were able to confirm the hypothesis that natural variations 
indeed occur, and that it leads to phenotypic changes. 
Dragon #9 and Dragon #10 were both collected in a vineyard in Bonn, and they 
showed changed behavior when cultured under laboratory conditions, compared to N2 
animals. Additionally, they showed enhanced resistance to TM and heat, altogether 
suggesting that natural variations in their genomes have occurred. The lifespan of 
these strains were, however, not significantly increased (data not shown). If anything, 
it seemed that Dragon #9 and Dragon #10 were short-lived compared to N2.  
In the C. elegans wild isolates obtained from CGC we also detected a handful 
of strains with increased resistance to TM or to heat. But we were not able to draw 
any connections between their phenotypic characteristics and their origin. Likewise, 
we did not observe any relationships between original location and social behavior 
possibly arising from a genetic mutation in the npr-1 gene.  
What kind of genetic variations that have occured in these strains is still unknown, but 
it would be very interesting to sequence their genomes in the attempt to identify the 
mutations leading to increased ability to cope with TM and heat.   
Our results support previous published work indicating that natural phenotypic 
variations are detectable in wild isolates, but whether the stress resistance seen is due 
to the same mutation in all strains, is unknown. I would, however, find it highly 
unlikely that all strains, independent of origin, climate and environment, have 
undergone the same natural variations, although we detected similar phenotypes in 
some of the wild isolates. Whether the increased resistance to TM- and heat-induced 
ER stress occurs from changes in the hexosamine pathway is also unknown. 
However, due to relatively small similarities between the wild isolates and the gfat-1 
gof mutants (besides the resistance to TM), the chances are not any more likely than 
other random mutations leading to stress resistance.  
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Supplemental Table 7.1 Behavior remarks of the wild C. elegans isolates 
This figure gives a schematically overview over the social behavior of the different C. 
elegans isolates. In the left column the name of the strain is indicated and in the right 
is any remarks about behavior and place of egg-lay indicated 	  
Strain Remark 
Europe 
JU829 Lay eggs mainly in edge of bacteria 
MY6 Accumulations of L1/2/3 worms, nearly no eggs in the middle of the plate 
CB4932 Accumulation of grown up worms on crowded plates also without starvation, on empty plates worms and eggs mainly in edge of bacteria 
ED3005 Worms and eggs mainly in edge of bacteria 
JU262 Accumulations of worms of all ages in edge of bacteria together with eggs 
JU393 Accumulations of L1/2/3 worms and eggs only in edge of bacteria 
JU258 Eggs mainly in edge of bacteria 
JU775 L1/2 mainly in accumulations in the edge of the bacteria, older worms all over the plate 
JU1400 All eggs mainly in the edge of the bacteria 
JU1401 L1/2 mainly in accumulations in the edge of the bacteria together with eggs, L3/4/adult worms all over the plate 
JU1440 Accumulations of L1/2/3, nearly no eggs in the middle of the plate 
North America 
CB4507 N2 like 
CB4555 N2 like 
CB4855 Accumulations of small worms 
CB4856 Eggs only in the edge of the bacteria 
DH424  N2 like 
PB306 Eggs mainly in edge of the bacteria 
PS2025 Accumulations of worms of different ages, adult single worms also mainly in edge together with eggs 
PX174 Eggs mainly in the edge of the bacteria 
PX176 Eggs mainly in the edge of the bacteria 
TR388 N2 like 
South America 
JU1171 Worms and eggs mainly in the edge of the bacteria 
JU1652 Eggs only in the edge of the bacteria 
Africa 
ED3040 Accumulations of L1/2/3 worms and eggs mainly in the edge of the bacteria 
ED3042 Accumulations of adult worms without starvation and worms and also eggs mainly in the edge of the bacteria 
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ED3072 Eggs mainly in the edge of the bacteria 
LKC34 Eggs mainly in the edge of the bacteria 
Australia 
JU1615 N2 like 
Asia 
JU1088 Accumulations of L1/2 worms, adult worms all over the plate 
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CHAPTER 8. NHR-62-Induced Autophagy is 
Required for the Dietary Restriction-Induced 
Longevity 
 
Part of this work has been published in Heestand et al. (2013). 
Dietary Restriction Induced Longevity Is Mediated by Nuclear Receptor 
NHR-62 in Caenorhabditis elegans. Plos Genetics 
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8.A.  Introduction 
Lifespan extension is a well-known consequence of DR (Colman, 2009), either 
by long-term restriction or as an acute response to reduced nutrients (Mair, 2003). The 
recent decades of research in the pathways modulating DR-induced lifespan extension 
have revealed many genes involved in these processes. These include down-
regulation of TOR  (Kapahi P, 2004)  (Eisenberg T, 2009), increased transcription of 
pha-4/Foxa (Panowski SH, 2007) and enhanced degradation by autophagy (Malene 
Hansen, 2008). TOR, PHA-4/Foxa and genes required for autophagy are additionally 
believed to be involved in fat metabolism, development and response to hormonal 
signaling  (Rajat Singh S. K., 2009)  (Jing Cui, 2013).   
Nuclear hormone receptors (NHR) are transcription factors, and have been 
found to be involved in the same cellular mechanisms  (Wollam J, 2011) (Magner 
DB, 2008).  Bree Heestand hypothesized that there was a common regulatory 
mechanism, and initiated a project where he searched for regulators of the DR-
induced longevity pathways among the 284 NHRs in C. elegans. In this work the eat-
2 mutant was used. eat-2 mutant animals have altered pharyngeal pumping leading to 
downstream processes mimicking DR (Avery, 1993).  
In this work, Heestand et al. found that especially NHR-62 was required for eat-
2 longevity, without changing the WT lifespan when knocked down  (Bree N. 
Heestand, 2013). Additionally, they found that NHR-62 was essential for the DR-
induced changes in fat metabolism, especially the changes in fatty acid composition 
during DR. Lipases are involved in the release of fatty acids from triglycerides, and 
have in addition previously been found to play an important role in longevity  
(Lapierre LR, 2011). Heestand et al. therefore screened through the 34 predicted 
lipases, and found that knockdown of C40H1.8 abolished the eat-2 longevity, at least 
partly. More interestingly he found an NHR-62-dependent increase in mRNA levels 
of C40H1.8 and lgg-1, suggesting that autophagy might also be upregulated in a 
NHR-62 dependent manner. 
 
	   148	  
8.B.  Results 
8.B.1 NHR-62 regulates C40H1.8 and autophagy 
To measure autophagy we made use of a transgenic C. elegans strain 
expressing lgg-1 fused to gfp.  LGG-1::GFP is being used to estimate the level of 
autophagy by quantifying the number of LGG-1::GFP forming puncta in seam cells of 
young larvae.  
Knockdown of nhr-62 using RNAi did not change the WT level of LGG-1::GFP 
puncta, however, when knocked down in eat-2 mutant animals, the enhanced level of 
autophagy detected, was completely abolished (Figure 8.1A). This suggests that the 
DR-induced autophagy is dependent on NHR-62.  
Expression of C40H1.8 was also found increased in eat-2 mutant animals. 
Lapierre et al. previously reported that glp-1 mutant animals are dependent on the 
lipase lipl-4 to maintain their long life and increased autophagy levels (Lapierre LR, 
2011). We therefore asked whether the eat-2-induced autophagy increase was 
dependent on C40H1.8. Interestingly, we found that a knockdown of C40H1.8 
shortened the lifespan of eat-2 mutant animals (Figure 8.1B), suggesting that DR-
induced longevity is dependent on functional lipolysis. 
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Figure 8.1 NHR-62-induced C40H1.8 expression is required for autophagy under 
DR 
(A, B). LGG-1::GFP quantification of indicated strains using indicated RNAi 
bacteria, n>3, ***P<0.001, EV, empty vector (L4440) (C). Lifespan analysis of 
indicated strains using indicated RNAi bacteria. Median lifespan; eat-2(gfpi): 27, eat-
2;nhr-62(gfpi): 22, eat-2(C40H1.8): 22, eat-2;nhr-62(C40H1.8): 23. eat-2;nhr-
62(C40H1.8) vs. eat-2;nhr-62(gfpi). (log-rank test p = 0.4798) 
 
A ! ! ! ! ! !B ! ! !       ! !     C!
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Next, we asked whether C40H1.8 also plays a role in eat-2 lifespan extension. Indeed 
it does; knockdown of C40H1.8 using RNAi completely reversed the eat-2 lifespan 
back to WT levels (Figure 8.1C). More interestingly, we did not observe any further 
decrease in the lifespan of the double mutant eat-2;nhr-62 (Figure 8.1C), suggesting 
that the lipase C40H1.8 could be a target of NHR-62, which is modulated by DR. 
Together, these results suggest that DR-induced longevity is under control of at least 
one of the NHRs. Additionally, our results indicate that an NHR-62 dependent 
induction of autophagy in the long-lived mutant eat-2. Whether this induction of 
autophagy is dependent for the eat-2 longevity is not completely clear, but since 
autophagy previously has been found to be required, and since NHR-62 and C40H1.8 
are dependent to maintain the extended life, we would assume that the NHR-62-
induced autophagy enhancement is also essential for the eat-2 longevity. 
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CHAPTER 9. Discussion and Future Perspectives 
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9.A.  Discussion  
Here, I have reported our findings on how we, by performing a forward genetic 
screen, revealed novel correlations between protein quality control mechanisms and 
longevity. I show how increased levels of hexosamines, either gained by genetic 
modifications of gfat-1 or pharmacologically by supplementing GlcNAc to the 
medium, result in resistance to TM-induced ER stress, extend C. elegans lifespan and 
improve protein quality control mechanisms. Additionally, I show data indicating that 
the stress resistance and longevity of gfat-1 gof mutants is dependent upon a 
functional ERAD pathway, ER UPR and autophagy.  
Additional mutants identified in the screen show increased stress resistance due 
to loss of chemosensory functions, which also leads to extended lifespan and 
improved ER quality control. However, this seems to be independent of the 
hexosamine pathway, as these mutants show distinct expression patterns of stress 
response genes, and also show at least partial dependence upon the insulin/IGF-
signaling pathway to maintain their extended lifespan (Kenyon J. A., 1999). 
Furthermore, we isolated some still unidentified long-lived mutant animals from the 
TM screen, which may be independent of the hexosamine pathway, as they do not 
contain mutations in any of the genes known to be involved (See section 10.C). 
In data unrelated to the TM screen, I show that natural variations in the C. elegans 
genome lead to TM resistance, and that there might be a broader protection against 
ER stress in the wild, as some of the C. elegans wild isolates also show resistance to 
heat.  
All together, the results suggest a novel association between protein quality 
control and longevity, and open up new possibilities to combat proteotoxic diseases. 
Additionally, the presented data point at new targets for understanding the 
relationship between improved stress resistance and longevity. 
 
9.A.1  GFAT-1 gof 
Using gfat-1 gof mutants and activation of the hexosamine pathway, we 
demonstrate that elevated levels of the endogenous metabolite UDP-GlcNAc extend 
WT lifespan and ameliorate various proteinopathies. Lifespan extension induced by 
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GlcNAc or gfat-1 gof required multiple aspects of ER function, including N-
glycosylation, ERAD, and ER UPR signaling. Importantly, GlcNAc supplementation 
or GFAT-1 gof alleviated, and in some cases reversed, proteotoxicity in models of 
neurodegenerative diseases in distinct tissues and cellular compartments. This 
suggests a broad-spectrum improvement in protein quality control. Moreover, 
elevated levels of UDP-GlcNAc are not seen in several other major models of 
longevity such as reduced insulin signaling, mitochondrial function, gonadal 
longevity or dietary restriction, suggesting that GFAT-1 gof invokes a novel 
mechanism promoting long life.  
	  	  
ER function, particularly related to its stress response pathways, have 
previously been linked to health and lifespan (Brown and Naidoo, 2012; Parodi, 
2000). Many age-related diseases and conditions, including diabetes, chronic 
inflammation, heart disease and neurodegenerative diseases, have also been 
associated with ER stress responses (Cao and Kaufman, 2013; Ozcan and Tabas, 
2012; Walter and Ron, 2011). In C. elegans, the ER UPR has recently been found to 
be essential for the longevity of daf-2 mutants. At the same time, Taylor and Dillin 
reported that constitutive activation of the ER UPR component XBP-1 was sufficient 
to extend the lifespan of C. elegans. Together with these results, our data support the 
hypothesis that improved protein quality control promotes longevity. Although gfat-1 
gof mutants showed requirement for ER UPR basal levels to sustain their extended 
lifespan and ameliorated proteotoxicity, and also displayed increased levels of SEL-1 
protein expression, enhanced autophagy degradation, and higher proteasomal activity, 
we surprisingly did not detect any changes in transcriptional induction of the ER 
UPR, as measured by xbp-1 splicing and mRNA levels of downstream target genes 
such as hsp-4. Instead, GlcNAc or GFAT-1 gof appear to coordinate post-
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transcriptional stimulation of protein quality control mechanisms, ERAD and 
autophagy. We also did not detect any transcriptional changes in mitochondrial UPR 
genes (hsp-6, hsp-60) or cytosolic heat shock response genes (hsp-16.2, hsp-70) when 
measured by qPCR. Furthermore, transcriptome analysis of gfat-1 gof mutants did not 
reveal any changes in mRNA levels of other known stress response genes. All 
together, these results support a post-transcriptional and proximal mechanism for 
longevity that works at the level of metabolites and their interaction with client 
proteins.  
 
9.A.2  Links between metabolites, ER, and autophagy 
How are hexosamine metabolites influencing ERAD, proteasome activity and 
autophagy? One possibility is that the phenotypes result from broad changes in the 
secretory apparatus, presumably by modulation of N-glycosylation. However, we did 
not observe any global changes in steady state protein glycosylation as measured by 
N-glycan labeling with ConcavalinA. Another possibility is that specific secretory 
proteins may be affected. Indeed, the observation that increased UDP-GlcNAc results 
in increased expression of SEL-1, involved in ERAD, may provide an important hint. 
Conceivably, elevated UDP-GlcNAc stimulates the covalent N-glycosylation of SEL-
1 and other ERAD components, thereby affecting their activity and/or stability. 
Consistent with this idea, increased transcription of sel-1 is sufficient to extend 
lifespan. In addition, we detected a dependence of gfat-1-induced aggregate clearance 
and longevity on components of the N-glycosylation machinery. It is noteworthy that 
Hrd3p, the yeast homologue of SEL-1, is itself a glycoprotein (Saito et al., 1999), 
which functions in a complex with the Hrd1p/SEL-11 ubiquitin ligase, and has been 
shown to autoregulate its own activity (Plemper et al., 1999). Presumably, elevated 
SEL-1 enhances ubiquitination, ERAD, and proteasome activity to improve protein 
degradation. Future experiments should clarify the possible mechanisms at work. 
Are ERAD and autophagy linked? In certain pathological serpinopathy 
models, ERAD has been shown to be stimulated concomitantly with autophagy, 
resembling our observations with GFAT-1 gof (Kroeger et al., 2009). We, however, 
failed to uncover evidence for endogenous protein misfolding stress in our mutants; 
animals had normal developmental timing and brood sizes, and demonstrated better 
	   155	  
handling of misfolded proteins. Another view is that organelle homeostasis within the 
ER may require intimate coordination of these processes. Autophagosomes form at 
ER-mitochondria contact sites and thus ER membranes might be an origin for 
autophagic vesicle formation (Hamasaki et al., 2013). Such sites may be used to 
initiate normal macroautophagy. Alternatively, they may facilitate so-called ERAD 
tuning, in which ERAD components are selectively removed from the ER to diminish 
the degradation response. During ERAD tuning, the unlipidated form of LC3 
physically associates with SEL-1 to mediate this process (Bernasconi et al., 2012). In 
gfat-1 gof mutants, however, we observed an increase in the lipidated form of LC3, 
consistent with canonical autophagy. 
Several other small molecule metabolites have been shown to stimulate 
autophagy including spermidine, trehalose, and others (Eisenberg et al., 2009) (Honda 
et al., 2010). It is unclear if they work in concert with GlcNAc, or influence ERAD 
function. Conceivably, these metabolites work in a unified or parallel pathway. It is 
striking that a single endogenous metabolite can stimulate both ER quality control and 
autophagy, suggesting a potential role as a signaling molecule. GlcNAc finds wide 
acceptance as a food supplement thought to improve osteoarthritis, albeit little is 
known about the mechanistic underpinnings and a metaanalysis did not reveal 
benefits. Our data strongly suggest that beyond these effects, it might improve protein 
homeostasis, promote health and increase lifespan. This study therefore provides 
promising potential to identify new strategies to ameliorate diseases caused by 
interruptions in protein homeostasis.  
 
9.A.3  Dyf mutants and improved protein quality control 
Lee et al. showed that chemosensory deficiencies are likely to cause resistance 
to stress, such as heat and oxidative stress. Additionally, these mutants have been 
found to be long-lived in a DAF-16 dependent manner. Because of the link to the 
insulin/IGF signaling pathway, it was surprising that they were identified in this 
screen, as daf-2 mutants are not resistant to TM at the concentration used. It is 
possible the phenotypes observed in the Dyf mutants are only partially dependent on 
DAF-16, and it is also likely that DAF-16 plays a major role in the lifespan extension. 
Regardless, the inability of daf-2 mutants to develop on TM suggests that there must 
be a DAF-2/DAF-16 independent mechanism modulated in the Dyf mutants.  
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In the screen, we identified 66 Dyf mutants, all of which showed significant lifespan 
extensions. The Dyf mutants also showed transcriptional changes in genes involved in 
stress response pathways, and we observed ameliorated protein aggregation in the ER. 
Whether the same mechanisms are involved for improving ER protein quality control 
in the Dyf mutants, as for the gfat-1 gof mutants, is not clear. However, we do not 
expect so.  
From the literature, and from personal communication with Dr. Sueng-Jae 
Lee, it is believed that the Dyf-induced longevity is completely dependent upon DAF-
16, however, our results indicate only partial dependence. A DAF-2/DAF-16 
independent mechanism must also be modulated, making the Dyf mutants able to 
develop on TM. This mechanism remains to be discovered, however, and further 
experiments are required to confirm this. In the presented data we used the daf-2 
mutant allele e1368, and the absence of TM-resistance in daf-2 mutant animals may 
be allele-specific. We can therefore only indicate that daf-2(1368) mutant animals not 
are resistant to TM.  
Besides modulating DAF-16, it is possible that the chemosensory defects 
stimulate the release of molecules that signal a DR state. DR worms are known to be 
long-lived, and are also characterized by resistance to oxidative and thermal stress 
(Koen Houthoofd, 2002). The major transcription factor required for autophagy and 
longevity in DR animals, PHA-4, might therefore play a major role in protein quality 
control mechanisms in the Dyf mutants. Additionally, the transcription factors DAF-
16 and PHA-4 have previously been shown, at least in C. elegans, to be 
simultaneously enhanced in other long-lived mutants, although they are involved in 
distinct mechanisms.  Whether PHA-4 plays a role in the Dyf mutants’ improved 
stress-resistance and longevity, however, is not known.  
 
9.A.4  What can we learn from nature? 
From the wild strains that we isolated in Bonn (the Dragon strains) and from 
the strains we received from CGC, we were able to confirm the hypothesis that 
natural variations in stress resistance do indeed occur.  
Dragon #9 and Dragon #10 were both collected in a vineyard in Bonn, and displayed 
behavioral differences when cultured under laboratory conditions, compared to N2 
animals. Additionally, they showed enhanced resistance to TM and heat, suggesting 
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that natural variations in their genomes have occurred. The lifespan of these strains 
were, however, not significantly different compared to N2 (data not shown). It even 
seemed that Dragon #9 and Dragon #10 were short-lived, if changed at all. The 
unchanged (or decreased) lifespan may also be due to the wild isolates’ nature; they 
are not adjusted to laboratory conditions.  
In the C. elegans wild isolates obtained from CGC, we also detected a handful of 
strains with increased resistance to TM or heat. We were, however, not able to draw 
any connections between their phenotypic characteristics and their origin. Relative to 
the surrounding substrates of the wild isolate’s origin (i.e. moisture, fruit, grass), we 
considered the possibility that some wild isolates probably live mostly as dauers 
during long periods of famine with only sporadic episodes of feasting. We did, 
however, fail in observing any correlation between environmental origin and 
phenotypes. Likewise, we did not observe any relationships between original 
geographic location and social behavior possibly arising from genetic mutations in the 
npr-1 gene.  
What kind of genetic variations that have occured in these strains is still 
unknown, but it would be very interesting to sequence their genomes in the attempt to 
identify the mutations leading to increased ability to cope with TM- and heat-induced 
stress.   
Our results support previously published work indicating that natural 
phenotypic variations are detectable in wild isolates, however, the finding that some 
of these wild isolates are resistant to TM is novel. This open up new possibilities that 
natural variations in the genome can reveal important information about stress 
resistance. Whether increased stress resistance is due to the same mutation in all 
strains, is unknown. It would be highly unlikely that they all strains, independent of 
origin, climate and environment, have undergone the same natural variations in their 
genomes, although we detected similar phenotypes in some of the wild isolates. 
Further experiments will be made to test the animals’ lifespan. In addition, we will 
investigate the mechanism(s) leading to resistance to TM in the wild isolates. We do 
not expect the wild isolates to be resistant to TM due to mechanisms involving the 
hexosamine pathway, but we can not exclude it completely. 
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9.B.  Future Perspectives 
All together, this data reveals a novel modulator of C. elegans lifespan through 
control of ER stress response pathways, although further investigation is necessary to 
clarify the exact mechanisms involved. It will be important to understand how 
changes in endogenous metabolite levels can bring about global improvements in 
protein homeostasis to influence lifespan. To this end, the three major future 
perspectives will be to perform in-depth molecular characterization of GFAT-1 and its 
regulation, to describe how N-glycosylation affects stress response pathways, and 
finally to address the role of the hexosamine pathway in human cells. Additionally, 
further investigation of the Dyf mutants to reveal their dependence on other longevity 
pathways such as the DR-induced longevity pathway will raise the opportunity to 
learn more about the interplay between chemosensation and the ER longevity 
pathway.  
 
9.B.1  GFAT-1 structural changes 
GFAT-1 is regulated by product inhibition and phosphorylation, and it would 
therefore be of great importance to study the specific point mutations identified in the 
gfat-1 gof mutants. At least two of the gfat-1 gof mutations (dh784 and dh785) lead to 
changes in amino acids that are located on the surface of the GFAT-1 protein. 
Investigating the exact changes of GFAT-1 could reveal information about whether 
the mutations might cause structural changes that lead to constitutive activation due to 
inability of UDP-GlcNAc to bind or structural changes that lead to inhibited 
phosphorylation. The significance of this also stems from the importance of 
identifying other regulators and components of the ER longevity pathway.  
 
9.B.2  GFAT-1 repressor screen 
GFAT-1 gof enhances the hexosamine pathway to promote longevity and alleviate 
proteotoxicity, but to shed light on other genes involved in the ER longevity pathway, 
it would be interesting to perform a GFAT-1 repressor screen. By randomly mutating 
srp-2::gfp transgenic animals crossed into the gfat-1 gof mutant background, we 
would select for mutants with reduced ability to prevent SRP-2 aggregation. In this 
way, we might be able to identity both up- and downstream regulators of the ER 
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longevity pathway, which would be of great importance in understanding 
howenhanced flux through the hexosamine pathway leads to alleviated protein 
aggregation. Along the same line, a GFAT-1-enhancement-screen could be 
interesting: screening different groups of small molecules and measuring the 
expression and activity of GFAT-1. This could include groups of sugars, sterols and 
fatty acids, and would be of great importance as it has the potential to identify small 
molecule metabolites that modulate ER stress and lifespan. 
 
9.B.3  GFAT-1 longevity pathway 
Looking downstream of the hexosamine pathway, a lot of questions remain to 
be answered. In particular, how elevated UDP-GlcNAc levels have the ability to 
improve protein quality control pathways, and how these pathways are all regulated 
and inter-regulated, will be an important focus of future studies. For example, is N-
glycosylation of specific proteins modulated in the gfat-1 gof mutants, and is this 
essential for the lifespan extension? Additionally, there is a chance that UDP-GlcNAc 
is affecting other metabolic pathways – in this case, which? And lastly, is there cross-
talk between ERAD and autophagy? In the current study, we have primarily focused 
on the degradation pathways, assuming that the GFAT-1 gof-improved protein 
homeostasis is due to increased degradation of mis- and unfolded proteins, preventing 
aggregation and toxicity. There is, however, also the possibility that mis- and 
unfolded proteins are re-folded. We did not observe any expression changes in the 
folding machinery including CNX and HSP-4, but investigating the protein folding 
pathways might be important to understand the exact mechanisms promoting healthy 
life in gfat-1 gof mutants. 
 
9.B.4  SEL-1 overexpression  
Expression of SEL-1 was increased in gfat-1 gof mutants, and further 
investigation showed that sel-1 over expression was sufficient to extend lifespan and 
ameliorate protein homeostasis. Conceivably, sel-1 overexpression leads to increased 
degradation of proteins in the ER, but we also detected enhanced autophagy turnover 
upon sel-1 overexpression. Using confocal and electron microscopy, it would be 
interesting to look at co-localization of ER resident proteins and proteins involved in 
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autophagy. This would shed light upon the correlation between these pathways, and 
give us the opportunity to investigate the possible reticulophagy, which is ER-specific 
autophagy degradation. 
 
9.B.5  Neuronal signalling and protein quality control  
 The work in the Dyf mutants opens new doors to understand how neuronal 
signalling affects distinct cellular tissues. Firstly, it would be interesting to investigate 
the role of the transcription factors, DAF-16 and PHA-4 in the downstream signaling 
events. If DAF-16 is the main regulator of the stress-reponse outputs in the Dyf 
mutants, we would expect similar transcriptional changes in daf-2 mutant animals, as 
observed in the Dyf mutants. We will therefore perform a comprehensive qPCR 
analysis of genes involved in ER stress response pathways in daf-2 mutant animals 
and compare it to the expression patterns obtained from the Dyf mutants. Additional 
links are however still missing, and some of them could presumably be revealed by 
answering the following questions: Are DAF-16 and PHA-4 required for the 
resistance to TM and the alleviated aggregation of SRP-2? Is TOR modulated in the 
Dyf mutants? Is DR sufficient to further extend the Dyf-induced longevity?  
 
9.B.6  The Role of ER Stress Pathways in Mammalian Health and Longevity 
GFAT-1 is highly conserved across various organisms. In fact, at the level of 
amino acid sequence, human GFAT-1 is 85% similar to the worm GFAT-1, and the 
function is presumably the same. It would therefore be interesting to further 
investigate the role of GFAT-1 gof in mammalian and even in human cells, to test 
whether the observed phenotypes found in C. elegans are conserved as well. Very 
preliminary data show that polyglutamine repeats are degraded in the presence of 
GlcNAc in cultured medium. However, more details about the role of hexosamines in 
modulating stress resistance pathways in mammalian cells remain to be determined. 
Glucosamine and GlcNAc have already reached wide acceptance as food 
supplements sold in various drug stores around the world. In the USA glucosamine is 
promoted almost as a panacea, to alleviate inflammation, chronic intestinal diseases, 
cancer, diabetes, lung diseases and even as a skin lightening agent. Whether GlcNAc 
or glucosamine can be considered as a multifunctional drug is not known. We do, 
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however, provide evidence for its role in protein homeostasis and lifespan extension. I 
present data that support the hypothesis that GlcNAc treatment is sufficient to 
ameliorate proteotoxic diseases by clearing or preventing protein aggregation 
formation in the roundworm C. elegans. Furthermore, our results suggest that several 
protein quality control mechanisms are enhanced upon treatment with GlcNAc, 
presumably playing a role in GlcNAc-induced lifespan extension.  
 We aim to translate these findings into mammalian cellular systems, and in the 
future, propose a clinical trial investigating the therapeautic usage of GlcNAc in 
human patients suffering from neurodegenerative disorders like Alzheimer’s disease. 
If successful, such translational studies would highlight the ability of basic genetic 
investigation in C. elegans to inform mammalian biology and positively impact 
human health and disease. 
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CHAPTER 10. Addenda  
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10.A.  Another gfat-1 gof mutant 
In the previous presented material, and in Denzel, Storm et al., we show that 
GFAT-1 gof extends lifespan and alleviates proteotoxicity of various models of 
neurodegenerative disorders. We demonstrate 3 independent alleles of gfat-1, all 
resulting in gof of the gene, and all extending lifespan. We did however identify an 
additional allele of gfat-1 (gfat-1(dh844)). The lifespan of gfat-1(dh844) was also 
remarkable extended (gfat-1(dh844) median lifespan 26 days, P<0.0001).  	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10.B.  Additional results 
From our results, we hypothesize that GFAT-1 gof extends lifespan through elevated 
levels of UDP-GlcNAc that are used as precursors for N-glycans. This would suggest 
a mechanism where N-glycosylation is increased, and in this way either improve the 
folding or re-folding of proteins in the ER. To test this, we knocked down 
components of the OST (oligosaccharyltransferase) complex, which carries out the N-
glycosylation of proteins. When we knock down components of this complex by 
RNAi in adulthood, the long-lived gfat-1 gof mutants lost their lifespan extension. 
Furthermore, the lowered levels of SRP-2 aggregation (presumably as a consequence 
of enhanced ERAD function) were rescued when components of the OST complex 
were knocked down (Figure 4.3). 
Interestingly, we observed that RNAi against ostb-1 did not change the level of 
SRP-2 aggregates. We repeated the experiment, and did again not see any changes. 
This can of course be due to a defective RNAi bacteria clone, and we will test if this 
is so. However, it could also open an interesting part and possible noven function of 
the C. elegans OST complex.  
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10.C.  A hexosamine pathway independent increase of UDP-GlcNAc? 
An additional interesting mutant from our screen is dh798. dh798 has several 
mutations in the genome, and they seem to be concentrated on chromosome III and X 
(see table). The dh798 mutant animals were long-lived (see lifespan curve, pink) and 
non-Dyf.  
 
  
 
 
In addition, they are not obviously associated with the hexosamine pathway 
(genetic mutations are shown in the two tables). Among the mutations identified in 
dh798, we found a genetic mutation in C56G2.1b, which encodes a protein called 
AKAP-1 (A-kinase anchor protein). A mutation in this gene was additionally detected 
in dh846 mutant animals, increasing the likelihood that this mutation causes the 
observed phenotypes. dh846 is also long-lived (see lifespan curve, yellow). We 
ordered a mutant that has a lof mutation in C56G2.1b and analyzed the lifespan. 
Interestingly, this mutant was long-lived (right lifespan curve, green), suggesting that 
C56G2.1b plays a role in longevity. 
 
Chromosome Location 
Referen
ce Base 
Sample 
Base 
Variant 
Type Classes Description 
III 785763 G A point 
three_prim
e_UTR none 
III 4640495 A G point missense 
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X 9463969 T G point missense 
GAT->GAG[Asp-
>Glu] 
IV 10112497 X X indel SNP none 
X 16461402 T G point ncRNA none 
X 17441958 X X indel nongenic -10349 upstream 
 
This table (upper) shows the genetic mutations in dh798 compared to WT 
animals. The lower table shows the parental features, and contains a description of 
what the mutated gene is encoding, when available.  
 
Parent Features Possible protein 
{F42G9.1a} Protein Phosphatase, Mg2+/Mn2+ dependent 
{F10F2.5} C-type LECtin 
{W03F8.3} 
T23B5.4 Isoform 1 of Probable peptide chain release factor C12orf65, 
mitochondrial 
{B0244.11},{B0244.2} phogrin 
{F25B5.1a},{F25B5.1b} DAF-16/FOXO Controlled, germline Tumor affecting 
{T07H6.4} 
lev-9 encodes a novel extracellular protein; lev-9 was identified in 
screens for mutants that are resistant to the anthelmintic levamisole; lev-9 
mutations result in weak levamisole resistance with respect to 
locomotion, but strong resistance with respect to egg laying. 
{C56G2.1b} AKAP-1 
{ZK899.6} UN 
{uCE4-1092}  
{F38E9.t2} UN 
{C36E6.2} Isoform 1 of Uncharacterized protein C6orf106 (phosphoserine domain) 
 
We do, however, not have further evidence that these mutants are associated, 
and we additionally, do not have further evidence that the mutations in C56G2.1b 
make the animals resistant to TM and make them long-lived.  
We are currently analyzing the sequences of these mutants again, to look for other 
mutations, as we observed an increased level of UDP-GlcNAc in the dh798 mutant 
animals. From our first analysis, these mutants have no hits in the hexosamine 
pathway, so we were surprised to detect an enhanced level of UDP-GlcNAc. The 
mechanisms and further correlations are however still unknown.  
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 10.D.  Lifespan table 
This table contains all lifespan experiments conducted with relation to the paper 
“Hexosamine pathway metabolites enhance protein quality control and prolong life”.  
Strain 
Treat-
ment 
(RNAi) 
Med
ian 
LS 
Differen
ce from 
cntl Animals 
Max 
LS 
Difference 
from cntl P value Reference cntl 
         
N2 (WT)  21  104/150 32    
gfat-1(dh784)  24 14.29% 108/150 38 18.75% <0.0001 vs. N2 
gfat-1(dh785)  24 14.29% 100/150 40 25.00% <0.0001 vs. N2 
         
N2  21  88/150 31    
gfat-1(dh784)  25 19.05% 63/150 41 32.26% <0.0001 vs. N2 
gfat-1(dh785)  23 9.52% 88/150 39 25.81% 0.0004 vs. N2 
         
N2  19  79/150 30    
daf-2(e1368)  30 57.89% 102/150 53 76.67% <0.0001 vs. N2 
gfat-1(dh468)  24 26.32% 94/150 38 26.67% <0.0001 vs. N2 
gfat-1(dh784)  24 26.32% 88/150 42 40.00% <0.0001 vs. N2 
gfat-1(dh785)  21 10.53% 85/150 40 33.33% 0.005 vs. N2 
         
N2  20  82/150 30    
daf-2(e1368)  32 60.00% 79/150 52 73.33% <0.0001 vs. N2 
gfat-1(dh468)  24 20.00% 104/150 34 13.33% 0.00016 vs. N2 
gfat-1(dh784)  25 25.00% 110/150 36 20.00% <0.0001 vs. N2 
gfat-1(dh785)  23 15.00% 89/150 34 13.33% 0.0017 vs. N2 
         
N2  20  103/150 26    
gfat-1(dh468)  22 10.00% 98/150 34 30.77% 0.0042 vs. N2 
gfat-1(dh784)  24 20.00% 88/150 36 38.46% 0.0003 vs. N2 
gfat-1(dh785)  24 20.00% 101/150 30 15.38% 0.0051 vs. N2 
         
N2  19  104/150 31    
ogt-1  17 -10.53% 67/150 33 6.45% ns vs. N2 
gfat-1(dh468)  23 21.05% 85/150 39 25.81% 0.0005 vs. N2 
daf-2(e1368)  29 52.63% 88/150 51 64.52% <0.0001 vs. N2 
         
N2  21  90/150 38    
gfat-1(dh468)  30 42.86% 49/150 41 7.89% <0.0001 vs. N2 
daf-2(e1368)  37 76.19% 55/150 61 60.53% <0.0001 vs. N2 
         
N2  20  95/150 32    
gfat-1(dh468)  28 40.00% 74/150 46 43.75% <0.0001 vs. N2 
         
N2  21  103/150 29    
gfat-1(dh468)  27 28.57% 87/150 37 27.59% <0.0001 vs. N2 
daf-2(e1368)  34 61.90% 64/150 51 75.86% <0.0001 vs. N2 
daf-16(mgDf50)  17 -19.05% 91/150 27 -6.90% <0.0001 vs. N2 
ogt-1(ok430)  23 9.52% 72/150 27 -6.90% ns  
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dh468;daf-2  40 90.48% 63/150 53 82.76% 0.00042 vs. daf-2(e1368) 
dh468;daf-16  22 4.76% 67/150 31 6.90% <0.0001 vs. daf-16(mgDf50) 
dh468;ogt-1  25 19.05% 81/150 39 34.48% 0.0056 vs. ogt-1 
 
         
N2  19  98/150 33    
gfat-1(dh468)  28 47.37% 91/151 42 27.27% <0.0001 vs. N2 
         
N2  20  37/150 33    
gfat-1(dh468)  27 35.00% 30/150 39 18.18% 0.0001 vs. N2 
daf-2(e1368)  31 55.00% 54/150 46 39.39% P<0.0001 vs. N2 
daf-16(mgDf50)  15 -25.00% 63/150 22 -33.33% P<0.0001 vs. N2 
ogt-1(ok430)  20 0.00% 66/150 29 -12.12% 0.2827 vs. N2 
oga-1(ok1207)  23 13.04% 71/150 31 -6.06 P<0.05 vs. N2 
dh468;daf-2  35 75.00% 55/150 46 39.39% 0.0042 vs. daf-2(e1368) 
dh468;daf-16  20 0.00% 72/150 29 -12.12% <0.0001 vs. daf-16(mgDf50) 
dh468;ogt-1  22 10.00% 78/150 31 -6.06% 0.0074 vs. ogt-1(ok430) 
dh468;oga-1  23 0.00% 83/150 31 0.00% ns vs. oga-1(ok1207) 
         
N2  21  110/122 32    
daf-2(e1368)  32 52.38% 107/120 46 43.75% <0.0001 vs. N2 
gfat-1(dh784)  23 9.52% 113/121 29 -9.38% <0.0001 vs. N2 
gfat-1(dh785)  23 9.52% 113/108 32 0.00% 0.0709 vs. N2 
         
N2  21  96/152 33    
gfat-1(dh468)  23 9.52% 94/143 33 0.00% 0.4014 vs. N2 
daf-2(e1368)  31 47.62% 84/141 49 48.48% <0.0001 vs. N2 
         
N2 live OP50  21  84/152 31    
N2 10 mM D-Arg   24  79/144 32    
N2 0 mM GlcNAc  24 0.00% 69/150 33 3.13% 0.5264 vs. N2 D-Arg 10 mM 
N2 0.2 mM GlcNAc  27 12.50% 91/150 32 0.00% 0.0243 vs. N2 D-Arg 10 mM 
N2 1 mM GlcNAc  31 29.17% 85/151 39 21.88% <0.0001 vs. N2 D-Arg 10 mM 
N2 5 mM GlcNAc  29 20.83% 112/150 32 0.00% 0.0007 vs. N2 D-Arg 10 mM 
N2 10 mM GlcNAc  31 29.17% 89/150 38 18.75% <0.0001 vs. N2 D-Arg 10 mM 
N2 25 mM GlcNAc  26 8.33% 78/148 32 0.00% 0.0411 vs. N2 D-Arg 10 mM 
         
N2 live OP50  20  91/168 30    
N2 10 mM D-Arg   28  16/106 33    
N2 0.2 mM GlcNAc  30 7.14% 22/101 37 12.12% 0.1995 vs. N2 D-Arg 10 mM 
N2 1 mM GlcNAc  30 7.14% 20/139 35 6.06% 0.0237 vs. N2 D-Arg 10 mM 
N2 5 mM GlcNAc  29 3.57% 29/126 45 36.36% 0.0252 vs. N2 D-Arg 10 mM 
N2 10 mM GlcNAc  33 17.86% 27/143 40 21.21% 0.0002 vs. N2 D-Arg 10 mM 
N2 25 mM GlcNAc  27 -3.57% 23/124 44 33.33% 0.4141 vs. N2 D-Arg 10 mM 
         
N2 live OP50  18  59/150 27    
N2 10 mM D-Arg  18  52/150 27    
N2 0 mM GlcNAc  20 11.11% 64/150 27 0.00% 0.5243 vs. N2 D-Arg 10 mM 
N2 1 mM GlcNAc  25 38.89% 30/150 32 18.52% 0.0000 vs. N2 D-Arg 10 mM 
N2 5 mM GlcNAc  25 38.89% 34/150 36 33.33% 0.0000 vs. N2 D-Arg 10 mM 
N2 10 mM GlcNAc  27 50.00% 30/150 36 33.33% 0.0000 vs. N2 D-Arg 10 mM 
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Pgfat-1::cfp  26  92/138 37    
Pgfat-1::gfat-1::cfp  28 7.69% 65/122 39 5.41% 0.0008 vs. Pgfat::CFP 
         
Pgfat-1::cfp  21  97/119 34    
Pgfat-1::gfat-1::cfp  30 42.86% 71/94 40 17.65% <0.0001 vs. Pgfat::CFP 
         
Pgfat-1::cfp  23  63/72 32    
Pgfat-1::gfat-1::cfp  27 17.39% 53/75 36 12.50% <0.0001 vs. Pgfat::CFP 
         
N2 L4440 17  107/150 32    
N2 atg-1 19 11.76% 117/150 31 -3.13% 0.7721 vs. N2 
N2 atg-18 19 11.76% 49/90 31 -3.13% 0.7496 vs. N2 
gfat-1(dh468) L4440 26 52.94% 67/180 38 18.75% <0.0001 vs. N2 
gfat-1(dh468) atg-1 26 0.00% 97/150 34 -10.53% 0.0986 vs. gfat-1(dh468) 
gfat-1(dh468) atg-18 22 -15.38% 103/150 34 -10.53% <0.0001 vs. gfat-1(dh468) 
         
N2 L4440 20  75/86 33    
N2 sel-1 23 15.00% 68/77 31 -6.06% 0.9525 vs. N2 (L4440) 
N2 sel-11 23 15.00% 46/54 29 -6.45% 0.9656 vs. N2 (L4440) 
N2 rpn-6 16 -20.00% 82/86 23 -20.69% <0.0001 vs. N2 (L4440) 
N2 rpn-8 17 -15.00% 69/83 33 43.48% 0.0006 vs. N2 (L4440) 
N2 pek-1 23 15.00% 56/85 33 0.00% 0.1328 vs. N2 (L4440) 
N2 atf-6 20 0.00% 58/70 31 -6.06% 0.6697 vs. N2 (L4440) 
N2 ire-1 23 15.00% 63/78 31 0.00% 0.2499 vs. N2 (L4440) 
N2 xbp-1 20 0.00% 68/77 31 0.00% 0.9325 vs. N2 (L4440) 
gfat-1(dh468) L4440 25 25.00% 52/87 37 19.35% <0.0001 vs. N2 (L4440) 
gfat-1(dh468) sel-1 23 -8.00% 58/70 33 -10.81% <0.0001 vs. dh468 (L4440) 
gfat-1(dh468) sel-11 23 -8.00% 47/76 31 -16.22% 0.0011 vs. dh468 (L4440) 
gfat-1(dh468) rpn-6 16 -36.00% 80/80 23 -37.84% <0.0001 vs. dh468 (L4440) 
gfat-1(dh468) rpn-8 17 -32.00% 77/95 35 -5.41% 0.0415 vs. dh468 (L4440) 
gfat-1(dh468) pek-1 25 0.00% 59/70 37 0.00% 0.2592 vs. dh468 (L4440) 
gfat-1(dh468) atf-6 25 0.00% 58/72 39 5.41% 0.7259 vs. dh468 (L4440) 
gfat-1(dh468) ire-1 20 -20.00% 48/59 31 -16.22% 0.003 vs. dh468 (L4440) 
gfat-1(dh468) xbp-1 20 -20.00% 56/80 31 -16.22% 0.001 vs. dh468 (L4440) 
         
N2 gfp 24  43/87 31    
N2 sel-1 22 -8.33% 32/66 29 -6.45% 0.9325 vs. N2 (gfp) 
N2 sel-11 24 0.00% 29/87 29 -12.12% 0.8705 vs. N2 (gfp) 
N2 dad-1 24 0.00% 26/76 33 0.00% 0.0559 vs. N2 (gfp) 
N2 ribo-1 24 0.00% 37/87 35 6.06% 0.1522 vs. N2 (gfp) 
N2 ZK686.3 26 8.33% 37/107 31 -6.06% 0.0088 vs. N2 (gfp) 
N2 ostb-1 24 0.00% 32/86 33 0.00% 0.2433 vs. N2 (gfp) 
N2 ire-1 22 -8.33% 30/92 31 -6.06% 0.3529 vs. N2 (gfp) 
N2 xbp-1 22 -8.33% 31/79 35 6.06% 0.6335 vs. N2 (gfp) 
gfat-1(dh468) gfp 29 20.83% 33/89 39 25.81% <0.0001 vs. N2 (gfp) 
gfat-1(dh468) sel-1 22 -24.14% 36/85 29 -25.64% 0.0007 vs. dh468 (gfp) 
gfat-1(dh468) sel-11 24 -17.24% 29/81 31 -20.51% 0.0019 vs. dh468 (gfp) 
gfat-1(dh468) dad-1 26 -10.34% 30/74 35 -10.26% 0.0156 vs. dh468 (gfp) 
gfat-1(dh468) ribo-1 24 -17.24% 29/68 33 -15.38% 0.0013 vs. dh468 (gfp) 
gfat-1(dh468) ZK686.3 26 -10.34% 36/92 35 -10.26% 0.0279 vs. dh468 (gfp) 
gfat-1(dh468) ostb-1 24 -17.24% 19/58 29 -25.64% 0.002 vs. dh468 (gfp) 
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gfat-1(dh468) ire-1 24 -17.24% 33/85 33 -15.38% 0.0048 vs. dh468 (gfp) 
gfat-1(dh468) xbp-1 22 -24.14% 33/81 31 -20.51% 0.0001 vs. dh468 (gfp) 
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10.E.  Selected sequencing files 
Sequencing file showing mutant variations for the dh468 mutants presented in the 
previous (gfat-1 mutation is highlighted with bolded font). 
 
Chrom
osome Location 
Reference 
Base 
Sample 
Base 
Variant 
Type Classes Description  
II 3902182 A G point missense 
AGT->GGT[Ser-
>Gly] {F53C3.4} 
II 4181214 C T point missense 
CTT->TTT[Leu-
>Phe] {R03H10.1} 
II 4870234 C T point missense 
GAG->AAG[Glu-
>Lys] {F11G11.11} 
II 6559526 A T point 
three_pri
me_UTR none {F18C5.10.1} 
II 9260428 C T point missense 
GGA->GAA[Gly-
>Glu] 
{C01G6.1a.1,C
01G6.1a.2,C01
G6.1b.1,C01G6.
1b.2} 
II 10714155 C T point missense 
GAA->AAA[Glu-
>Lys] {C09G5.2} 
II 11594909 C T point missense 
GAA-
>AAA[Glu->Lys] 
{F07A11.2a,F0
7A11.2b.1,F07
A11.2b.2,F07A
11.2b.3} 
II 14286245 C T point missense 
GCT->ACT[Ala-
>Thr] {Y54G11A.12} 
II 14474753 C T point ncRNA none {C13B4.t1} 
III 5467696 T C point 
three_pri
me_UTR none {F48E8.2} 
X 391641 G A point missense 
GCC->GTC[Ala-
>Val] {R04A9.7} 
X 5289823 G A point 
three_pri
me_UTR none {F32A6.4a} 
X 5897509 G A point missense 
GAT->AAT[Asp-
>Asn] {F49E10.1} 
X 6598276 G A point missense 
CCG->TCG[Pro-
>Ser] 
{T28B4.4.1,T28
B4.4.2} 
X 7113751 G A point missense 
TGC->TAC[Cys-
>Tyr] {C36B7.1} 
X 8895158 G A point missense 
GCT->ACT[Ala-
>Thr] {C13E3.1} 
X 13083431 G A point missense 
GGA->AGA[Gly-
>Arg] {R03G8.5} 
X 16855333 G A point missense 
CAC->TAC[His-
>Tyr] {T20F7.5} 
X 16878162 G A point 
missense,
three_pri
me_UTR 
TCT->TTT[Ser-
>Phe],none 
{T20F7.7},{T2
0F7.1} 
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 10.F.  Pile-up table 
Table showing possible hits and selected mutations in other TM resistant mutants 
from the screen.  
Mutant Institution DiI 
Premature Stop 
Mutations Other hits Comments 
dh428 CCG Dyf  che-3 - missense in pos. 8062111  
dh467 CCG Dyf  dyf-2 - 5'UTR in pos. 13686249  
dh431 CCG Dyf dyf-2 - pos. 13676150   
dh435 CCG Dyf 
tat-6 - pos. 3131801, 
crp-1 - pos. 10480295 
srv-6 - pos. 4258064 (also a hit in 
dh454) 
crp-1 (RB855) was 
ordered at CGC, and 
was tunicamycin 
resistant first time, and 
sensitive the second. 
dh468 CCG Filling  
GFAT (F07A11.2) - confirmed 
by LC/MS  
dh438 CCG Dyf  
nhr-214 - missense in pos. 
12701758 
nhr-214 (VC1356) was 
ordered at CGC. But 
was NOT resistant to 
TM 
dh440 CCG Dyf  No mutations that pile with any  
dh441 CCG Dyf 
Y76B12C.6 - pos. 
1990628, osm-3 - pos. 
3796925 osm-3 - pos. 3796925  
dh442 CCG Dyf  che-3 - missense in pos. 8072943  
dh443 CCG Dyf 
glh-2 - pos. 6514897, 
ZK858.8 - pos. 9125432 
C13E3.1 - missense in pos. 16333 
(also hit in 468), nhr-214 - 
missense in pos. 12701753 
glh-2 (KB2) will be 
ordered 
dh447 CCG Dyf 
srz-43 - pos. 15636436, 
F14D7.6 - pos. 
14305952 
rbc-1 (F54E4.1b) - nrRNA in pos. 
14617426 (also hit in dh461)  
dh448 CCG Dyf  No mutations that pile with any  
dh461 CCG Dyf  
rbc-1 - indel insertion in pos. 
14614978 (also a hit in dh447)  
dh449 CCG Dyf  dyf-2 5'UTR in pos. 13679167  
dh451 CCG Dyf  No mutations that pile with any  
dh454 CCG Dyf  
srv-6 - pos. 4258255 (also a hit in 
dh435)  
dh456 CCG Dyf dyf-17 - pos. 19129038 
egl-30 (M01D7.7b) 5'UTR in pos. 
1837821 (also a hit in dh443)  
dh457 CCG Dyf  
dyf-2 - missense in pos. 
13679167  
      
dh784 CCG Filling  
GFAT (F07A11.2) - confirmed 
by LC/MS  
dh785 CCG Filling  
GFAT (F07A11.2) - confirmed 
by LC/MS  
dh786 CCG Filling 
vit-2 - pos. 5104020, 
K01B6.3 - pos. 9303527 vit-2 - pos. 5104020 
Strain is requested 
from Carmen 
dh799 CCG Filling    
dh798 CCG Filling  
Has a hit in C56G2.1 (6362931) - 
also a hit in dh846 (6363870)  
      
dh844 MPIZ Filling 
exp-1 - pos. 6157373, 
T15D6.10 - pos. 
12395126, cho-1 - pos. 
13213269 
GFAT (F07A11.2) - pos. 
11592503 
exp-1 (3 strains 
available) and cho-1 
strains are ordered 
dh846 MPIZ Filling  
Has a hit in C56G2.1 (6363870) - 
also a hit in dh798 (6362931)  
dh848 MPIZ Filling  
Y69A2AR.14 - pos. 2555780 
(also a hit in dh856)  
dh856 MPIZ Filling  
Y69A2AR.14 - pos. 2555862 
(also a hit in dh848)  
dh861 MPIZ Filling 
che-3 - pos. 8072875 - 
FILLS (05.05.12) 
Has a couple of interesting hits; 
elo-6, cdh-12, sri-40 and a couple 
of unc's 
elo-6 and cdh-12 
strains are ordered 
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dh852 MPIZ Filling    
dh820 MPIZ Filling    
dh824 MPIZ Filling    
dh825 MPIZ Filling  
D1046.5 - pos. 8957612, TPRA-1 
(human TRansmembrane Protein, 
Adipocyte associated 1) ortholog  
dh783 MPIZ Filling    
dh802 MPIZ Filling  
C23F12.2 - completely unknown; 
nothing available or known 
It encodes a putative 
diacylglycerol kinase 
dh867    
Has a hit in F08B1.1a, which was 
also a hit in 301A (dh844) 
F08B1.1a is vhp-1, 
which is a MAP kinase 
phosphatase that is 
known to be resistant 
to pathogens when 
knocked down 
dh868 MPIZ Filling  
Has 2 independent hits in 
C56G2.5  
dh860 MPIZ Filling  
Has a hit in K04B12.1 that was 
also a hit in 327G 
the gene is called plx-2 
and is one of two C. 
elegans plexins, 
conserved 
transmembrane 
proteins that function 
as semaphorin 
receptors 	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10.G.  Hexosamine Pathway Metabolites enhance Protein Quality 
Control and Prolong Life 
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10.H.  Dietary Restriction Induced Longevity Is Mediated by Nuclear 
Receptor NHR-62 in Caenorhabditis elegans 
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10.I. Dissertation work contributions  
 
Figure 1.1 The total number of both men and women over 65 is increasing. 
Figure 1.2 The endoplasmic reticulum (ER). NS 
Figure 1.3 The ER Unfolded protein response pathways. NS 
Figure 1.4 Induction of autophagy. NS 
Figure 1.5 The autophagy genes. NS 
Figure 3.1 A developmental TM resistance screen. A. NS B. NS + MD C. NS + MD 
Figure 3.2 Mutations in gfat-1 result in resistance to TM. A. NS + MD B. MD C. NS 
+ MD 
Figure 3.3 Knockdown of gfat-1 causes TM sensitivity in gfat-1 mutants. MD 
Figure 3.4 gfat-1 gof mutations lead to resistance to TM. MD 
Figure 4.1 gfat-1 gof mutants show less induction of ER stress responses. MD 
Figure 4.2 Enhanced hexosamine pathway flux extends lifespan. NS 
Figure 4.3 gfat-1 gof mutants are long-lived, independent of the DAF-2/DAF-16 
longevity pathway. A, B, C. MD D, E, F. NS 
Figure 4.4 Enhanced hexosamine pathway flux alleviates SRP-2H302R aggregation in 
the ER. NS 
Figure 4.5 GFAT-1 gof improves SRP-2H302R aggregation without affecting overall 
SRP expression. A. NS B, C. MD 
Figure 4.6 GFAT-1 gof improves ER functions in a post-translational manner. A, B. 
NS + MD C, D. MD 
Figure 4.7 Improved ER functions in gfat-1 gof mutants are dependent on ER-UPR 
and N-glycosylation components. NS 
Figure 4.8 Enhanced flux through the hexosamine pathway increases the expression 
of SEL-1. AG 
Figure 4.9 ERAD is required for GFAT-1 gof-induced longevity. NS 
Figure 4.10 Increased the hexosamine pathway metabolites improve protein 
degradation by the proteasome. A. NS + MD B, C, D. MD 
Figure 4.11 GFAT-1 gof enhances the level of autophagy. A. NS B. MD C. NS  
Figure 4.12 GlcNAc induces autophagic degradation. A. NS B. MD C, D. NS 
Figure 4.13 gfat-1 gof mutants are dependent on autophagy to remain protected 
against SRP-2H302R aggregation and to sustain longevity. NS 
Figure 4.14 GFAT-1 gof-induced autophagy increase is dependent on Nglycosylation 
components and ERAD. NS 
Figure 4.15 GFAT-1 gof alleviates proteotoxicity. A, B. NS C, D. MD 
Figure 4.16 GFAT-1 gof alleviates proteotoxicity in manner dependent on autophagy 
and ERAD. NS 
Supplemental Figure 4.1 Additional Characterization of the gfat-1 gof mutants. A. 
MD B, C, D, E, F. NS 
Figure 5.1 sel-1 over expression is sufficient to extend lifespan and enhance 
Autophagy. A, B. NS C, D. MD 
Figure 5.2 sel-1 over expression is sufficient to alleviate proteotoxicity. NS 
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Figure 6.1 C. elegans sensory system. NS 
Figure 6.2 Dyf mutants are protected against TM induced ER stress. NS 
Figure 6.3 Dyf mutants have improved protein aggregation conditions. NS 
Figure 7.1 Natural variations in C. elegans animals found in the nature result in ER 
stress resistance. NS 
Figure 8.1 NHR-62-induced C40H1.8 expression is required for autophagy under DR. 
NS 
 
NS, Nadia Storm 
MD, Martin Denzel 
AG, Aljona Gutschmidt 
 
LC/MS experiments were performed in collaboration with Yvonne Hinze, qPCR 
experiments were performed by Ruth Baddi, survival assays were confirmed by Ruth 
Baddi, figure 6.1, 6.2 and 6.3 were assisted by Rebecca Osterauer. 
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